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RESUMEN 
 
 
 
 
Resumen 
 
 
Diversos estudios sugieren que la respuesta a los desafíos metabólicos es 
diferente entre machos y hembras. Como consecuencia de un aumento en el 
consumo de calorías, se producen diferencias en la ganancia de peso, así como 
en el aumento y distribución de tejido adiposo, pero, además, la respuesta al 
sobrepeso y obesidad es diferente entre los sexos. Sin embargo, aunque se sabe 
que las alteraciones nutricionales tempranas pueden tener efectos a largo plazo 
en el metabolismo, las diferentes respuestas entre los sexos son 
insuficientemente conocidas hasta la fecha. Junto a ello, estudios recientes 
indican que los astrocitos hipotalámicos están implicados en el control 
neuroendocrino del metabolismo, así como en el desarrollo de las 
complicaciones secundarias asociadas a la obesidad. No obstante, se desconoce 
en gran medida si los astrocitos hipotalámicos de machos y hembras responden 
de manera diferente a los desafíos metabólicos. 
El objetivo de esta Tesis fue determinar si la sobrenutrición neonatal como 
resultado de una reducción en el número de crías por madre durante el período 
de lactancia, produce efectos similares en el crecimiento y metabolismo de ratas 
macho y hembra a lo largo del desarrollo. Es bien sabido que los esteroides 
sexuales desempeñan una función crítica en las diferencias post-puberales entre 
machos y hembras en su metabolismo y distribución y función del tejido adiposo. 
No obstante, los efectos metabólicos de las variaciones en los esteroides sexuales 
durante la etapa neonatal deben ser estudiados en mayor profundidad. Por esta 
razón, empleamos también un modelo de androgenización neonatal en hembras 
para determinar sus efectos a corto y largo plazo en el metabolismo. Igualmente, 
la respuesta hipotalámica y, concretamente de los astrocitos hipotalámicos a la 
sobrenutrición neonatal, fue estudiada en ambos sexos. 
Por tanto, en el estudio de sobrenutrición neonatal en machos y hembras, 
se analizó el perfil metabólico, las respuestas inflamatorias y distribución y 
función del tejido adiposo, así como posibles alteraciones en los astrocitos 
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hipotalámicos. Para ahondar en el estudio de las posibles diferencias entre los 
sexos específicamente en los astrocitos hipotalámicos, se estudió la respuesta in 
vitro de estas células gliales a determinados ácidos grasos, así como el posible 
efecto protector de los estrógenos a la inflamación producida por los ácidos 
grasos. 
Los resultados de estos estudios indican la diferente respuesta entre los 
sexos a alteraciones nutricionales en el periodo neonatal, siendo esta respuesta 
diferente también, en función de la edad o etapa del desarrollo en la que se 
encuentran. Asimismo, las modificaciones en los esteroides sexuales en el 
neonato, podrían contribuir a las diferencias metabólicas observadas a largo 
plazo a consecuencia de la sobrenutrición neonatal, así como en los diferentes 
efectos vistos en machos y hembras. Aún más, los astrocitos hipotalámicos 
procedentes de ratas macho y hembra, responden de manera diferente a la 
sobrenutrición neonatal, así como a los tratamientos in vitro con ácidos grasos y 
estrógenos. 
Por consiguiente, los astrocitos hipotalámicos no solamente estarían 
implicados en la fisiología y fisiopatología del control neuroendocrino del 
metabolismo, sino que también podrían estar participando en las respuestas a los 
cambios nutricionales tempranos y en las respuestas sexualmente dimórficas del 
sistema metabólico. 
PALABRAS CLAVE: dimorfismo sexual, sobrenutrición neonatal, desarrollo, 
hipotálamo, astrocitos. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY 
 
 
 
 
Summary 
 
 
The responses to metabolic challenges are suggested to be different in 
males and females. Not only is there a difference in weight gain and adipose tissue 
accumulation and distribution in response to increased energy intake, but the 
secondary complications in response to being overweight or obese also differ 
between the sexes. However, less is known about the differential sex response to 
early nutritional changes that can affect long-term metabolism. In addition, recent 
studies have indicated that hypothalamic astrocytes are involved in the 
neuroendocrine control of metabolism, as well as the development of secondary 
complications in response to obesity. However, whether hypothalamic astrocytes 
from male and female rats respond differently to metabolic challenges remains to 
be thoroughly analyzed. 
The aim of this thesis was to determine if neonatal overnutrition as a 
consequence of the reduction in the number of pups per dam during nursing 
produces similar effects on growth and metabolism in male and female rats 
throughout development. Moreover, although sex steroids are clearly involved in 
the post-pubertal differences between males and females in metabolism and 
adipose tissue distribution and function, less is known regarding the effect of 
changes in the neonatal sex steroid environment on metabolism. Hence, we 
employed a model of neonatal androgenization of females to determine how this 
affected both short-term and long-term metabolism.   
Metabolic profile, inflammatory responses and adipose tissue distribution 
and function, as well as possible alterations in hypothalamic astrocytes were 
analyzed in these studies. To further explore the sex differences in hypothalamic 
astrocytes, the response of these glial cells to fatty acids and the possible 
protective effect of estrogens against fatty acid-induced inflammation were 
analyzed  in vitro employing primary hypothalamic astrocyte cultures.   
The results of these studies indicate that the response to nutritional 
disturbances during the neonatal period differ between the sexes and are age 
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dependent. In addition to changes in insulin and leptin levels, differences in the sex 
steroid environment during the neonatal stage could participate in the distinct 
long-term metabolic responses to neonatal overnutrition and the differential 
effects in males and females. We also demonstrate that hypothalamic astrocytes of 
male and female rats respond differently to neonatal overnutrition, as well as to 
fatty acid and hormonal treatments in vitro.  
Thus, hypothalamic astrocytes are not only involved in the physiological and 
physiopathological neuroendocrine control of metabolism, but they may also 
participate in developmental responses to early nutritional changes and sexually 
dimorphic metabolic responses. 
 
KEY WORDS: sexual dimorphism, neonatal overnutrition, development, 
hypothalamus, astrocytes. 
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1. Obesity and energy balance  
Obesity and overweight are major public health concerns throughout the 
industrialized world as both conditions are risk factors for the development of 
additional diseases such as type 2 diabetes (T2D), cardiovascular diseases or cancer 
(Lustig and Weiss, 2008; Daniels, 2009; Anteneh et al., 2015). Obesity can be defined as 
an abnormal/excessive fat accumulation (Garrow, 1988; Ofei, 2005) that usually leads 
to an increase in total body weight. Body mass index (BMI) is used as a simple 
indirect measurement of obesity. A person’s BMI is calculated as their weight (in 
kilograms) divided by the square of his or her height (in meters). When the BMI is 
30 or higher, a person is considered to be obese (WHO, 1995).  
It is well accepted that the accumulation of excessive adiposity is due to an 
imbalance between energy intake and energy expenditure over time (Garrow, 1988), 
although the specific causes of the dramatic rise in this epidemic are still under 
debate. The genetic make-up of each individual, as well as the hormonal and 
nutritional environment and psychosocial factors are all involved in the etiology of 
this metabolic imbalance (Dong et al., 2003; Mendieta-Zeron et al., 2008; Argente, 2011; 
Stein et al., 2011). Therefore, development of obesity in an individual depends on 
their genetic predisposition, environmental factors such as lack of exercise and/or 
poor dietary habits, and the interaction between these factors (Figure 1). 
 
 
 
 
 
 
Figure 1. Overweight and obesity occur due to an imbalance between calorie intake and energy 
expenditure over time, with the genetic make-up of each individual, hormonal and nutritional 
environment, psychosocial factors, stress and circadian rhythms influencing this imbalance. 
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The prevalence of obesity began to increase at an alarming rate at the end 
of the 20th century and continues to rise, with no signs of abating. Indeed, obesity is 
considered to be the most important epidemic of the 21st century, with at least 2.8 
million people dying each year as a result of being overweight or obese, according 
to the World Health Organization (WHO) (WHO, 2015). Obesity affects all ages, 
including children and adolescents, particularly in developing countries (Ogden et al., 
2007; Prevention, 2013). Obesity during infancy is currently one of the most serious 
public health concerns and its rates have doubled over the past 20 years, while in 
adolescents the rate has tripled (Ford et al., 2014). Obese children will likely continue 
to be obese as adults and thus, will have an increased probability of developing 
obesity-associated comorbidities in the future including T2D, cardiovascular 
diseases, insulin resistance syndrome, arthritis, dyslipidemias, infertility or 
psychological disorders among others (Horvath, 2005; Despres, 2007; Gundogan et al., 
2009; Martos-Moreno and Argente, 2011; Gungor, 2014). The dramatic rise in the 
incidence of obesity, in concert with the huge economic impact attributed to its 
associated disorders, makes obesity a primary health concern and emphasizes the 
need for a deeper understanding of its etiology and the identification of new 
targets to fight against this disease. 
2.  Early life nutritional influences on metabolism 
Poor nutrition, the lack of physical activity and the interaction of these two 
factors with an individual’s genetic background, predispose a person to weight 
gain, due to excessive fat accumulation, that finally leads to them being overweight 
and/or obesity. In addition, animal models and human studies have demonstrated 
that early environmental influences, including nutritional factors, can have effects 
on adult metabolic homeostasis (Roseboom et al., 2006; Barker, 2007; Levin, 2008; 
Fuente-Martin et al., 2012b; Spencer, 2012; Liu et al., 2013; Collden et al., 2015; Long et al., 
2015). Thus, not only does a person’s current lifestyle and genetic background make 
them susceptible to becoming obese, but an increased propensity to develop 
obesity can begin in utero or during the early postnatal stages, such as during 
lactation. Indeed, an excessive nutrient supply and rapid weight gain in early life 
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can have long-term effects, even when the individual or animal is exposed to a 
normal diet during postnatal life (Barker, 2007; Levin, 2008; Fuente-Martin et al., 2012b; 
Spencer, 2012; Liu et al., 2013; Collden et al., 2015; Long et al., 2015).  
Maternal health and nutrition during gestation, as well as fetal exposure to 
stress, abnormal levels of hormones and environmental toxins, have all been 
shown to disrupt metabolic homeostasis in later life (Roseboom et al., 2006; Barker, 
2007; Shin et al., 2012; Regnier et al., 2015). For example, maternal obesity and 
diabetes frequently complicate pregnancy (Anna et al., 2008), altering maternal 
metabolism and thus potentially disrupting metabolic homeostasis in the offspring 
(Yu et al., 2013). In rodents, the initial postnatal weeks are critical for the formation 
of hypothalamic neurocircuits, with approximately postnatal day (PND) 20 being 
the end of this critical period for hypothalamic differentiation and development 
(Bouret et al., 2004a; Grayson et al., 2006). In contrast, this sensitive period in humans 
predominantly occurs in utero during the third trimester of gestation (Clancy et al., 
2007).  
Although the majority of studies analyzing the long-term effects of early 
environmental influences on metabolism have been performed in males, here is 
evidence that the metabolic responses to these early disturbances may be different 
in females (Garcia-Caceres et al., 2010; Fuente-Martin et al., 2012c; Mela et al., 2012; 
Reynolds et al., 2015b). In addition, these responses may also be age dependent, for 
example appearing in some occasions only in later adulthood (Habbout et al., 2013; 
Granado et al., 2014).  
Animal studies have illustrated that modification of the litter size in which 
animals are reared can have long term-effects on their metabolic homeostasis. 
Diverse studies show that when the number of pups per dam is reduced, weight 
gain is promoted, while the opposite occurs when the number of pups per dam is 
greatly enlarged during nursing (Frolkis et al., 1993; Plagemann et al., 1999c; Cunha et al., 
2009; Fuente-Martin et al., 2012b; Fuente-Martin et al., 2012c; Kayser et al., 2015). Some 
studies have attributed this weight gain to overfeeding as a result of increased food 
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availability during suckling that engenders increased energy intake (Fiorotto et al., 
1991; Fink et al., 2001; Cunha et al., 2009). The consequences of this increased food 
intake and weight gain are involved in the observed long-term metabolic effects. 
Other factors, such as maternal nurturing, can also participate in the long-term 
effects due to litter size modification (Connor et al., 2012; Reynolds et al., 2014; Segovia 
et al., 2014). In rodents, these early nutritional modifications during nursing are 
taking place precisely when neuronal circuits are developing and the central 
nervous system (CNS) is still maturating. Hence, the perinatal nutritional 
environment could have a decisive influence on the development of neuronal 
circuits involved in energy balance and metabolic homeostasis.  
Under normal physiological conditions, at the same time that hypothalamic 
neurocircuits are maturing, there is a surge in circulating leptin levels in neonatal 
rodents. Leptin levels increase progressively by PND 5, and peak between PND 9 
and PND 10 remaining elevated until approximately day 13 (Ahima et al., 1998; 
Delahaye et al., 2008). This increase in leptin is crucial for the outgrowth of key 
neuronal projections in the hypothalamus. Indeed, either a deficiency or an excess 
in leptin levels during the perinatal period can cause important changes in 
hypothalamic circuits involved in metabolic homeostasis, appetite and food intake 
behavior, possibly predisposing an individual to obesity and metabolic disorders 
later in life (Bouret and Simerly, 2007). Importantly, not only are neurons affected 
during this critical period but also, astrocytes proliferate and expand within the 
brain, with leptin suggested to promote astrogenesis during this early age (Ahima et 
al., 1999; Rottkamp et al., 2015). 
It should be taken into consideration that unlike rodents, the increase in 
leptin in humans takes place in utero, with leptin concentrations increasing 
dramatically in fetal arterial cord blood by the end of gestation, with newborns 
with intrauterine growth retardation reported to have lower leptin levels than 
those with normal growth (Jaquet et al., 1998). Although experiments have shown 
that leptin appears to be secreted preferentially to the maternal side of the 
placenta, there is also secretion to the fetal side (Linnemann et al., 2000; Hoggard et 
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al., 2001). The rat placenta is reported to be permeable to leptin (Smith and Waddell, 
2003). Both human (Masuzaki et al., 1997) and murine (Hoggard et al., 1997) placenta 
express leptin and the leptin receptor (Hoggard et al., 1997; Masuzaki et al., 1997; 
Linnemann et al., 2000), suggesting that this hormone has an important role during 
gestation. In addition, during lactation, leptin can pass from the mother to the 
offspring through the maternal milk (Teixeira et al., 2002).  
Although insulin does not cross the placenta or in very low amounts, glucose 
from the mother does, and this glucose acts on the fetal pancreas to stimulate 
insulin secretion (Buse et al., 1962; Freinkel et al., 1979). Studies have demonstrated 
that obesity in the mother, produced by gestational diabetes or an inadequate diet, 
is associated with hyperinsulinemia, hyperleptinemia, hyperphagia and increased 
adiposity in the offspring (Catalano et al., 2003; Harvey et al., 2007; Samuelsson et al., 
2008; Nivoit et al., 2009). Thus, the long-term effects on the offspring’s metabolism 
may occur not only through modifications in leptin, but also insulin levels, as this 
hormone also influences hypothalamic development (Vogt et al., 2014).  
A well-known and important example of the dramatic influence of early 
nutritional factors on human offspring is what occurred during the Second World 
War, when pregnant women suffered from famine. The offspring were affected in 
different ways depending on which trimester of gestation the mother suffered 
starvation. Several studies have illustrated that the offspring from mothers affected 
during the first trimester of pregnancy, had a higher risk for the development of a 
wider spectrum of metabolic diseases than babies born from mothers affected 
either in the second or third trimester of pregnancy. However, the offspring from 
mothers experiencing starvation during the second or third trimester had a higher 
risk to develop metabolic diseases than a baby born from a healthy mother (Kyle 
and Pichard, 2006; Lumey et al., 2011; Roseboom et al., 2011). 
Therefore, nutritional modifications produced during both the intrauterine 
and the perinatal period should be considered as potential risk factors for 
metabolic alterations in the adult. Part of these alterations is most likely due to 
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modifications in hormonal signals at critical moments in the development of 
hypothalamic metabolic circuits. 
3.  Differences between the sexes in obesity and metabolism 
The importance of taking into consideration the differences between males 
and females has been recently highlighted by the National Institutes of Health (NIH) 
in the United States, as the inclusion of both sexes in clinical trials and basic 
research has become mandatory (Clayton and Collins, 2014; Health, 2014). Indeed, 
understanding how physiological processes and the responses to metabolic 
challenges differ between males and females will allow more accurate treatments 
according to sex.  
3.1 Sex differences in the propensity to become obese, adipose tissue 
physiology and the development of secondary complications 
The relation between obesity and associated complications and mortality is 
well established (Gundogan et al., 2009; Martos-Moreno and Argente, 2011). However, 
the link between obesity and its secondary complications has been more 
thoroughly studied in men than in women. Studies indicate that the propensity to 
become obese is different between the sexes and that this is largely owing to the 
direct influence of sex steroids. Indeed, estrogens protect from body weight gain, 
fat mass accumulation and obesity complications (Stubbins et al., 2012; Dakin et al., 
2015). They also have inhibitory effects on appetite and increase energy 
expenditure by increasing the activity of anorexigenic signals and exert the 
opposite effect on orexigenic signals (Tarttelin and Gorski, 1971; Clegg et al., 2006; Clegg 
et al., 2007; Shen et al., 2010; Zhu et al., 2013). Declining androgens levels have also 
been associated with obesity and metabolic disorders such as T2D (Dhindsa et al., 
2010; Grossmann, 2011). Differences between men and women in the propensity to 
become obese also reside in their dissimilarities regarding adipose tissue 
distribution. 
Adipose tissue is an active endocrine organ in constant communication with 
the CNS by releasing numerous adipokines and responding to hormones and 
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neuropeptides from the CNS (Galic et al., 2010; Rosen and Spiegelman, 2014). Expansion 
of fat mass can occur by hypertrophy of the existing adipocytes or by hyperplasia 
due to recruitment of new preadipocytes (Jo et al., 2009). Some studies relate 
hyperplasia with subcutaneous adipose tissue (SCAT) and hypertrophy with visceral 
adipose tissue (VAT) (Wang et al., 2013). An increase in the size of adipocytes is 
associated with higher metabolic risk (Lundgren et al., 2007). Estrogens are suggested 
to favor hyperplasia, increasing adipocyte progenitor cells and facilitating vascular 
supply to adipose tissue (Gealekman et al., 2011; Kim et al., 2014b). 
Males and females differ not only as to the amount and distribution of 
adipose tissue (Kotani et al., 1994), but also with regard to adipose tissue metabolism 
and function (Havel et al., 1996; Tran et al., 2008; Macotela et al., 2009). It is clear that 
differences in circulating sex steroids play a critical role in some of the observed 
sexual dimorphisms, but not all metabolic dissimilarities can be explained by 
differences in gonadal hormone levels. Indeed, some sex differences in metabolism 
are present even before puberty (Taylor et al., 2010), although they become more 
evident in adulthood. In addition, as reported by Chen et al, the number of X 
chromosomes also influences adiposity in mice (Chen et al., 2012). 
Unlike males, which reach their maximum levels of fat accumulation at 
puberty, females have a continuous increase in fat mass throughout development, 
with women having higher levels of adiposity compared to men throughout 
lifespan (Gallagher et al., 1996). Females tend to accumulate more SCAT in the gluteal 
and femoral zones, acquiring what is often referred to as the typical pear shape 
(Figure 2). In contrast, males accumulate more visceral (abdominal) adipose tissue 
with the characteristic apple shape distribution (White and Tchoukalova, 2014). It is 
well known that the accumulation of fat mass in the upper zone of the body 
(abdominal fat) is more related to obesity-associated comorbidities such as 
cardiovascular diseases or diabetes; on the contrary, fat mass accumulation in the 
gluteal-femoral region is not and could even be protective (Wajchenberg, 2000; Tran 
et al., 2008; Manolopoulos et al., 2010).  
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Figure 2. Apple-shaped (male) and pear-shaped (female) distribution of adipose tissue. Men tend to 
accumulate fat above the waist, whereas women do so below the waist. 
Different fat mass localization implies different adipose tissue function, 
including variations in regards to adipokine production, insulin sensitivity, 
mitochondrial function, fatty acid release and lipolysis, as well as the inflammatory 
profile (Power and Schulkin, 2008; Macotela et al., 2009). For example, serum levels of 
leptin exhibit a sexual dimorphic pattern in both humans and rodents. Women 
have higher circulating leptin levels than men (Hickey et al., 1996; Argente et al., 1997). 
Inversely, male rodents have higher serum leptin levels compared to female 
rodents (Landt et al., 1998). These differences are not only due to the variations in 
the amount and distribution of adipose tissue, but also to its capacity to produce 
this adipokine. 
The signals that adipose tissue receives from the CNS are also sexually 
dimorphic. Neurons projecting to visceral fat are more numerous in males than in 
females, whereas in females the neurons projecting to subcutaneous fat are more 
abundant than in males (Adler et al., 2012). In addition, female brains appear to be 
more sensitive to the effects of leptin on the regulation of food intake and energy 
expenditure, which is suggested to indicate a tight relationship between leptin and 
estrogens (Clegg et al., 2006). 
MEN 
Apple shape 
More visceral fat 
Higher risk of obesity 
related comorbidities 
WOMEN 
Pear shape 
Less visceral fat 
Lower risk of obesity 
related comorbidities 
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3.2 Sexual dimorphic responses to perinatal changes 
The long-term effects of early nutritional modifications can be sex specific 
(Cheverud et al., 2011; Fuente-Martin et al., 2012b; Sanchez-Garrido et al., 2013). However, 
the majority of the experimental studies analyzing these effects have not been 
performed simultaneously in both sexes. Males and females have metabolically 
different responses not only to early nutritional changes (Sardinha et al., 2006; 
Erhuma et al., 2007; Fuente-Martin et al., 2012b), but also to stressful conditions during 
early life (Bowman et al., 2004; Garcia-Caceres et al., 2010; Mela et al., 2012; Tibu et al., 
2014). Moreover, the sexually dimorphic responses to these early interventions 
often vary according to age (Fuente-Martin et al., 2012b; Mela et al., 2012). Although 
gonadal steroids are clearly responsible for some of the post-pubertal differences 
between males and females (Kanaley et al., 2001; Stubbins et al., 2012; Dakin et al., 
2015), they cannot explain all of these differences, let alone sex differences 
observed in early neonatal life. Males experience a surge in testosterone during 
neonatal life (Miyachi et al., 1973). As alterations in gonadal steroid levels during 
development have been implicated in metabolic disturbances in adulthood (Nohara 
et al., 2013c; Ongaro et al., 2015), it is possible that this event is involved in the 
development of some of the sexually dimorphic characteristics of metabolism.  
Administration of testosterone to neonatal females has been classically used 
as an experimental model to study the mechanisms underlying sexual dimorphism 
in the brain (Raisman and Field, 1973). This experimental model of androgenization 
has also been employed to study the long-term effects of increased neonatal 
androgen levels on the female reproductive axis and the development of polycystic 
ovary syndrome (Dunlap et al., 1972; Gellert et al., 1977; Goomer et al., 1977; Ongaro et 
al., 2015). More recently, this experimental model of neonatal androgenization has 
been used to study metabolic abnormalities in females (Nohara et al., 2013b; Mauvais-
Jarvis, 2014; Ongaro et al., 2015). 
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4. Hypothalamic regulation of energy homeostasis 
Food intake, energy balance and body weight are regulated by the CNS, 
which senses the overall metabolic status through the reception of hormonal and 
nutritional signals. A wide range of circulating peptides from the gut (stomach, 
small intestine and pancreas) and adipose tissue act on the hypothalamus, brain 
stem and afferent autonomic nerves through the vagus nerve and the superior 
cervical ganglion (SCG) to modulate energy metabolism (Halford and Blundell, 2000; 
Ring and Zeltser, 2010). The CNS then integrates these inputs and executes the 
appropriate hunger or satiety signal by releasing orexigenic or anorexigenic 
neuropeptides, respectively.  
Although various brain regions such as the solitary nucleus, the amygdala 
and prefrontal cortex are implicated in metabolic control, the hypothalamus is 
considered the main integration site for the regulation of feeding behavior 
(Schwartz et al., 2000; Horvath, 2005; Abizaid and Horvath, 2008). Hypothalamic 
involvement in the control of food intake was first observed when alterations in 
food intake were produced in animals with hypothalamic lesions (Hetherington and 
Ranson, 1940; Hetherington and Ranson, 1942) and later, in animals with hypothalamic 
tumors (Brobeck, 1946). 
 The hypothalamus is the brain region where peripheral signals, including 
hormones and metabolites such as glucose and fatty acids, converge and are 
integrated to achieve appropriate appetite regulation, with the arcuate nucleus 
being key in this process. This nucleus is located adjacent to the floor of the third 
ventricle and the median eminence, making it more accessible to incoming 
peripheral signals. Lesions of the arcuate nucleus in rats have been shown to 
produce a profound deregulation of appetite that leads to hyperphagia, with some 
of the first demonstrations of this phenomenon occurring over 4 decades ago 
(Olney, 1969; Young et al., 1994).  
The arcuate nucleus contains two of the main populations of neurons 
implicated in the regulation of energy balance (Cone, 2005). From the arcuate 
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nucleus, these neurons send their projections to other hypothalamic nuclei 
involved in food intake regulation, including 
the paraventricular nucleus (PVN), the 
dorsomedial hypothalamus (DMH) and the 
lateral hypothalamic area (LHA) (Elias et al., 
1998b; Elmquist et al., 1998b) (Figure 3).  
These neuronal populations located 
in the arcuate nucleus are known as 
primary order neurons and express 
neuropeptides that exert opposite actions (Figure 4). One neuronal population co-
expresses neuropeptide Y (NPY) and agouti-related protein (AgRP) (Tatemoto et al., 
1982; Hahn et al., 1998), as well as the inhibitory neurotransmitter gamma-
aminobutyric acid (GABA) (Horvath et al., 1997). Both neuropeptides exert a potent 
orexigenic action, which means that their actions will stimulate appetite (Horvath et 
al., 1997). These neurons are activated in deficient energy states, such as during 
fasting or when leptin and insulin levels are below normal, to promote food intake 
and inhibit energy expenditure. On the contrary, high levels of leptin and insulin 
inhibit this neuronal population (Schwartz et al., 2000). 
The other important neuronal population is anorexigenic, inhibiting appetite 
and stimulating energy expenditure, and co-expresses proopiomelanocortin 
(POMC) and cocaine and amphetamine-related transcript (CART). The precursor 
POMC protein is processed to produce α and β melanocyte-stimulating hormone 
(MSH), amongst other peptides (Cone et al., 1996). These melanocortin peptides 
have anorexigenic effects by acting through the melanocortin receptors 3 (MC3-R) 
and 4 (MC4-R). A positive energy balance activates these neurons, in part due to 
the resulting high concentrations of leptin, stimulating melanocortin release and 
subsequently inhibiting food intake and stimulating energy expenditure (Elias et al., 
1998a). These anorexigenic neurons receive innervation from NPY/AgRP neurons, 
with AgRP having antagonistic effects on MC3-R and MC4-R (Fan et al., 1997; Ollmann 
et al., 1997). Thus, AgRP is a potent orexigenic signal not only by directly stimulating 
Figure 3. Hypothalamic nuclei 
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food intake, but it also acts indirectly through inhibition of anorexigenic signals at 
melanocortin receptors. Another POMC-derived peptide is β-endorphin (β-EP), 
which has orexigenic effects and also antagonizes the effects of MSH on food 
intake and body weight (Grossman et al., 2003; Dutia et al., 2012; Koch et al., 2015).     
 
Figure 4. NPY and POMC/AgRP neurons in the ARC nucleus of the hypothalamus are first order neurons 
that respond to circulating signals from adipose tissue (e.g., leptin), stomach (e.g., ghrelin) and pancreas 
(e.g., insulin). These neurons release orexigenic (NPY and AgRP) or anorexigenic (CART and the POMC-
derived peptide α-MSH) peptides, which impact on second order neurons in other areas of the 
hypothalamus to regulate food intake and energy homeostasis by stimulating or inhibiting hunger and 
satiety (B). 
 
5. The control of food intake: communication between the periphery 
and central nervous system  
Communication between peripheral signals and the CNS includes a complex 
gut-brain-adipose network in which the interaction and actions of hormones and 
neuropeptides is crucial in the control of metabolic homeostasis and energy 
balance. Peripheral signals coming from diverse organs or tissues and nutrients are 
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integrated by the hypothalamus, where, according to the information received, the 
appropriate signals will be elaborated in order that energy requirements are 
adequately fulfilled. These hormones come from at least three different sites: 
adipocytes, the gastrointestinal (GI) tract and the pancreas. 
5.1 Signals from adipose tissue  
Adipose tissue, once relegated to the category of a passive organ storing 
triglycerides (TG), is now considered to be an active endocrine organ per se (Antuna-
Puente et al., 2008; Coelho et al., 2013). There is a constant dialogue between adipose 
tissue and the CNS (Figure 5), mediated by a variety of adipokines secreted by the 
adipose tissue, which inform the brain about energy stores. Regarding their actions 
in the brain, leptin is the most well studied adipokine (Halaas et al., 1995; Maffei et al., 
1995a). Although CNS actions of other adipokines such as adiponectin, resistin and 
apelin have also been reported (Rajala et al., 2004; Kadowaki et al., 2006; Pope et al., 
2012). Moreover, the brain produces “adipotropins” that act on adipocytes through 
the activation of specific receptors (Schaffler et al., 2006). 
 
 
Figure 5. Adipose tissue and brain communication, showing an active role of adipose tissue in the 
regulation of food intake. 
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5.1.1 Leptin  
In 1994, the cloning and characterization of the Ob gene by Jeffrey Friedman 
and colleagues (Zhang et al., 1994b) resulted in the identification of its protein 
product, leptin (leptos from latin: thin). This discovery was a milestone in the 
understanding of appetite control since leptin is one of the most important signals 
secreted by adipose tissue participating in the regulation of energy homeostasis 
and the pathogenesis of obesity. Leptin is anorexigenic and is secreted almost 
exclusively by adipose tissue, although to a minor extent by the liver, stomach, 
hypothalamus, placenta and ovaries (Hoggard et al., 1997; Bado et al., 1998; Mantzoros, 
1999). Defects in leptin expression in ob/ob mice (Drel et al., 2006), as well as rare 
mutations of the leptin gene in humans leading to leptin deficiency, result in 
profound obesity with affected individuals showing hyperphagia and decreased 
energy expenditure (Farooqi et al., 1999). Leptin replacement in humans has been 
shown to normalize these symptoms (Farooqi et al., 2002). 
Plasma leptin concentrations positively correlate with fat stores and also 
increase with overfeeding and decrease in starvation states (Considine et al., 1996; 
Friedman and Halaas, 1998). However, in addition to food intake and BMI, leptin 
concentrations also vary according to sex, age and circadian rhythms (Argente et al., 
1997; Blum et al., 1997; Mantzoros, 1999). Leptin circulates either free or bound to a 
soluble form of its receptor, Ob-R (Ob-Re). Leptin passes through the blood-brain-
barrier (BBB) by using a saturable transporter system and reaches one of its main 
sites of action, the hypothalamus, where it acts to decrease food intake and 
increase energy expenditure (Frederich et al., 1995a; Houseknecht et al., 1998). 
Specifically, leptin exerts its anorexigenic effects in the arcuate nucleus by 
inhibiting NPY/AgRP neurons and stimulating POMC neurons. (Schwartz et al., 2000; 
Horvath, 2005; Simpson et al., 2009). In 1997, Halaas and colleges showed that intra-
cerebral ventricular (ICV) injection of leptin provoked these effects without 
modifying circulating leptin levels, indicating a central action of leptin (Halaas et al., 
1997). Under normal conditions, there is a tight relationship between circulating 
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leptin levels and its transport into the brain. Thus, fasting states decrease the 
transport of leptin into the brain due to its low levels in blood, while food 
consumption produces both an increase in circulating levels and in the transport of 
leptin across the BBB (Kastin and Pan, 2000).  
5.1.1.1 Leptin’s structure 
Leptin, a 167 amino acid peptide hormone with a molecular weight of 16 
kilodalton (kDa) is encoded by the Ob gene. The human Ob gene is located on 
chromosome 7q31-3 and is composed of three exons separated by two introns (Isse 
et al., 1995). The three-dimensional structure of leptin is organized into four 
antiparallel α-helices connected by two long crossover links and one short loop. 
There is an interchain disulphide bond that is key for the stability and biological 
activity of this hormone (Zhang et al., 1997; Fruhbeck, 2006). Human leptin shares high 
homology with that of other mammals, sharing up to 84% of homology with mouse 
leptin and 83% with rat leptin.  
5.1.1.2 Leptin receptors and signaling 
The leptin receptor, Ob-R, was discovered in 1995 by Tartaglia and 
coworkers and resembles a class 1 cytokine receptor (Tartaglia et al., 1995). While 
the CNS accounts for the majority of leptin’s target sites (Elmquist et al., 1998a; Cohen 
et al., 2001; McMinn et al., 2005; Pan et al., 2008), Ob-R is also expressed in other 
tissues, including pancreatic beta cells, adipose tissue and the testis (Kielar et al., 
1998; Tena-Sempere et al., 2001; Covey et al., 2006). This receptor is encoded by the 
diabetes (db) gene and has at least six-splice variants, denoted Ob-Ra to Ob-Rf. 
These isoforms can be classified into three classes: short, long and secretory 
(Tartaglia et al., 1995).  
Ob-Ra, Ob-Rc, Ob-Rd and Ob-Rf, the short isoforms of the leptin receptor 
lacking the intracellular domain, are involved in the internalization and breakdown 
of leptin (Tartaglia et al., 1995; Uotani et al., 1999). Ob-Ra is the most ubiquitous 
isoform in most tissues and cells (Tartaglia et al., 1995). Ob-Re is the soluble and 
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smallest isoform and is involved in transporting circulating leptin to its membrane 
receptors. 
Ob-Rb, the longest leptin receptor isoform with the longest intracellular C-
terminal domain, has intracellular signal-transducing capabilities. Ob-Rb is highly 
expressed in the hypothalamus (Tartaglia, 1997; Scott et al., 2009) and is 
predominantly responsible for mediating leptin’s metabolic actions in the CNS.  
(Schwartz et al., 2000). Both POMC/CART and NPY/AgRP neurons express Ob-Rb 
(Cheung et al., 1997; Baskin et al., 1999), as do neurons distributed throughout the 
VMH, DMH and LHA that participate in the regulation of feeding (Elmquist et al., 
1998a; Dhillon et al., 2006; Hommel et al., 2006). In addition to neurons, astrocytes also 
express Ob-Rb (Pan et al., 2008; Kim et al., 2014a), suggesting that these cells also 
participate in mediating leptin’s effects on metabolism.  
The amino acid sequences of human and murine leptin receptors also share 
high homology, including 78% identity in the extracellular and 71% in the 
intracellular domains (Chen et al., 1996). While the majority of transcripts encoding 
the short intracellular domain isoforms are found in almost all tissues, the long 
intracellular domain form is less abundant except for in the hypothalamus, where it 
is expressed at high levels (Ghilardi et al., 1996). Similar to leptin deficient humans 
and mice, leptin receptor deficient humans and mutant mice (db/db) display 
hyperphagia and decreased energy expenditure, presenting early onset obesity 
(Chua et al., 1996). 
5.1.1.3 Mechanism of action of leptin 
Leptin binds to Ob-Rb to activate intracellular signaling transduction through 
the Janus Activated Kinases (JAK)/Signal Transducer and Activators of Transcription 
(STAT) pathway. Although this is not the only pathway activated by leptin, it is the 
most studied with regards to food intake control. Leptin binds Ob-Rb causing a 
conformational change and inducing auto-phosphorylation and activation of JAK 
family proteins, in particular JAK-2 tyrosine kinase, which in turn produces 
phosphorylation of STAT family proteins (Figure 6) (Vaisse et al., 1996; Banks et al., 
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2000), which have two important phosphorylation sites. First, STAT-3 is 
phosphorylated on tyrosine-705 (Tyr705), which causes dimerization, translocation 
to the nucleus and DNA binding (Guschin et al., 1995). Then, a second 
phosphorylation takes place at serine-727 (Ser727). Whereas Tyr705 
phosphorylation is mediated by Janus kinases, Ser727 activation may be mediated 
by several kinases and has a role in transcriptional activation (Zhang et al., 1998; 
Decker and Kovarik, 2000). This signaling cascade results in the activation of the key 
genes involved in mediating leptin’s actions (Ghilardi et al., 1996; Harvey and Ashford, 
2003; Allison and Myers, 2014). The phosphorylation of the STAT family proteins also 
induces the expression of genes such as suppressor of cytokine signaling 3 (SOCS3), 
which mediates feedback inhibition of the leptin pathway (Bjorbaek et al., 1998). Of 
note, leptin suppresses AMP-protein kinase (AMPK) stimulating food intake 
(Minokoshi et al., 2004). 
 
 
 
 
 
 
 
 
 
 
Figure 6. Simplification of the leptin signaling pathway. Leptin is secreted by adipose tissue to the 
bloodsteam postpandrially. Leptin binds to Ob-Rb to activate JAK2 and then STAT3, which translocates 
to the nucleus to activate the expression of the key genes involved in leptin’s satiety effects. STAT3 also 
induces the expression of SOCS3 that has an inhibitory effect on JAK2, suppressing leptin’s actions. The 
leptin pathway converges with the insulin intracellular signaling pathway at the level of PI3K activation.  
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5.1.1.4 Leptin’s functions 
As stated above, leptin is an anorectic hormone secreted to the bloodstream 
accordingly to the amount of stored adipose tissue an individual has (Frederich et al., 
1995a; Argente et al., 1997). Although leptin has been used as an efficient treatment 
in obese leptin deficient patients to reduce the amount of adipose tissue (Farooqi et 
al., 2002; Mantzoros et al., 2011), high leptin levels are usually found in obese 
individuals. This implies that there is a resistance to leptin’s effects on weight loss 
(Frederich et al., 1995b; Maffei et al., 1995b). In addition, obese individuals are reported 
to have reduced leptin transport across the BBB, which would contribute to the 
leptin resistance observed in obese subjects (El-Haschimi et al., 2000). Indeed, diverse 
studies exposing mice to high fat diet (HFD) showed an increase in food intake 
probably due to the development of leptin resistance (Lin et al., 2000; Enriori et al., 
2007; Knight et al., 2010).  
Leptin also influences brain development and participates in the maturation 
of neuronal circuits implicated in appetite control and food intake behavior (Bouret 
et al., 2004b). As previously stated, either a deficiency or an excess of leptin during 
this perinatal period can have long-term effects on the metabolic control (Steppan 
and Swick, 1999; Bouret, 2010a; Granado et al., 2014; Mela et al., 2015) and this is at least 
in part due to modifications in the development of metabolic circuits.  In rodents, 
the projections from the arcuate nucleus to other important hypothalamic nuclei 
implicated in feeding behavior are immature at birth, becoming fully mature 
around PND20 (Bouret et al., 2004a). Mice genetically lacking leptin (ob/ob mice) 
have modifications in the number of projections and synaptic inputs to NPY and 
POMC neurons. This synaptic connectivity can be rapidly restored to that seen in 
wild type (WT) mice by administration of leptin (Pinto et al., 2004). Bouret and 
colleges demonstrated that ob/ob mice have permanent alterations in the 
neuronal projections from the arcuate nucleus. Leptin treatment during the 
neonatal period rescues the development of these projections, while no effect is 
found in adult animals, indicating that there is a critical window when leptin is 
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capable of influencing the development of hypothalamic feeding circuits (Bouret et 
al., 2004b). 
 Leptin modulates lipid and glucose metabolism, stimulating lipolysis and 
inhibiting lipogenesis in liver and adipose tissue (Hynes and Jones, 2001). It also has 
antagonic effects on insulin, decreasing glucose-stimulated insulin secretion (Hynes 
and Jones, 2001; Muzumdar et al., 2003).  Leptin is also implicated in numerous other 
physiological functions such as reproduction, immunity and adipogenesis (Friedman 
and Halaas, 1998).  
5.1.1.5 Leptin and astrocytes 
Astrocytes express receptors for leptin (Pan et al., 2008; Hsuchou et al., 2009; 
Kim et al., 2014a) and leptin also plays an important role in astrocyte development 
(Pan et al., 2012; Rottkamp et al., 2015). Calcium waves are induced in astrocytes in 
response to leptin, indicating that the leptin receptors in these glial cells are 
functional (Hsuchou et al., 2009). Increased expression of leptin receptors in 
astrocytes has been reported in obese animals (Pan et al., 2008; Hsuchou et al., 2009). 
Moreover, we have previously shown that leptin induces morphological changes in 
astrocytes, both in vivo and in vitro (Garcia-Caceres et al., 2011; Kim et al., 2014a), and 
these morphological changes are involved in leptin-induced modifications in 
synaptic inputs to NPY and POMC neurons (Kim et al. 2014). Leptin also modifies the 
ability of hypothalamic astrocytes to transport both glutamate and glucose, with 
the time of leptin exposure producing different responses (Fuente-Martin et al., 
2012a).  
5.1.2 Adiponectin 
Adiponectin is a 30kDa protein composed of 247 amino acids. It is 
exclusively and abundantly secreted by adipose tissue and is thought to play 
important roles in glucose and lipid metabolism (Hu et al., 1996; Brochu-Gaudreau et 
al., 2010). Adiponectin is released into the bloodstream in three different isoforms 
that differ in molecular weight, with the activity of adiponectin in tissues 
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depending on the amount of each isoform (Waki et al., 2003). 
 
At least in the adult, adiponectin is associated with beneficial effects and it is 
reported to be an anti-diabetic hormone. This is due to its activation of AMPK 
(Yamauchi et al., 2002) and the peroxisome proliferator activated receptor α (PPARα) 
(Kersten et al., 2000) in liver and skeletal muscle. The adiponectin receptor AdipoR1, 
is abundantly expressed in skeletal muscle, while AdipoR2 is more highly expressed 
in liver. Although the neuroendocrine function of adiponectin has been less 
studied, receptors for this adipokine are also expressed in the arcuate nucleus of 
the hypothalamus (Koch et al., 2014). Binding of adiponectin to these receptors 
stimulates the activation of AMPK and PPARα, respectively (Yamauchi et al., 2003). 
Oxidative stress in adipose tissue is associated with decreased plasma adiponectin 
levels (Kadowaki and Yamauchi, 2005; Yamauchi et al., 2007). Adiponectin has been 
associated with anti-inflammatory effects, with increased plasma adiponectin 
levels reducing adipose tissue inflammation in obesity through PPARα activation 
(Tsuchida et al., 2005). Adiponectin can also up-regulate interleukin 10 (IL-10) 
expression in macrophages and leukocytes, resulting in a potent anti-inflammatory 
activity (Wolf et al., 2004). 
The effect of adiponectin on hypothalamic metabolic circuit development 
remains unknown; however, levels of this adipokine in cord blood are positively 
correlated with leptin levels and adiposity and it is suggested to play a role in early 
growth (Tsai et al., 2004; Ballesteros et al., 2011). Although adiponectin is reported to 
increase insulin sensitivity in adults (Yamauchi et al., 2001), in neonates adiponectin 
levels do not correlate with insulin sensitivity (Meral et al., 2011).  
Adiponectin expression by white adipose tissue (WAT) is reported to be 
sexually dimorphic, with females having higher adiponectin production (Amengual-
Cladera et al., 2012; Capllonch-Amer et al., 2014). Secretion of this adipokine is 
influenced by testosterone, as castrated rodents and hypogonadal men have higher 
serum total and high molecular weight adiponectin concentrations, while 
testosterone treatments decreases its levels (Nishizawa et al., 2002; Xu et al., 2005). 
Introduction 
21 
5.2 Signals from the pancreas 
5.2.1 Insulin  
Insulin was isolated for the first time by Banting and Best in 1922 (Banting, 
1924; Raju, 2006). It is almost exclusively secreted by the pancreas and, once in the 
circulation, it crosses the BBB by a saturable transport system (Baura et al., 1993). In 
the CNS, insulin also communicates the metabolic status to the hypothalamus, thus 
being another key molecule for the control of energy homeostasis (Vogt and Bruning, 
2013). Pancreatic beta cells secrete this protein in response to elevated blood 
glucose levels, after consumption of a meal for example, with insulin thus being the 
major regulator of glycemia. It stimulates the uptake of glucose by liver, muscle and 
adipose tissue and suppresses hepatic glucose production (Kahn, 1994). Importantly, 
and like leptin, circulating insulin levels are correlated to body adiposity (Polonsky et 
al., 1988).  
Insulin exerts its actions in both the periphery and the CNS after binding to 
its receptor (IR), a tyrosine kinase receptor (Kahn, 1994). Insulin receptors are 
present throughout the brain, including the hypothalamus (Wozniak et al., 1993) 
where they are highly expressed in the arcuate nucleus (van Houten et al., 1979). 
Insulin activation of the phosphoinositide-3 kinase pathway (PI3/Akt), where AKT 
triggers forkhead-O transcription factor (FOXO) phosphorylation which is 
translocated to the nucleus and degraded, is essential for maintenance of energy 
homeostasis by the CNS (Plum et al., 2006), and the mitogen-activated protein kinase 
(MAPK) signaling pathway (White, 2003), which negatively regulates FOXO activity 
(Biggs et al., 1999). There is crosstalk between insulin and leptin signaling pathways 
in the hypothalamus and specifically, insulin signaling converges with leptin 
signaling at the level of PI3K activation to increase the firing of POMC neurons 
(Niswender et al., 2003; Belgardt et al., 2009). Blockade of PI3K inhibits the anorexic 
effects on food intake of both leptin and insulin (Niswender and Schwartz, 2003). 
5.2.1.1 Peripheral and central effects of insulin 
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Glucose-stimulated insulin secretion regulates appetite through direct 
activation of POMC and inhibition of AgRP expression (van Houten et al., 1979; Bruning 
et al., 2000), causing inhibition of food intake and increased energy expenditure 
(Woods et al., 1979; Qiu et al., 2014). Correct IR signaling is indeed important for body 
weight control, as IR deficiency in mice leads to increased fat mass and leptin levels 
(Bruning et al., 2000).  It is important to note that insulin exerts independent actions 
in the periphery and centrally, with this hormone having important functions on 
metabolism, neural plasticity and cognition (Banks et al., 2012). In the brain, IR 
expression is reported to be higher in neurons than glial cells (Unger et al., 1989). 
Moreover, aging is associated to decreased IR density in the brain (Frolich et al., 
1998; Bosco et al., 2011), which is related with decreased cognitive function and could 
also have a role in the increased propensity to gain weight with age. 
Hyperinsulinemia as a consequence of obesity can lead to insulin resistance 
and eventually type 2 diabetes (Moller and Flier, 1991). Hyperinsulinemia and 
decreased insulin sensitivity have been proposed to be perpetuated by the 
inflammatory state that occurs in obesity, due to an abnormal accumulation of 
lipids in adipose tissue and the production of proinflammatory cytokines (De Souza 
et al., 2005; Shoelson et al., 2006), with serine kinases such as c-Jun N-terminal kinases 
(JNKs) mediating the proinflammatory signals and impairing insulin signaling 
(Hirosumi et al., 2002; Hotamisligil, 2003). Indeed, TNFα and IL6 production by adipose 
tissue of obese individuals can induce peripheral insulin resistance (Hotamisligil et al., 
1993; Rotter et al., 2003). 
5.2.1.2 Insulin and brain development 
Insulin is essential for adequate CNS development and function, including 
neuronal differentiation, maturation and survival (Recio-Pinto et al., 1986; Valenciano 
et al., 2006), synaptic plasticity, learning and memory (Dou et al., 2005) and neuronal 
circuitry formation (Chiu et al., 2008; Chong et al., 2015). Equilibrated insulin levels 
during prenatal and neonatal life are fundamental, as insulin actively participates in 
the normal development of metabolic neuronal circuits (Dorner and Plagemann, 1994; 
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Plagemann et al., 1999c; Konner et al., 2009). Indeed, the formation of POMC 
projections from the arcuate nucleus is disrupted as a consequence of 
hyperinsulinemia in the offspring due to maternal HFD intake during lactation (Vogt 
et al., 2014).   
5.3 Gastrointestinal (GI) hormones 
There are numerous other hormones and factors that have been implicated 
in metabolic control [for a review see (Maric et al., 2014)] by targeting specific 
neurons in the brain and/or by modulating vagal nerve function (Cummings and 
Overduin, 2007). Some of the most studied hormones participating in food intake 
control and secreted mainly in the gastrointestinal tract are ghrelin, cholecystokinin 
(CCK), peptide YY (PYY), glucagon and amylin. 
Ghrelin is mainly secreted in the oxyntic cells of the stomach (Kojima et al., 
1999; Nakazato et al., 2001) and exerts its actions through the ghrelin receptor (GHS-
R1a). Ghrelin is the only GI hormone that stimulates food intake. It also stimulates 
adipose tissue accumulation and modulates energy expenditure and glucose 
homeostasis (Tschop et al., 2000; Wren et al., 2001; Muller et al., 2015). Its secretion is 
induced in fasting conditions to stimulate NPY/AgRP neurons and to inhibit POMC 
neurons in the hypothalamic arcuate nucleus, which express GHS-R1a (Kamegai et 
al., 2001; Riediger et al., 2003; Wang et al., 2014b). The stimulatory effect of ghrelin on 
food intake is also mediated by GABA release from AgRP neurons, impeding 
melanocortin signaling by inhibiting POMC neurons (Cowley et al., 2001; Wu et al., 
2008). Contrary to leptin, ghrelin stimulates AMPK activity in the hypothalamus, 
consequently increasing food intake (Andersson et al., 2004). 
CCK is synthesized in the intestine and acts as potent satiety signal, 
decreasing meal size by acting in vagal afferents and the hindbrain (Moran and 
Kinzig, 2004). Disorders in food intake and obesity have been found in rats lacking 
CCK receptors (Miyasaka et al., 1994; Moran et al., 1998). Leptin interacts with CCK, 
increasing its actions (Peters et al., 2006; Grill, 2010). 
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PYY is secreted in the lower intestine and regulates appetite, mediating its 
effects through the NPY receptors. Serum PYY levels rise postpandrially, in 
response to calorie intake, resulting in the inhibition of food intake (Batterham et al., 
2002; Batterham and Bloom, 2003).  
The peptide hormone glucagon is secreted in the alpha cells of the pancreas. 
It is released to the bloodstream when glucose levels are low in order to restore 
glycemia levels by converting glycogen stored in the liver into glucose (Woods et al., 
2006). It is also secreted postpandrially, providing a satiety signal (Geary, 1990). 
Amylin is synthesized by pancreatic β-cells to decrease food intake. Amylin 
can interact with leptin to regulate metabolism (Lutz, 2010). 
5.4 Sex steroids in metabolism 
5.4.1 Estrogens 
Estrogens are an important group of hormones produced mainly by the 
ovaries in females and the testes in males, although they are also produced to a 
lesser extent by other tissues including adipose tissue (Simpson, 2003). In addition to 
their role in the reproductive system (Christensen et al., 2012), estrogens also 
modulate the neuroendocrine, skeletal, adipogenic, and cardiovascular systems 
(Hughes et al., 2009; Xiao et al., 2010). Estrogens mediate their actions through 
estrogen receptors (ERs), including estrogen receptor alpha (ER-α) and estrogen 
receptor beta (ER-β) which are located throughout the CNS, including the arcuate 
nucleus of the hypothalamus (Simerly et al., 1990; Shughrue et al., 1997; Osterlund et al., 
1998; Mitra et al., 2003) and are encoded by distinct genes and located in different 
chromosomes (Kong et al., 2003). Of note, ERβ expression in the hypothalamus is 
lower than ERα and, importantly, ERα is the isoform that is most implicated in 
energy homeostasis (Heine et al., 2000).  
ERs belong to the steroid hormone superfamily of nuclear receptors (NRs), which 
act as transcription factors after binding to estrogen (Osz et al., 2012). ERα and ERβ 
are expressed in adipose tissue of both males and females and influence adiposity 
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(Mizutani et al., 1994; Shimizu et al., 1997; Davis et al., 2013). Estrogens are suggested to 
increase the sympathetic tone to adipose tissue depots, in a different manner in 
men and women, favoring lipid deposition in the subcutaneous depot in women 
and visceral in men, as shown by increased abdominal adiposity in females as a 
consequence of ERα deletion in certain neurons (Xu et al., 2011). In the brain, 
estrogens play an important role in neuronal development and circuit formation in 
the fetus and neonate (Arai et al., 1986; McCarthy, 2008) and also modulate dendritic 
morphology, synaptic inputs, neurotransmitter and neuropeptide secretion and 
nuclear volume in the post-pubertal animal (DeVoogd and Nottebohm, 1981; Garcia-
Segura et al., 1986; Carrer et al., 2005). They also regulate the expression of BDNF in 
the hypothalamus that can be related with the browning of fat (Cao et al., 2011; 
Nookaew et al., 2013).   
Not only neurons, but also astrocytes are involved in the neuroprotective 
actions of estradiol (Acaz-Fonseca et al., 2014; Arevalo et al., 2015). Indeed, ERs are also 
expressed in astroglial cells (Jung-Testas et al., 1991; Langub and Watson, 1992), with 
glial cells participating in the metabolism of gonadal hormones and the synthesis of 
endogenous steroids (Kabbadj et al., 1993; Melcangi et al., 1993; Garcia-Segura et al., 
1996a).  
5.4.1.1 Estrogens in food intake regulation 
Estrogens have protective effects against weight gain, increased adiposity 
and obesity associated disorders (Stubbins et al., 2012; Dakin et al., 2015), with 17β-
estradiol being the most potent endogenous estrogen in appetite regulation (Geary, 
2000), functioning at least in part by decreasing food intake and increasing leptin 
sensitivity (Palmer and Gray, 1986). Activation of ERα in the CNS has been shown to 
regulate food intake, glucose homeostasis and energy expenditure (Musatov et al., 
2007; Xu et al., 2011). Estrogens have been shown to exert their “protection” on 
metabolism due to their inhibitory effects on appetite by increasing the activity of 
anorexigenic signals such as leptin, cholecystokinin, BDNF or apolipoprotein A-IV 
and decreasing orexigenic signals like ghrelin or melanin-concentrating hormone 
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(Tarttelin and Gorski, 1971; Clegg et al., 2006; Clegg et al., 2007; Shen et al., 2010; Zhu et al., 
2013).  
The menstrual cycle in women is reported to induce fluctuations in calorie 
intake, with a decrease during the periovulatory phase when estradiol reaches its 
peak (Barr et al., 1995; Buffenstein et al., 1995; Davidsen et al., 2007). This is also seen in 
female rodents, which consume less during diestrous (right after the preovulatory 
rise in estradiol secretion) and increase food intake during estrus when estradiol 
levels are lower, reinforcing the association between estradiol levels and food 
intake (Tarttelin and Gorski, 1971; Asarian and Geary, 2013). In addition, female rats are 
reported to gain less weight compared to males when exposed to a HFD, but this 
sex difference is no longer observed after ovariectomy (Stubbins et al., 2012). 
Estrogens also increase energy expenditure (Gambacciani et al., 1997). Indeed, 
activation of ERs in the VMN of the hypothalamus in rodent models increases 
energy expenditure (Musatov et al., 2007; Xu et al., 2011). Post-menupausal women 
generally tend to increase body weight due to decreased estradiol levels and they 
are also reported to have a lower rate of energy expenditure during exercise and 
sleep (Lovejoy et al., 2008). Therefore, estrogens protect against weight gain through 
both inhibition of food intake and stimulation of energy expenditure. Estrogens are 
also important for men as blockade of androgen conversion to estrogen leads to 
impaired insulin sensitivity and metabolism (Finkelstein et al., 2013).  
 
5.5 Nutrient derived signals: Glucose and fatty acids 
Control of energy homeostasis by the hypothalamus is modulated not only 
by peripheral hormones, but also by nutrients such as glucose or fatty acids. 
5.5.1 Hypothalamic glucose sensing 
Claude Bernard observed that hypothalamic lesions produced 
hyperglycemia in dogs, with this being the first observation that the brain is 
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implicated in the control of blood glucose levels (Bernard, 1855). Later, specific cells 
in the hypothalamus that monitor glucose concentrations and translate the 
variations in glucose levels into chemical signals to control feeding were identified 
(Mayer, 1953). Subsequently, numerous studies have illustrated that glucose acts on 
hypothalamic sites that are involved in the control of energy homeostasis (Jordan et 
al., 2010; Levin et al., 2011). Due to its location close to the median eminence, the 
arcuate nucleus is one of the first central sites to be exposed to circulating glucose 
levels.  
Neurons with the ability to sense blood glucose levels alter their action 
potential frequency in response to changes in interstitial glucose levels (Ashford et 
al., 1990). Of special interest are glucose-sensing neurons found in the 
ventromedial, lateral, paraventricular and arcuate nuclei (Oomura et al., 1964; Kow 
and Pfaff, 1989; Song et al., 2001; Wang et al., 2004). In the arcuate nucleus, in addition 
to glucose-sensing neurons (Wang et al., 2004; Fioramonti et al., 2007), astrocytes 
(Morgello et al., 1995; Kacem et al., 1998; Fuente-Martin et al., 2012a) and other glial cells 
like tanycytes (García et al., 2003; Salgado et al., 2014) surrounding the third ventricle 
are also involved in sensing glucose levels.  
 
Glucose transport and sensing in the brain is carried-out through glucose 
transporters (GLUT) 1, 2, 3 and 4, expressed in the vasculature, glial cells and 
neurons. GLUT1 is highly expressed in the astrocyte endfeet that envelop capillaries 
and is the principal glucose transporter in the BBB (Morgello et al., 1995; Kacem et al., 
1998). GLUT2 is expressed in hypothalamic astrocytes, ependymal-glial cells, 
tanycytes and glucose-sensitive neurons (García et al., 2003; Guillod-Maximin et al., 
2004; Kang et al., 2004) and is especially important for the glucose-sensing process, 
actively participating in the homeostatic control of circulating glucose levels (Bady 
et al., 2006; Stolarczyk et al., 2010). GLUT3 is mainly expressed in neurons (Gerhart et 
al., 1995). AMPK is a fuel sensor (Kemp et al., 1999) and is suggested to be a mediator 
of hypothalamic glucose-sensing, as it is activated when energy stores are low (low 
generation of ATP) and stimulates food intake (Claret et al., 2007; Jordan et al., 2010).  
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Direct icv administration of glucose inhibits feeding through modulation of 
glucose-sensing neurons (Kurata et al., 1986; Chang et al., 2005). However, this central 
hypophagic effect of glucose is abolished when an individual is exposed to chronic 
high fat diet during 8 weeks, with glucose-excited (POMC) and glucose-inhibited 
(NPY) neurons being less responsive to glucose fluctuations (Levin et al., 1998; de 
Andrade et al., 2015), suggesting defective neuronal activation by glucose caused by 
high fat diet. 
5.5.2 Hypothalamic fatty acid sensing 
Although glucose is the primary source of energy for neurons and acts as a 
signaling molecule, some hypothalamic neurons also sense long-chain fatty acids 
(LCFAs) (Oomura et al., 1975). Moreover, enzymes responsible for fatty acid synthesis 
are also present in neurons of the arcuate nucleus (Kim et al., 2002). Like insulin and 
leptin, levels of fatty acids and glycerol are proportional to adiposity and thus are 
also signals of nutrient abundance that modulate hypothalamic function to 
maintain homeostasis (Kennedy, 1953; Friedman, 2000). 
The intake of fat rich diets has increased alarmingly and, although certain 
levels of fatty acids are necessary, elevated levels of free fatty acids (FFAs) can be 
harmful. Serum FFAs are increased in obesity (Reaven et al., 1988; Boden, 2008) and 
their elevation is associated with adipocyte dysfunction and the development of 
insulin resistance (Boden et al., 2001; Guilherme et al., 2008). Moreover, elevated levels 
of FFAs in perinatal life may also affect hypothalamic neurocircuit development 
(Sullivan et al., 2011). In addition, FFAs, especially saturated fatty acids, can activate 
an inflammatory response in different cell types (Boden and Shulman, 2002; Iyer et al., 
2010), as well as induce endoplasmic reticulum (ER) stress (Gregor and Hotamisligil, 
2007). Excess FFAs derived from the diet accumulate in the adipocyte and form TGs 
that are stored as energy (one TG is composed of three fatty acids and one 
molecule of glycerol) in fat droplets in the adipocyte (Gregor and Hotamisligil, 2007). 
The main features of the most abundant fatty acids in diet are summarized in Figure 
7. 
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Figure 7. Main characteristics of the most abundant unsaturated (oleic acid) and saturated (palmitic 
acid) fatty acids in the diet. 
 
Circulating fatty acids access the brain through passive diffusion (Hamilton 
and Brunaldi, 2007) or by active transport (Mitchell et al., 2011) and are reported to  
access the CNS in proportion to their concentrations in plasma (Miller et al., 1987; 
Rapoport, 1996), although Goto and Spitzer quantified around 6% in the cerebro 
spinal fluid of their plasma concentration in fasting dogs (Goto and Spitzer, 1971). 
Once LCFAs enter into the brain and then into hypothalamic glial cells and neurons, 
they are esterified by acetyl-coA synthase (ACS) to long chain fatty acyl-CoA (LCFA-
CoA), whose accumulation will induce inhibitory effects on food intake and glucose 
production by the liver. Thus, LCFA-CoA accumulation is essential for lipid sensing 
in the hypothalamus and consequent inhibition of glucose production in the liver 
(Woods et al., 1984; Chu et al., 2002; Yue and Lam, 2012). LCFA-CoA enters the 
mitochondria for beta oxidation by carnitine palmitoyl transferase 1 (CPT-1) (Caspi 
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et al., 2007). This oxidation is regulated by malonyl-CoA that inhibits CPT-1 activity 
(McGarry et al., 1983). Hence, circulating lipids also act as signals to the 
hypothalamus regarding the nutritional status and modulate neuronal activity to 
control energy homeostasis (Woods et al., 1984; Matzinger et al., 2000). 
LCFAs are able to excite or inhibit neurons in the arcuate nucleus (Morgan et 
al., 2004; Migrenne et al., 2006; Le Foll et al., 2014). Centrally infused oleic acid inhibits 
food intake and glucose production by the liver, at least in part through inhibiting 
the expression of the orexigenic neuropeptides NPY and AgRP (Obici, 2002; Morgan et 
al., 2004). In addition, oleic acid has been reported to stimulate neurogenesis of 
metabolic neurons (Nascimento et al., 2015) and to improve insulin resistance in 
obese mice (Oliveira et al., 2015). In contrast, exposure to saturated LCFAs, like 
palmitic acid, leads to resistance to leptin’s anorexigenic actions (Milanski et al., 
2009) and appears to exacerbate the inflammatory responses observed in obesity 
and to cause lipotoxicity (Listenberger et al., 2001; Beeharry et al., 2003). Palmitic acid is 
reported to cause inflammatory responses in both astrocytes and microglia (Gupta 
et al., 2012; Valdearcos et al., 2014), which most likely participates in the disruption of 
appropriate metabolic sensing in neurons. 
 
6. Inflammation in obesity 
Inflammation is a host response to protect against an insult and is necessary 
to repair the tissue and restore homeostasis (Calder et al., 2009). Obesity is 
characterized by a chronic, low-grade inflammatory state (Gregor and Hotamisligil, 
2011). However, the inflammation associated with obesity is different from the 
classical inflammation in which pain, redness, swelling and heat are typical and a 
rapid immune response eliminates the insult and resolves the inflammation in the 
site of injury (Medzhitov, 2008). The first report of systemic inflammation related to 
obesity was published by Hotamisligil and co-workers, where they reported an 
elevation in TNFα levels in obese compared to lean mice (Hotamisligil et al., 1993; 
Hotamisligil et al., 1995). In addition to TNFα, the expression of other inflammatory 
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cytokines, such as IL1β and IL6, has also been shown to be elevated in obesity (Berg 
and Scherer, 2005; Shoelson et al., 2006).  
In obesity, adipose tissue is the main site of increased systemic cytokine 
production, including IL6, TNFα and IL1β amongst others, with excess nutrient 
intake suggested to activate this inflammatory response (Fried et al., 1998). The 
increased secretion of inflammatory cytokines such as TNFα can impair insulin 
signaling and thus contribute to the development of insulin resistance (Stephens et 
al., 1997). The inflammatory response in adipose tissue is associated with adipocyte 
hypertrophy, but not adipocyte proliferation (Weisberg et al., 2003). Indeed, 
adipocyte hypertrophy is associated with immune cell, macrophage and T cell 
infiltration in addition to the local proinflammatory environment (Minihane et al., 
2015). The distribution of adipose tissue in overweight and obese subjects seems to 
be important in determining the inflammatory milieu, with VAT appearing to 
contribute to a greater extent than SCAT to the inflammatory process and cytokine 
production (Weiss, 2007a). 
Importantly, the cytokines released by adipose tissue are also metabolic 
signals that can cross the BBB and reach the metabolic control units, including both 
neurons and astrocytes within the hypothalamus (Banks et al., 1995; Benveniste, 
1998). Moreover, these cytokines can also be locally produced in the brain 
(Benveniste, 1998). Indeed, in addition to adipose tissue, other tissues involved in 
metabolism such as the brain (De Souza et al., 2005), liver (Cai et al., 2005), pancreas 
(Nicol et al., 2013) and muscle (Saghizadeh et al., 1996) may also participate in the 
inflammatory state in obesity. 
There is evidence that inflammatory responses can be directly evoked by 
nutrients (Aljada et al., 2004; Cani et al., 2007; Erridge et al., 2007). Nutrients and/or 
inflammatory signals can activate JNK, a major intracellular contributor to the 
induction of inflammation in metabolic tissues, inhibitor of nuclear factor kappa-B 
kinase (IKK) and/or other kinases, which can interfere with the insulin-signaling 
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cascade by targeting IRS-1 for inhibitory phosphorylation (Boura-Halfon and Zick, 
2009; Tanti and Jager, 2009). 
Sex differences in inflammatory markers have been investigated in a few 
studies, but the reported studies are contradictory. Some studies report no 
differences between male and female humans and mice (Forsey et al., 2003; 
Medrikova et al., 2012), while others indicate a sex difference in humans and 
chimpanzees (Bouman et al., 2004; Obanda et al., 2014). Hence, further investigation is 
required where both sexes are compared in order to achieve clear conclusions in 
this field. 
 
7. Glial cells in metabolic control  
7.1 Astrocytes in metabolic control  
The contribution of astrocytes, the most abundant glial cells in the CNS, to 
the physiological and pathophysiological control of metabolism is increasingly 
evident (Garcia-Caceres et al., 2012; Argente-Arizón et al., 2015), although further 
investigation is needed to completely understand their role in both physiological 
and pathophysiological metabolic control.  
7.1.1 Astrocyte functions 
Astrocytes are essential for the communication between the periphery and 
the CNS (Tsacopoulos and Magistretti, 1996). These glial cells are strategically 
positioned to sense the nutritional status, being part of the BBB and in intimate 
contact with vascular and synaptic elements (Abbott et al., 2010; Wang et al., 2014c). 
They are therefore capable of providing blood-borne nutrients to neurons, 
promoting neuronal survival and contributing to CNS homeostasis.  
Astrocytes regulate neuronal differentiation, proliferation, and 
synaptogenesis during development (Nedergaard et al., 2003; Clarke and Barres, 2013). 
These glial cells highly express the glutamate transporters GLT-1 and GLAST and 
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modulate synaptic transmission by up-taking glutamate from the synaptic cleft 
(Pines et al., 1992; Schmitt et al., 1997). This not only terminates excitatory 
transmission, but also protects against excitotoxicity (Araque et al., 1999; Ransom et 
al., 2003). One single astrocyte contacts various neurons and thousands of synapses 
(Bushong et al., 2002; Theodosis et al., 2008), highlighting the importance of how 
changes in astrocytes can extensively influence neuronal activity. 
In response to CNS injuries, infections or foreign substances, astrocytes 
become activated and respond by producing cytokines, thus participating in central 
immune responses (Aschner, 1998a; b). Depending on the type of stimulus and its 
intensity or time of exposure, the cytokines produced from astrocytes can have 
protective or beneficial effects or, in contrast, detrimental inflammatory effects 
often associated with scar tissue formation (Choi et al., 2014). Astrocytes also 
participate in diverse processes that could affect metabolism, such as glucose and 
lipid sensing, and they express receptors for various hormones that participate in 
the control of food intake, including leptin, insulin, ghrelin and glucocorticoid 
receptors (Vielkind et al., 1990; Zhu et al., 1990; Hsuchou et al., 2009; Baquedano et al., 
2013).  
7.1.2 Astrocytes in glucose and fatty acids sensing 
The astrocyte endfeet surrounding blood vessels express glucose 
transporters GLUT1 and GLUT2 to transport glucose from the circulation into the 
brain (Morgello et al., 1995; Vannucci et al., 1997; Marty et al., 2005; Stolarczyk et al., 
2010). Glucose can be stored inside astrocytes as glycogen or be metabolized to 
lactate, which can be released to serve as an energy substrate for neurons (Levin et 
al., 2011). Notably, astrocytes also secrete endozepines, which in addition to 
exerting anorexigenic effects (do Rego et al., 2007), participate in glucose-sensing, 
possible through the melanocortin pathway (Lanfray et al., 2013). 
Astrocytes are the sole cells in the CNS able to β-oxidize FAs to produce 
ketone bodies; thus, these cells are the main source of FA oxidation in the brain. 
Ketone bodies produced by astrocytes serve as a fuel to neurons, especially in 
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situations of intense neuronal activity or fasting (Auestad et al., 1991; Guzman and 
Blazquez, 2001). However, ketone bodies are also produced during chronic HFD 
intake, with this possibly disrupting FA signaling mechanisms involved in metabolic 
control (Le Foll et al., 2014). 
Astrocytes express PPARγ, an important sensor of lipids and regulator of 
metabolism (Cristiano et al., 2005), and apolipoprotein E (ApoE), the major lipid 
transporter in the CNS (Boyles et al., 1985; Krul and Tang, 1992). ApoE can also act as a 
satiety factor, possibly by mediating some of the inhibitory effects of leptin (Shen et 
al., 2008; Shen et al., 2009a), and may play a protective role against apoptosis of 
astrocytes (Zhou et al., 2013). 
7.1.3 Influence of metabolic hormones on astrocytes 
Astrocytes express receptors for leptin (Hsuchou et al., 2009; Kim et al., 2014a), 
as well as receptors for insulin, ghrelin and glucocorticoids (Vielkind et al., 1990; Zhu 
et al., 1990; Baquedano et al., 2013). Different isoforms of Ob-R are expressed in 
hypothalamic astrocytes (Pan et al., 2008; Hsuchou et al., 2009), with an increase in 
their expression in obese rodents (Pan et al., 2008). Leptin modifies astrocyte 
morphology by changing primary projections length and/or number (Garcia-Caceres 
et al., 2011; Kim et al., 2014a), affecting synaptic inputs onto POMC and NPY neurons 
and thus their function (Kim et al., 2014a). These changes in morphology, for 
example as a consequence of HFD, may be an adaptation to the new metabolic 
condition; however, if this situation is maintained, these responses could become 
pathophysiological. Indeed, the glial response to leptin is time dependent, and 
prolonged exposure to this hormone stimulates astroglial production of cytokines 
(Garcia-Caceres et al., 2011). Leptin also modifies the ability of hypothalamic 
astrocytes to transport both glutamate and glucose, with the time of leptin 
exposure producing different responses (Fuente-Martin et al., 2012a). Leptin’s effect 
on glucose uptake by astrocytes could possibly change the local transport of 
glucose and its metabolites to neurons, which could in turn modify glucose sensing 
mechanisms and neuronal control of energy homeostasis. 
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As demonstrated by Kim and colleges (Kim et al., 2014a), loss of Ob-R 
specifically in GFAP positive cells, affects the synaptic organization of the 
melanocortin system, modifying the satiety response to leptin and increasing the 
ghrelin response to fasting. The number and length of astrocyte projections in the 
arcuate nucleus is reduced in the absence of Ob-R. This is associated with 
decreased astrocytic coverage of POMC neurons and an increase in the number of 
synaptic inputs to these neurons in addition to modification in the electrical activity 
of both POMC and AgRP neurons. 
Astrocytes also express receptors for estrogens, androgens and 
progesterone (Pfaff and Keiner, 1973; Garcia-Segura et al., 1996b; Melcangi et al., 2001; 
Garcia-Ovejero et al., 2005) with gonadal steroid modulation of these glial cells 
possibly participating in the reported sexual dimorphism in the inflammatory 
response to HFD (Louwe et al., 2012; Morselli et al., 2014). Indeed, females are 
suggested to be more resistant than males to obesity associated comorbidities, at 
least in part, due to the expression of ERα in astrocytes (Morselli et al., 2014).  
Although how leptin and estrogens affect astrocytes has begun to be 
elucidated, little is known regarding how other metabolic hormones or nutrients 
modulate astrocyte function and participation in metabolic control. For instance, 
glucocorticoids modulate astrocytes in the suprachiasmatic nucleus (Maurel et al., 
2000), but whether this affects circadian rhythms of food intake remains to be 
elucidated. The orexigenic hormone ghrelin has also been reported to have direct 
effects on hypothalamic astrocytes (Garcia-Caceres et al., 2014), although how this 
affects overall metabolism is still unknown. Although most studies on the role of 
astrocytes in obesity have been performed in models of HFD-induced obesity, 
fructose is also able to induce astrogliosis (Li et al., 2014). However, a high sucrose 
diet, which causes increased adiposity, does not produce the classical hypothalamic 
astrogliosis reported in HFD-induced obesity (Fuente-Martin et al., 2013b). Hence, 
although astrocytes appear to be involved in mediating central metabolic signals, 
there is still much to be learned regarding the mechanisms involved. Illustration of 
Introduction 
36 
hypothalamic astrocytes in a physiological and a pathophysiological state is shown 
in Figure 8. 
 
Figure 8. Hypothalamic astrocytes in a normal physiological and in a pathological state in response to 
HFD or obesity. 
A. Astrocytes are sensors of the general metabolic status due to its privileged location between the 
periphery and the central nervous system. They are the main energy source in brain by providing energy 
to neurons from circulation supplying them with glucose, lactate or ketone bodies. Only astrocytes can 
βoxidize fatty acids to produce ketone bodies. The major lipid carrier protein in the CNS, ApoE is 
produced by astrocytes.  Astrogial cells express receptors for important metabolic hormones, such as 
leptin and insulin, and thus may participate  in their signaling effects. They also release endozepines, 
which exert anorexigenic effects and act as gliotransmitters by modulation of neuronal activity through 
GABA. 
Together these functions make astrocytes key elements for neuronal support and survival, regulation of 
synaptic transmission, maintenance of the BBB and players in the central immune response. 
B. High fat diet consumption and in consequence, obesity, leads to disruption of metabolic status and to 
an increase in important metabolic hormones as leptin. Astrocytes can be activated, changing their 
morphology, affecting their contact with blood vessels and neuronal coverage, as well as the number of 
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synaptic inputs to metabolic neurons. Astrocytes also increase the number of receptors for leptin, 
possibly causing changes in leptin transport. 
If the elevated exposition to leptin is prolonged and, in consequence astrocyte activation, production of 
cytokines and neurotoxic substances by astrocytes can occur, leading eventually, to detrimental effects. 
Ketone bodies produced by astrocytes from fatty acids are a source of energy for neurons  in cases of 
high neuronal activity or fasting. However, in chronic HFD, they are also synthesized, impairing FA 
signaling. 
Figure legend: EZ:Endozepines; FA: Fatty acids; KB: Ketone bodies; BBB: blood brain barrier; IL-6: 
Interleukin 6; IL1β: Interleukin 1 β; TNFα: Tumor necrosis factor α; MCT-1: Monocarboxylate transporter 
1; MCT-4: Monocarboxylate transporter 4; GLAST: Glutamate aspartate transporter; GLUT-1: Glucose 
transporter 1; GLUT-2: Glucose transporter 2; ApoE: Apolipoprotein E; PPARγ: Peroxisome proliferator 
activated receptor γ; NO: Nitric oxide. 
 
7.2 Microglia in metabolic control  
Microglia are the immune cells of the CNS (Rivest, 2009). In physiological 
conditions, these cells are continuously maintaining the cellular environment by 
cleaning debris (Aloisi, 2001; Nimmerjahn et al., 2005), modulating synapses (Batchelor 
et al., 1999; Zhong et al., 2010), as well as through the production of diverse 
substances that include cytokines when necessary (Shoelson et al., 2006). It has been 
proposed that microglia and astrocytes cooperate to support and modulate neural 
communication (Schafer et al., 2013). 
Microglia can become reactive as a consequence of HFD or obesity, resulting 
in morphological changes and the release of diverse substances. Saturated fatty 
acids can directly active these glial cells (Milanski et al., 2009), and this activation 
occurs specifically in the hypothalamus after HFD intake (Thaler et al., 2012). This 
microglial response can involve the production of cytokines, reactive oxygen 
species (ROS) and nitric oxide (NO) that, upon becoming chronic, can exacerbate 
microglia activation and may cause neuronal impairment and toxicity, with POMC 
neurons being particularly vulnerable (Block and Hong, 2007). In turn, NPY and α-MSH 
can modulate the release of cytokines and NO by microglia (Delgado et al., 1998; 
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Ferreira et al., 2011; Gonçalves et al., 2012), suggesting that there is direct 
communication between metabolic neurons and microglia and that this cross-talk 
may participate in the inflammatory process. 
Leptin can directly active microglia (Tang et al., 2007; Lafrance et al., 2010; Gao et 
al., 2014), suggesting that this hormone participates in the activation of these cells 
in obese subjects. Ob/Ob mice that lack leptin have lower levels of hypothalamic 
microglia activation than control mice (Gao et al., 2014). Despite the fact that HFD 
intake by these mice increases microglia activation in the hypothalamus, it does not 
reach control levels. Moreover, leptin administration increases microglia number 
and ramification even though these animals lose weight (Gao et al., 2014). Thus, 
independently of body weight, metabolic hormones and nutrients control 
hypothalamic microglial activity. 
Pro-inflammatory cytokines released by activated microglia may also 
participate in the development of insulin resistance that can accompany central 
inflammation (De Souza et al., 2005; Shoelson et al., 2006). Of note, exercise 
counteracts microglia activation produced by HFD, as well as improves glucose 
tolerance (Yi et al., 2012). Thus, exercise not only has beneficial effects by increasing 
energy expenditure, but it also ameliorates central inflammation. 
The early nutritional environment influences the maturation of these immune 
cells, causing long lasting effects in the response to neuroimmune challenges (Bilbo 
et al., 2010; Clarke et al., 2012). Indeed, HFD intake during gestation and the release of 
proinflammatory cytokines by microglia has been shown to affect the development 
of the melanocortin circuit in nonhuman primates (Grayson et al., 2006). In rodent 
models, the offspring of mothers fed with a HFD during gestation had increased 
hippocampal microglial activation at birth, as well as increased microglial density in 
adulthood (Bilbo and Tsang, 2010). Moreover, neonatal overnutrition in rats results in 
microglial activation in hypothalamic areas and other brain areas, which is 
accompanied by an increase in the expression of inflammatory genes in the adult 
hypothalamus (Tapia-González et al., 2011; Tu et al., 2011; Ziko et al., 2014). 
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The number of microglia and their morphology is reported to differ between 
the sexes in some brain areas (Schwarz et al., 2012). However, there is little 
information in the literature as to whether males and females differ in their 
microglial response to metabolic challenges.  
 
8. The question in context 
As stated above, it is clear that the early nutritional status has long-term 
effects on energy homeostasis, with specific metabolic outcomes possibly being 
affected differently depending on age. Moreover, although males and females are 
known to respond differently to metabolic challenges, the mechanisms underlying 
this dimorphism are not fully elucidated. Differences in gonadal steroid production 
are obviously involved in postpubertal sex differences, but they cannot explain 
what occurs in early development. As the neonatal hormonal/nutritional 
environment modulates the development of hypothalamic neuronal circuits 
involved in the control of energy homeostasis, it is possible that differences 
between males and females exist even during this early developmental stage and 
this impacts on the development of these circuits. Moreover, the response to 
metabolic challenges during perinatal life could also affect males and females 
differently.  
Studies analyzing the effect of early nutritional/hormonal changes on the 
development of hypothalamic metabolic circuits have focused on neurons. 
However, glial cells are involved not only in the development, but also the correct 
functioning of these circuits in adulthood. Indeed, the involvement of astrocytes 
and microglia in the physiological and pathophysiological neuroendocrine control 
of metabolism has become an area of increasing interest in the investigation of 
obesity, but little is known regarding the effect of perinatal nutritional changes on 
glial cell development or their involvement in later metabolic abnormalities. 
Moreover, how astrocytes differ between males and females remains to be fully 
explore.   
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Obesity courses with a chronic mild inflammatory state that includes the 
hypothalamus, a process in which astrocytes and microglia participate. These glial 
cells also respond to specific hormonal and nutritional signals, becoming activated 
and producing cytokines and other factors, with hypothalmic gliosis and 
inflammation being implicated in the development of secondary complications of 
obesity. Thus, if hypothalamic astrocytes differ between males and females, they 
could participate not only in the physiological differences between the sexes in 
metabolic control, but also the pathophysiologial consequeces of a poor diet and 
obesity.  
Together, these observations have lead us to the following hypothesis and 
objectives.  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
II. HYPOTHESIS 
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Males and females respond differently to nutritional 
challenges and this could be in part due to sex differences 
in hypothalamic astrocytes. 
 
 
   
 
 
 
 
 
 
 
 
 
 
III. OBJECTIVES 
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Objective 1. To evaluate the changes in peripheral hormones, body 
weight and adipose tissue in response to overnutrition due to a 
reduction in litter size of male and female rats at different stages of 
postnatal development. 
 
Objective 2. To correlate the peripheral changes as a consequence of 
the reduction in litter size, with central changes in the hypothalamus 
and specifically in astrocytes, throughout development of male and 
female rats. 
 
Objective 3. To analyze whether males and females respond 
differently to neonatal over-nutrition. 
 
Objective 4. To investigate whether hypothalamic astrocytes from 
male and female rats respond differently to free fatty acids. 
 
Objective 5. To determine if estrogens affect the response of 
hypothalamic astrocytes to free fatty acids. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
IV. MATERIALS AND METHODS 
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1. Experimental Models 
All experiments were designed according to the European Communities 
Council Directive (86/609/EEC; 2010/63/UE) and NIH guidelines for animal care. 
Experiments in these studies complied with the Royal Decree 53/2013 pertaining to 
the protection of experimental animals. The studies were approved by the 
Commission of Investigation of the Hospital Infantil Universitario Niño Jesús and the 
corresponding university ethics committee where the experiments were performed, 
including the Ethical Committee of Animal Experimentation of the Universidad 
Complutense de Madrid, Ethical Committee of Animal Experimentation of the 
Universidad Autónoma de Madrid, Ethical Committee of Animal Experimentation of 
the Universidad de Córdoba or the Institutional Animal Care and Use Committee of 
Yale University. The animals were always treated respectfully and the least possible 
number of animals was used in all experiments. 
 
1.1 IN VIVO STUDIES 
1.1.1 Neonatal overnutrition throughout development  
Male and female adult Wistar rats were purchased from Harlan Interfauna 
Ibérica S.A., (Barcelona, Spain) and allowed to acclimate for two weeks before 
mating. One male was placed in a cage with three virgin females (all weighing 
approximately 150 g) females. Each dam was then housed individually and fed ad 
libitum. Rats were maintained at a constant temperature (22-24ºC) and humidity 
(50-55%) in a 12 hour light-dark cycle, with lights on at 07:30. Animals were given 
free access to chow (commercial diet for rodents A04-10/15022, Panlab, Barcelona, 
Spain) and tap water.  
a) Experimental design 
Only mothers that gave birth to between 8 and 12 pups were employed for 
the study (mean litter size 10.3 ± 0.2 pups born/litter). All litters were arranged on 
the day of birth, postnatal day (PND) 0. At this time, pups were weighed, measured 
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and organized into two different litter sizes: litters of 12 pups per dam (L12: 6 males 
and 6 females), as control (CT) litters or litters of 4 pups per dam (L4: 2 males and 2 
females) as neonatal overnutrition (NON) litters. A total of 12 litters of 12 pups per 
dam and 36 litters of 4 pups per dam were employed in these studies. Cross-
fostering was used and every litter contained a balanced number of males (M) and 
females (F). Litters were arranged such that the mean initial weights did not differ 
between groups (ML4: 5.8 ± 0.1 g, ML12: 6 ± 0.1 g; FL4: 5.7 ± 0.1 g, FL12: 5.7 ± 0.1 g). 
Rats were raised in these litters from birth to weaning, which took place at PND21.  
This procedure is a relatively physiological way of inducing overnutrition by 
increasing milk availability due to the reduction in the number of pups/dam (Fiorotto 
et al., 1991; Fink et al., 2001). This procedure may also affect maternal nurturing 
(Fiorotto et al., 1991; Koskela et al., 2009), which can also have long-term effects on 
metabolism.  
After weaning, the rats were housed 2 per cage, according to sex and 
experimental litter size. From this point on, the animals were given free access to 
normal rat chow and tap water. Body weight, length and food intake were monitored 
once a week until sacrifice. Daily food intake was measured once a week by placing a 
known amount of food in the cage and weighing the remaining amount of food at 
the same time the following day. To account for spillage, food was retrieved from the 
bedding before weighing. The number of cages was used as the n for statistical 
analysis. The amount of chow ingested per animal was calculated by dividing the 
total amount of food eaten by the number of rats per cage. Body length was 
monitored by placing the animal on a ruler and measuring the longitude from the 
snout to the base of the tail. Rats older than 90 days were lightly anesthetized with 
isoflurane in order to immobilize the animal and obtain a more accurate 
measurement. This anesthesia was not applied on the day of sacrifice.  
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Rats were sacrificed at different time points throughout development. These 
time-points were chosen as they represent key developmental periods (Figure 9. For 
a review on how a rat’s age relates to that in humans see (Sengupta, 2013).  
Figure 9: “The laboratory rat: relating rat’s age to that in humans”. Taken from Sengupta, 2013. 
In the present study, rats were sacrificed on the following days: 
- Postnatal day 10: Day 10 is a crucial stage in rat development due to the leptin 
surge that takes place around this period of time. Serum leptin levels start to 
increase around PND 5 and peak at PND 9-10 (Ahima et al., 1998; Delahaye et al., 
2008).  
- Postnatal day 21: Rats were weaned at PND 21, thus concluding the period of 
exposure to different nutritional environments due to litter size. From this point 
on, all rats were allowed to eat and drink ad libitum.  
- Posnatal day 30: Rats are still pre-pubertal on day 30 after birth, but 
approaching pubertal onset. In our facilities, males reach sexual maturation 
around PND 42-44 and females around PND 32-35 (Castellano et al., 2011). 
- Postnatal day 50: At this age rats are post-pubertal, but still in the 
periadolescent period, approaching adulthood. 
- Postnatal day 85: At PND85 rats are adult, with numerous published studies 
using rats between PND60-PND90 for metabolic analysis. 
- Postnatal day 150: This stage allows the study of older adult rat where some 
effects of aging on metabolism may begin to appear. 
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The experimental design of neonatal overnutrition protocol is shown in Figure 
10. 
 
Figure 10. Diagram of the experimental design for neonatal overnutrition (NON) throughout development 
in male and female Wistar rats. N= 12 for each experimental group; BW: body weight, BL: body length, FI: 
food intake, PND= Postnatal day. HPT = Hypothamamus, SCAT = Subcutaneous adipose tissue, VAT = 
Visceral adipose tissue. 
b) Sacrifice and sample collection 
Animals were placed under fasting conditions 12 hours before sacrifice, 
except for the rats sacrificed on PNDs 10 and 21, which were allowed to nurse until 
sacrificed in order to not induce additional stress on being removed from their 
mothers. On the day of sacrifice, body weight and length were measured. Blood 
glucose levels were determined in a drop of blood from the tip of the tail by using a 
glucometer (Optimum Xceed, Abbot). A quick vaginal swap was performed in the 
female rats to determine the estrous cycle stage at the moment of sacrifice.  
A total of twelve animals per group were sacrificed between 09:00 and 11:00. 
Six rats were processed to obtain fresh tissue and the other six were perfused as 
described below. Of note, PND10 and PND21 rats were not transcardially perfused, 
but their brains and fat pads were directly fixed by placing the brains and fat pads in 
4% paraformaldehyde and left overnight (O/N). To obtain fresh tissue, rats were 
killed by rapid decapitation. Blood was collected from the trunk, allowed to clot and 
preserved on ice before being centrifuged at 3000 RPM during 20 minutes at 4°C to 
obtain serum. Serum samples were kept at -80°C until processed. 
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After decapitation, the brain was rapidly removed and the hypothalamus, 
defined rostrally by the optic chiasm and caudally by the anterior margin of the 
mammillary bodies, was dissected out with a depth of approximately 2 mm. 
Subcutaneous (inguinal) and visceral (perigonadal) adipose depots were removed, 
weighed, frozen on dry ice and stored at -80°C until processed. Six animals per group 
were perfused transcardially and the tissue then collected as described below. 
Serum samples were processed for the analysis of leptin, insulin, interleukin 
(IL) 1β, 6, tumor necrosis factor alpha (TNFα) and adiponectin, as described below. 
Testosterone and 17β-estradiol were measured in males and females, respectively. 
Rats that were killed at PND150 were subjected to an oral glucose tolerance 
test (OGTT) one week before sacrifice. Rats were fasted over-night (from 20:00 to 
8:00 h) and at 8:00 h basal glycemia was measured with a glucometer (Optium Plus, 
Abbot Diabetes Care, Witney Oxon, UK). A bolus of 3 mg/g-bw of glucose was then 
orally administered to the rats by means of a lavage tube. Glycemia was measured at 
30, 60 and 120 min after glucose administration by venous tail puncture. The total 
area under the curve (AUC) for the glucose response was calculated by using the 
following formula: AUC = 0.25 × (fasting value) + 0.5 × (30-min value) + 0.75 × (1-h 
value) + 0.5 × (2-h value).  
Proteins involved in gliosis and intracellular signaling pathways were analyzed 
in the hypothalamus by Western blotting. Relative levels of mRNA of various 
cytokines and adipokines were quantified in the hypothalamus and adipose tissue by 
real time PCR. 
Perfused brains from PND150 rats were processed for GFAP and Iba1 
immunohistochemistry to determine the number and morphology of GFAP and 
number of Iba1 positive cells in the hypothalamus. Double immunohistochemistry 
was also performed to analyze the expression of the leptin receptor (ObR) in GFAP 
positive cells.  
Materials and methods 
51 
 
Table 1 and 2 outline the experimental groups and ages of sacrifice, as well as 
the description of the samples collected at each age and the analysis performed in 
each of them. 
 
EXPERIMENTAL GROUPS 
Males from litters of 12 pups  ML12 
Males from litters of 4 pups  ML4 
Females from litters of 12 pups  FL12 
Females from litters of 4 pups  FL4 
 
 
 
Table 1 & 2. Description of the experimental groups, the ages at which they were sacrificed as well as the 
samples collected and the analysis performed. PND: postnatal day, AT: adipose tissue, IHC: 
Immuohistochemistry. 
 
1.1.2 Neonatal androgenization  
Wistar rats raised in the animal facility of the Medical School of University of 
Córdoba, Spain, were used for this study. The rats were kept under conditions of 
constant temperature (22-24ºC) and humidity (50-55%) and 12 hour light-dark 
 
AGE OF SACRIFICE 
  PND 10 PND 21 PND 30  PND 50 PND 85 PND 150 
Samples 
     
  
BLOOD X X X X X X 
HYPOTHALAMUS  X X X X X X 
SCAT X X     X X 
VAT   X     X X 
Perfused brain           X 
Analysis              
Serum hormones and cytokines X X X X X X 
Serum lipids           X 
Cytokine expression in AT X X     X X 
Proteins involved in gliosis X X X X X X 
IHC             X 
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cycles. They were allowed ad libitum access to chow diet (A04-10/15022 Panlab, 
Barcelona, Spain) and tap water.  
c) Experimental design 
In order to better understand the effect of neonatal sex steroids on 
metabolism, three groups of animals were generated. On PND1, female rats received 
a subcutaneous injection of 1.25 mg of testosterone propionate (SIGMA T-1875) 
dissolved in 100 µL of olive oil [approximately 208 mg/kg; androgenized females 
(AF)] or 100 µL of olive oil, as vehicle (control females, F). Males (M) also received 
vehicle (100 µL of olive oil). Rats were sacrifice on PND10 or PND90. Vehicle treated 
adult females sacrificed at PND90 were monitored to control the estrus cycle by 
performing vaginal swabs two weeks before sacrifice being all of them sacrificed on 
the morning of diestrus. Androgenized females did not show external signs of 
puberty or regular cycles. The experimental design is shown in Figure 11. 
 
 
Figure 11. Schematic representation of the neonatal androgenization protocol in male (M), female (F) and 
androgenized female (AF) Wistar rats. T: testosterone; V: vehicle; PND: postnatal day.  
 
d) Sacrifice and sample collection 
Half of each group was killed on PND10 and half on PND90. PND 90 animals 
were fasted for 12 hours before sacrifice. At PND 90, 3-4 rats of each group were 
perfused transcardially as described below. The number of animals in each group is 
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shown in Table 3. Body weight, length and glycemia were determined on the day of 
sacrifice. 
 
  PND 10 PND 90 
  Fresh Perfused Fresh 
Males M (n=10) X M (n=6) 
Females F (n=10) X F (n=8) 
Androgenized females AF (n=10) X AF (n=8) 
 
Table 3. Description of the experimental groups in the neonatal androgenization study and the total 
number of animals in each group. 
 
The hypothalamus was removed as described above. Fat pads (subcutaneous 
and visceral) were collected and weighed.  
Serum levels of testosterone, 17β-estradiol, leptin, insulin, IL6, IL1β, TNFα 
and adiponectin were measured by ELISA or multiplex arrays in all samples.  
Vimentin and GFAP levels were analyzed by Western blotting in the 
hypothalamus of PND10 and 90 rats.  
IL6, TNFα, IL1β, leptin and adiponectin, mRNA levels were determined in 
subcutaneous (PND 10 and PND 90) and visceral (PND 90) adipose tissues by RT-PCR.  
Perfused visceral fat was processed for analysis of adipocyte morphology 
after  hematoxilin-eosin staining at PND 90.  
 
1.2 IN VITRO STUDIES 
All plastic materials used to perform primary astrocyte cultures were acquired 
from Falcon (Becton Dickinson, Franklin Lakes, NJ, United States). The culture media 
was from Gibco (Invitrogen Co., Auckland, New Zeeland). 
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1.2.1 Primary cultures of hypothalamic astrocytes 
Primary cultures of hypothalamic astrocytes were prepared from PND2 
Wistar rat pups. Both sexes were used and male and female cells were cultured 
separately. Ano-genital distance was used to determine the sex of the animal. Pups 
were sacrificed by decapitation and the brain quickly removed and immediately 
placed on ice in Dulbecco’s modified Eagle’s medium: Nutrient mixture F-12 
(DMEM/F12) supplemented with 1% penicillin/streptomycin and anti-mycotic 
(Ab/Am; Gibco). Hypothalami were carefully dissected and the meninges carefully 
removed. Hypothalami were then triturated in the same media. The tissue was 
dissociated by first using a P1000 pipette and then pulled Pasteur pipettes several 
times until the suspension was clear. The suspension was then centrifuged at 1000 
rpm for 7 minutes. The resulting pellet was resuspended in DMEM/F12 enriched 
with 10% fetal bovine serum (FBS) plus 1% Ab/Am solution. Cells (1 mL) were then 
seeded in 75 cm2 culture flasks (BD Falcon), containing 9 mL of DMEM/F12 plus 10% 
FBS and 1% Ab/Am. The cells were incubated at 37 °C and 5% CO2. After three days, 
the flasks were washed twice with tempered phosphate buffered saline (PBS) and 
fresh media was added. Media was changed three times a week and after a total of 
9-10 days of incubation, when the cells reached approximately 90% confluence, 
flasks were placed in a 37 °C shaking incubator (SI-300, Jeoi Tech; Medline Scientific) 
at 280 rpm for 6 hours.  
After shaking, flasks were washed twice with PBS to remove non-attached 
cells. Then, 1 mL of trypsin (0.05% trypsin/EDTA solution; Biochrom AG) was added 
and the flasks hit together 10 times (in order to detach and harvest the astrocytes). 
DMEM/F12 plus 10% FBS and 1% Ab/Am was added to the flasks to stop the action 
of the trypsin and resuspend the cells. The suspension was centrifuged for 5 minutes 
at 1150 rpm. After centrifugation, the supernatant was discarded and the pellet 
resuspended in DMEM/F12 plus 10% FBS and 1% Ab/Am. Astrocytes were seeded in 
60 mm or 100 mm culture plates, that had been previously treated with poly-L-lysine 
hydrobromide (10 μg/ml; Sigma-Aldrich), at a density of 4.35X105 or 1X106 
cells/plate, respectively. Cells were then grown for 24 hours. After 24 hours, the 
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media was changed to DMEM F-12 plus 1% Ab/Am (without FBS). Thus, the cells 
were serum starved for 24 h before the experimental treatments were added. The 
treatments were prepared with the same media (DMEM F-12 plus 1% Ab/Am, 
without FBS). In each experiment, treatments were done in triplicate; each 
experiment was repeated 3 to 4 times (n = 3 to 4). Figure 12 resumes the procedure 
followed to obtain cultures of primary hypothalamic astrocytes and Figure 13 the 
protocol followed after purification. 
Figure 12. Schematic representation of the main steps carried out to obtain primary astrocyte 
cultures. 
 
This protocol results in astrocyte enriched cultures. The purity was assessed 
by immunocytochemistry for glial fibrilary acidic protein (GFAP), a marker of 
astrocytes, and ionized calcium-binding adapter molecule 1 (Iba1), a marker of 
microglia. No staining with the Iba-1 antibody was found, as shown in figure 14. In 
addition, the expression of Iba1, galactocerebroside (GalC) a marker for 
oligodendrocytes and S100 calcium binding protein A4 (S100A4) as a marker of 
fibroblast were analyzed by RT-PCR. The expression of these markers decreased 
inversely with the time of shaking before plating the cells.  
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Figure 13. Protocol followed after purification to obtain astrocyte enriched primary cultures. FBS: fetal 
bovine serum. 
 
 
 
 
 
 
 
Figure 14. Double immunocytochemistry for GFAP (green) and Iba1 (red) to verify astrocyte primary 
cultures purity. No immunolabeling of Iba1 can be observed. 
 
1.2.1.1 Treatments  
Astrocytes from males and females received the following treatments: 
a) Fatty acids  
All reagents were purchased from Sigma-Aldrich, Inc. (Saint Louis, MO, USA). 
Fatty acid supplemented medium was prepared according to previously published 
protocols (Huynh et al., 2014).  
Palmitic acid (PA) and oleic acid (OA) were used to treat astrocytes. Fatty 
acid-free bovine serum albumin (BSA) was added to ensure lipid solubility in the 
aqueous solution. A dose-response curve of increasing concentrations (0.05mM, 
0.1mM, 0.25mM and 0.5mM) was performed for PA. When used in combination, PA 
and OA were used at a concentration of 0.5mM each [0.5mM oleate:palmitate (1:1)]. 
Control plates received an equivalent amount of vehicle solution.  
GFAP 
Merge 
GFAP Iba1 Merge 
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Stock solutions of sodium oleate (Sigma, O-3880), palmitic acid (Sigma, P-
5585), BSA (Sigma, A-9205) and L- carnitine (Sigma, C-0283) were prepared and 
sterilized by filtration with 0.45 µm filters and stored at -20°C until used. 
A stock solution of 100 mM sodium oleate was prepared in H2O. To facilitate 
solubilization of the fatty acid, 25 µL of 1N NaOH were added. The solution was 
incubated at 37°C in a water bath during approximately 30 minutes and vortexed 
occasionally until the solution was clear. The PA stock solution was prepared at 200 
mM in ethanol and vortexed until the solution was clear. The BSA stock solution was 
prepared at 30% and L-carnitine at 200 mM; both of them were dissolved in H2O.  
Fatty acids were then conjugated with fatty acid-free BSA to act as a carrier 
and ensure lipid solubility in the aqueous solution. Fatty acid-albumin solutions were 
diluted in DMEM F-12 plus 1% Ab/Am (without FBS) medium to achieve the desired 
final fatty acid concentration. The L-carnitine (1 mM) was added to the final fatty 
acid concentration solution before being added to cultures, as this appears to be an 
essential component of the lipid-induced insulin resistance with certain fatty acids. 
 
b) β-estradiol  
17β-estradiol (Sigma, E-8875) was purchased from Sigma-Aldrich. A stock 
solution of 1 mg/mL was prepared in ethanol. Then, 10-9 M working solution was 
made in DMEM F-12 plus 1% Ab/Am (without FBS) medium to treat cultured 
astrocytes. 
When 17β-estradiol was used in combination with PA, astrocytes were “pre-
treated” with 10-9 M β-estradiol for 3 hours previous to PA addition.  
 
c) Ultrapure lipopolysaccharide from Rhodobacter sphaeroides (LPS-RS) - TLR4 
antagonist  
LPS-RS Ultrapure was purchased from InvivoGen (San Diego, CA, USA) as a 
purified preparation of the TLR4 antagonist LPS-RS. A stock solution of 1mg/mL was 
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prepared in water. Serial dilutions were prepared to obtain a working concentration 
of 300ng/mL according to the commercial source recommendations and literature 
(Lu et al., 2013). Primary astrocytes were pretreated with LPS-RS for 2 hours followed 
by treatment with PA 0.1mM. 
 
2. Techniques and  Protocols 
Reagents were acquired from Merck KGaA (Darmstadt, Germany) or Sigma-
Aldrich, Inc. (Saint Louis, MO, USA), unless stated otherwise. 
2.1 Determination of glycemia and serum hormone, cytokine and lipid 
concentrations 
2.1.1. Blood glucose levels 
Glycemia was determined by using a glucose meter and test strips (Optium 
Plus, Abbot Diabetes Care, Witney Oxon, UK) in blood obtained from a lateral tail 
vein puncture. 
2.1.2 Determination of serum levels of leptin, adiponectin, estradiol and 
testosterone by enzyme-linked immunosorbent assay (ELISA) 
Serum leptin and adiponectin levels were quantified by using ELISAs 
purchased from Millipore (Millipore, Billerica, MA, USA) and performed according to 
the manufacturer’s instructions.  
Briefly, assay buffer and samples were added to the corresponding wells and 
incubated for 2 hours at room temperature while shaking at 400-500 rpm. All 
subsequent incubations were done under the same conditions of temperature and 
shaking. As instructed, for the adiponectin assay serum samples were diluted (1:500) 
with assay buffer. Molecules of adiponectin in the samples were captured by the 
microtiter plate coated with a monoclonal adiponectin antibody. After the 2 hour 
incubation, the wells were washed to remove unbound antibody. In contrast, the 
leptin assay requires that the antiserum solution be added to the sample and then 
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the resulting complexes are added and bound to the wells that were previously 
coated with another anti-leptin antibody (sandwich). The following steps were 
similar for both assays. A purified biotinylated antibody (anti-rat adiponectin or anti-
rat leptin) was added to detect the immobilized adiponectin or leptin molecules and 
incubated for 1 hour. After the corresponding washes were carried out in a 
HydroFlex (Tecan) microplate washer, streptavidin-horseradish peroxidase conjugate 
was added for during 30 minutes to bind to the immobilized biotinylated antibody 
and washed afterwards to remove the excess of free enzyme conjugates. Lastly, 
peroxidase substrate was added and horseradish peroxidase (HRP) activity 
monitored until the stop solution was added. Quantification was measured in a 
spectrophotometer (Tecan Infinite M200, Grödig, Austria) at a wavelength of 450 nm 
and corrected at 590 nm. The increase in absorbency is directly proportional to the 
amount of captured rat leptin or adiponectin in the unknown samples. The 
concentrations were calculated from the standard curve supplied with the kits. 
Sensitivities of the method for leptin and adiponectin were 0.08 and 0.4 ng/ml, 
respectively. All samples were run in duplicate. The intra-assay coefficient of 
variation (CV) was 2.2 % for leptin and 1.3% for adiponectin and the inter-assay CV 
was 3.4 % for leptina and 6.9 % for adiponectin.  
 
Serum estradiol and testosterone levels were determined by using an ELISA 
kit from Cusabio Biotech CO., LTD (Wuhan, P.R. China) according to the 
manufacturer’s protocol. Microtiter plates pre-coated with a goat-anti-rabbit 
antibody towards the substance to be analyzed were used. Standards or samples 
were added in duplicate to the appropriate wells followed by addition of HRP-
conjugated testosterone or estradiol. Then, a specific antibody was added to each 
well. The plates were incubated for 1 hour for the testosterone assay and 2 hours for 
estradiol. After incubation and the appropriate washes, substrate solutions were 
added to each well and incubated for 15 minutes at 37ºC. Stop solution was then 
added to terminate the enzyme-substrate reaction. Finally, the color change was 
measured at a wavelength of 450 nm (Tecan Infinite M200). Estradiol and 
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testosterone concentrations in the samples were calculated comparing the O.D. of 
the samples to the standard curve. The estradiol assay has a sensitivity of 25 pg/ml 
and the testosterone assay 0.06 ng/mL. Inter- and intra-assay coefficients of 
variation are <15% for both assays. All samples were run in duplicate. 
 
2.1.3 Determination of serum levels of insulin, interleukin 6, interleukin 
1β and tumor necrosis factor α with a multiplex bead immunoassay 
Circulating levels of insulin, IL6, IL1β and TNFα were determined in duplicate 
by using a multiplexed bead immunoassay kit according to manufacturer’s 
specifications (Millipore). Briefly, beads conjugated to the appropriate antibodies 
and serum samples (25 µl each) were incubated overnight at 4°C and under 
moderate shaking. The next morning, plate wells were washed three times with the 
provided wash buffer. Then, the biotinylated detection antibody (50 µl) was added 
and incubated for 2 hours at RT while shaking at 500 rpm. Finally, 50 µl of the 
reporter dye, streptavidin-conjugated phycoerythrin, was added and incubated for 
30 minutes. After washing, the beads were analyzed in a Bio-Plex suspension array 
system 200 (Bio-Rad Laboratories, Hercules, CA, USA) and mean fluorescence 
intensity was analyzed using Bio-Plex Manager Software 4.1. 
 Insulin IL-6 IL1-β TNF-α 
Sensitivity (pg/mL) 52.5 8.8 1.2 3.2 
Intra-assay CV (%) 1.7-4.2 1.7-4.2 1.7-4.2 1.7-4.2 
Inter-assay CV (%) 2.8-13.6 2.8-13.6 2.8-13.6 2.8-13.6 
Table 4. Assay sensitivities (minimum detectable concentrations, pg/mL), intra- and inter-assay coefficient 
of variation for multiplex bead immunoassay. CV=coefficient of variation 
2.1.4 Determination of triglycerides in serum samples 
Total triglycerides were measured in serum samples of PND150 rats by using 
a commercial kit purchased from Randox Laboratories Limited (United Kingdom). 
Serum samples were diluted 1:2 in saline. Triglycerides in the samples are quantified 
after enzymatic hydrolysis with lipases. The colorimetric indicator is quinoneimine 
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formed from hydrogen-peroxide, 4-aminophenazone and 4-chlorophenol under the 
catalytic influence of peroxidase. The reaction mix was incubated for 10 minutes at 
room temperature and the absorbance measured at a wavelength of 500 nm (Tecan 
Infinite M200). Triglyceride concentrations (mg/dl) in the samples were calculated 
comparing the O.D. of the samples to the standard curve. 
2.1.5 Determination of non-esterified free fatty acids in serum samples 
The kits for the quantitative determination of non-esterified free fatty acids 
(NEFA) were purchased from Wako (Neuss, Germany) and followed the ACS-ACOD 
(Acyl-CoA synthethase – Acyl-CoA oxidase) method. The concentrations of NEFA 
were determined by a reaction of the serum sample with reactive A (0.3 kU/l acyl-
CoA-synthetase, 3 kU/l ascorbate oxydase; 06 g/l coenzyma A, 5 mmol/l ATP, 1.5 
mmol/l 4-aminophenazone, 50 mmol/l phosphate buffer, pH = 6.9; 3 mmol/l 
magnesium chloride ). After an incubation of 10 minutes at 37 ºC reactive B (6.6 kU/l 
acylCoA oxidase; 7,5 kU/l peroxidase; 1.2 mmol/l methyl-N-ethyl-N-hydroxyethyl 
aniline) was added. The mixture was incubated again for 10 minutes at at 37 ºC, 
after which the absorbance was measured at 550 nm. The concentration of NEFA 
was than determined by comparison with a standard curve prepared from serial 
dilutions of oleic acid in saline. 
 
2.2 Protein analysis 
2.2.1 Total protein extraction  
a)  Protein extraction from tissue 
Individual hypothalami were homogenized on ice in 300-500 ul of lysis buffer, 
with the volume of buffer varying according to the size of the hypothalamus. The 
lysis buffer, radioimmunoprecipitation assay buffer (RIPA), contained sodium 
phosphate buffer (PBS, 0.1 M, pH 7.4), 1 % Triton X-100, sodium dodecyl sulphate 
(SDS, 0.1 %), sodium azide (0.5 %), ethylenediaminetetraacetic acid (EDTA; 2 mM), 
sodium deoxycholate (0.5 %), phenylmethanesulfonyl fluoride (PMSF; 1 mM) and a 
Materials and methods 
62 
 
protease inhibitor cocktail (Roche Diagnostics, GmbH). Lysates were incubated 
overnight at -80°C and then centrifuged at 14000 rpm for 10 minutes at 4°C. 
Supernatants were collected and stored at -80°C for later use. Total protein 
concentration was determined by the method of Bradford (Protein Assay; Bio-Rad 
Laboratories).  
b) Protein extraction from hypothalamic astrocytes primary cultures 
To extract protein from primary astrocyte cultures, the cells were first washed 
twice with PBS. The PBS was then totally removed and the cells lysed with 200 µl of 
lysis buffer (25 mM HEPES, 150 mM KCl, 2 mM  EDTA, 0.1% Igepal, 1 mM PMSF, 10 
uM benzamidine and leupeptin and 0.5 mM DTT) in each dish. The samples were 
frozen at - 80°C to boost cell lysis. Next, samples were centrifuged for 20 minutes at 
14000 rpm (4°C). Following centrifugation, supernatants were removed and frozen 
over night. Finally, the samples were lyophilized (Cryodos. TELSTAR. Tarragona, 
Spain) and the resulting pellet resuspended in 40 µl of sterile water and stored at – 
80°C. 
Total protein concentration was determined by the method of Bradford (Protein 
Assay; Bio-Rad Laboratories). 
2.2.2 Quantification of protein concentration 
Total protein concentration was determined by the method of Bradford 
(Protein Assay; Bio-Rad Laboratories), developed by Marion M. Bradford in 1976 
(Bradford, 1976). This colorimetric method is based on the principle of protein-dye 
binding and the shifts caused in the absorbance that is measured by using a 
spectrophotometer.  
Samples were diluted in distilled water (primary cultures) or lysis buffer 
(tissue) and mixed with Bradford reagent (Bio-Rad Laboratories, Inc., Hercules, CA, 
USA), following the manufacturer’s instructions and incubated for 5 minutes at room 
temperature (RT). For each assay, a standard curve was prepared with increasing 
concentrations, from 0 to 25 µg/µl of BSA. The standard curve and unknown samples 
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were pipetted into a 96-well plate and the absorbance measured at 595 nm in an 
TECAN Infinite M200 spectrophotometer. 
2.2.3 Western blotting 
The reagents used for western blotting analysis were purchased from Bio-Rad 
Laboratories, Inc. except when indicated. 
An appropriate concentration of total protein (10, 40 or 60 µg depending on 
the protein to be analyzed) was mixed with an equal volume of Laemmli  buffer (2x), 
containing Tris-HCl  (1 M, pH 6.8), glycerol (25 %), SDS (2 %) and bromophenol blue 
(0.01 %) and denatured in a thermoblock for 5 minutes at 100 ºC. 
The protein was resolved on SDS-polyacrylamide gels under denaturing 
conditions and electro-transferred to polyvinylidene difluoride (PVDF) membranes. 
Transfer efficiency was determined by Ponceau red dyeing. Membranes were 
blocked with Tris-buffered saline (TBS, 20 mM) containing 0.1% Tween 20 and 5% 
nonfat dried milk or 5% BSA for 2 hrs and incubated overnight at 4°C under agitation 
with the primary antibody at a concentration of 1:1000 unless otherwise stated. 
Primary antibodies used were against glial structural proteins and indicators of glial 
activation: GFAP, vimentin, Iba1; intra- cellular signaling proteins: pAKT (1:500), AKT, 
pIKB (1:500), STAT3, pSTAT3(tyr705) (1:500), pSTAT3(Ser634) (1:500), pIRS (1:500), pPTEN 
(1:500), PTEN, SOCS3 and the housekeeping protein glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) and actin. Membranes were washed with TBS and 
incubated with the corresponding secondary antibodies conjugated with peroxidase 
(Pierce Biotechnology, Rockford, IL, USA). Peroxidase activity was visualized by 
chemiluminescence (Perkin Elmer Life Science, Boston, MA, USA) and quantified with 
a Kodak Gel Logic 1500 Image Analysis system and Molecular Imaging Software, 
version 4.0 (Rochester, NY, USA) and ImageQuant Las 4000 Software (GE Healthcare 
Life Sciences, Barcelona, Spain). Gel loading variability was normalized with either 
the non-phosphorylated form of the protein, GAPDH or actin. Data were normalized 
to control values on each gel. 
 
Materials and methods 
64 
 
2.2.4 Determination of hypothalamic levels of leptin, IL1β, IL6, IL10 and 
TNFα by using a multiplex magnetic bead immunoassay 
Hypothalamic levels of leptin, IL6, IL1β, IL10 and TNFα were determined in 
duplicated by a multiplexed magnetic bead immunoassay kit according to the 
manufacturer’s specifications (Millipore). Beads conjugated to the appropriate 
antibodies and 5 µg of hypothalamic lysate in assay buffer (25 µl each) were 
incubated for 2 hours at RT and under moderate shaking. Afterwards, plate wells 
were washed two times with the provided wash buffer and 25 µl of the biotinylated 
detection antibody was added and incubated for 1 hour at RT while shaking at 500 
rpm. Finally, 25 µl of the reporter dye, streptavidin-conjugated phycoerythrin, was 
added and incubated for 30 minutes. After washing, the beads were analyzed in a 
Bio-Plex suspension array system 200 (Bio-Rad Laboratories) and mean fluorescence 
intensity was analyzed using Bio-Plex Manager Software 4.1. 
 Leptin IL-6 IL1-β IL10 TNF-α 
Sensitivity (pg/mL) 10.2 30.7 2.8 2.7 1.9 
Intra-assay CV (%) 3.4 2.3 3.6 3.8 2.7 
Inter-assay CV (%) 14.3 12.7 11.3 9 10.8 
Table 5. Assay sensitivities (minimum detectable concentrations, pg/mL), intra- and inter-assay coefficient 
of variation for rat cytokine magnetic bead immunoassay. CV = coefficient of variation 
2.2.5 Multi-pathway magnetic bead kit primary cultures  
A Multi-Pathway Signaling Magnetic Bead kit, was used to detect changes in 
phosphorylated ERK/MAP kinase 1/2 (Thr185/Tyr187), Akt (Ser473), STAT3 (Ser727), 
JNK (Thr183/Tyr185), p70 S6 kinase (Thr412), NFkB (Ser536), STAT5A/B 
(Tyr694/699), CREB (Ser133), and p38 (Thr180/Tyr182) and the corresponding total 
protein levels in astrocyte cell lysates using the Luminex® xMAP® technology.  
After corresponding treatments, astrocytes were lysed in the supplied lysis 
buffer with protease inhibitors added. The amount of protein/well was adjusted to a 
concentration of 15 µg by diluting with the provided assay buffer. The protocol was 
followed according to the manufacturer’s specifications (Millipore). Beads 
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conjugated to the appropriate antibodies and astrocytes cell lysates (25 µl each) 
were incubated O/N at 4°C with shaking and protected from light. The next morning, 
plate wells were washed two times with the provided assay buffer and 25 µl of the 
biotinylated detection antibody was added and incubated for 1 hour at RT with 
shaking and in dark. Then, 25 µl of the reporter dye, streptavidin-conjugated 
phycoerythrin, was added and incubated for 15 minutes after which 25 µl 
amplification buffer was added for 15 minutes. Finally, the beads were analyzed in a 
Bio-Plex suspension array system 200 and mean fluorescence intensity was analyzed 
using Bio-Plex Manager Software 4.1. 
 
2.3 Quantification of relative levels of mRNA 
2.3.1 Total RNA isolation 
Total mRNA was isolated from the entire hypothalamus, subcutaneous and 
visceral fat pads, and astrocyte cultured cells using the TRIzol® Reagent method 
(Invitrogen) and according to manufacturer’s instructions. Primary astrocytes grown 
in petri dishes were rinsed with ice-cold PBS before 1 mL of TRIzol® was added in 
order to lyse and collect the cells. For the hypothalamus or adipose tissue, 1 mL of 
TRI-Reagent was used.  
Total mRNA concentration was quantified using the spectrophotometer 
Nanodrop 1000, from Thermo Scientific.  
2.3.2 Quantitative real-time polymerase chain reaction assay (qRT-PCR) 
Relative mRNA levels were quantified in subcutaneous and visceral adipose 
tissue and primary cultured astrocytes by qRT-PCR. Complementary DNA (cDNA) was 
synthesized from 1 or 2 μg of total mRNA by using a high capacity cDNA reverse 
transcription kit (Applied Biosystems, Foster City, CA, USA).  
Quantitative RT-PCR was performed by using assay-on-demand kits (Applied 
Biosystems, Foster City, CA, USA). Taq-Man Universal PCR Master Mix (Applied 
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Biosystems) was used for amplification according to the manufacturer’s protocol in 
an ABI PRISM 7000 Sequence Detection System (Applied Biosystems). Values were 
normalized to the housekeeping genes 18S and Rpl13a. According to manufacturer’s 
guidelines, the ΔΔCT method was used to determine relative expression levels. 
Statistics were performed using ΔΔCT values. All data are expressed as % control at 
each age. 
In adipose tissue, leptin, adiponectin, (IL) 1β, 6 and TNFα genes were 
analyzed. In adipose tissue, various housekeeping genes were analyzed to find an 
internal control that did not vary between groups. However, we were unable to find 
suitable housekeeping genes that did not vary with age, sex and litter size; thus, the 
mRNA levels of the genes analyzed in adipose tissue were not compared between 
ages. Results are compared at each age to determine the effects of sex and litter size 
and were normalized to two of the following: phosphoglycerate kinase 1 (Pgk-1), 
cyclophilin A (PPIA) or ribosomal protein S 18-like (Rps18). The housekeeping genes 
used did not change between groups at a given age. All data are expressed as the 
percent of the values of L12 males at each age. 
In primary cultures the following genes were analyzed:  GFAP, vimentin, (IL) 
1β, 6, TNFα DDIT, IGF-1, Esr1, Esr2, NFκb, Iκbb Results were normalized to Rps18 or 
ribosomal protein L13a (Rpl13a).  
The primers (Applied Biosystems) employed for the analysis of gene 
expression by RT-PCR are shown in Table 6. 
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Gene Reference 
Adiponectin Rn00595250_m1 
CHOP Rn00492098_g1 
GFAP Rn00566603_m1 
IGF-1 Rn99999087_m1 
IKBKB Rn00584379_m1 
IL-1β Rn01336189_m1 
IL-6 Rn01410330_m1 
IL-10 Rn00563409_m1 
Leptin Rn00565158_m1 
NFKBIA Rn01473657_m1 
PPIA Rn00690933 
Pgk-1 Rn00821429 
Rpl13a Rn00821946_g1 
TNFα Rn01525859_g1 
Vimentin Rn00579738_m1 
18s Rn01428915_g1 
 
Table 6. List of primers used in adipose tissue and astrocyte primary cultures. 
 
2.4 Transcardial perfusion 
Tissue fixation was carried out by transcardial perfusion in vivo with 0.1 M 
phosphate buffer (PB) and then PB-buffered 4% paraformaldehyde (PFA; pH 7.4) and 
1% glutaraldehyde (GA) in PB, perfusing approximately 300 mL/rat. The animals 
were previously profoundly anesthetized with an intraperitoneal (IP) injection of 
pentobarbital (1 mg/kg; Braun Vetcare, Barcelona. Spain). 
When perfusion was completed, brains and subcutaneous and visceral fat 
pads were collected and post-fixed overnight in 4% PFA overnight at 4°C. After three 
washes with PB 0.1 M, they were stored in cryoprotection solution (30% sucrose, 
30% ethylene glycol in PB) at -18°C until used. PND 10 and 21 rats were not perfused 
in vivo. At sacrifice, the brains and fat pads were directly placed into 4% PFA (pH 7.4) 
and fixed in this solution overnight at 4°C. 
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2.4.1 Histological sections  
2.4.1.1 Perfused brain sections 
Perfused brains were used to obtain 40 µm coronal sections by using a 
vibratome (Leica VT1200S, Leica Biosystems Nussloch GmbH, Nussloch, Germany). 
According to Paxinos and Watson atlas “The rat brain in stereotaxic coordinates”, all 
sections that contained the arcuate nucleus (between 2.3 and 3.3 mm from Bregma), 
were collected and preserved in cryoprotecion solution and stored at -18ºC until 
used for immunohistochemistry. 
2.4.1.2 Visceral adipose tissue sections 
Visceral adipose tissue was sectioned for subsequent histological study of 
adipocyte morphology. Sections of 15 µm were obtained with a cryostat (Leica, 
Madrid, España).  
Samples were equilibrated to -15ºC inside the cryostat workstation for 45 
minutes. A block of frozen visceral fat was then carefully attached to a microtome 
chuck with aspecial tissue glue that allows frozen sectioning at the optimal cutting 
temperature (OCT media; Tissue Tek, Electron Microscopy Sciences, Hatfield, PA, 
USA). 
The 15 µm sections were mounted onto poly-lysine treated microscope slides 
and stored at -20ºC until stained with hematoxilyn-eosin for examination. 
 
2.5 Staining techniques for histological studies 
 2.5.1 Immunohistochemistry in the hypothalamus 
Immunohistochemistry was performed on coronal free-floating brain sections 
(40 µm). Six sections per animal were selected throughout the arcuate nucleus. All 
experimental groups were assayed in parallel.  
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All washes and antibody incubations were done under mild shaking on a 
rotating platform. The wash solution (PBT) consisted of PB (0.1M; pH 7.4), 0.3% 
Triton X-100 and 0.3% BSA. This buffer was used in all washes and incubations.  
Free-floating sections were first washed several times with PB to completely 
remove the cryoprotection solution. Next, suppression of endogenous peroxidase 
activity was carried-out by incubating the sections in 30% methanol containing 3% 
hydrogen peroxide for 30 minutes at room temperature. The sections were rinsed 
with wash solution (3 times, 10 minutes each) and incubated in blocking solution (3% 
triton X-100 and 3% BSA in PB) for 2 hours at room temperature to reduce non-
specific binding. 
The sections were then incubated with a primary antibody that recognizes 
either GFAP (Sigma, 1:1000) or Iba1 (Wako, 1:500) overnight at 4ºC. The following 
day, the sections were washed (3 times for ten minutes each) and incubated in 
biotinylated anti-mouse secondary antibody (1:2000 for 2 hours at RT) or 
biotinylated anti-rabbit secondary antibody (1:1000 for 2 hours at RT). Afterwards, 3 
washes were done and sections were placed in avidin-biotin complex (ABC 32020; 
Pierce Biotechnology) for signal amplification during 2 hours. The ABC complex was 
diluted 1:500 in washing solution plus 5% BSA. The slices were then washed 3 times. 
Finally, peroxidase activity was revealed by incubating sections with 0.03% 3-
3’ diaminobenzidine (DAB; Sigma) and 0.01% hydrogen peroxide in PB. The reaction 
was monitored until the signal was clearly developed (approximately 2-3minutes). 
The sections were then placed in 0.1 M PB and mounted on poly-L-lysine hydro-
bromide (50 µg/ml; Sigma) coated glass slides. Lastly, and after dehydration in 
increasing concentrations of ethanol (70%, 96%, 100%) and then xylol, samples were 
covered with Depex (BDH Laboratory Supplies, United Kingdom) and a coverslip 
applied. The slides were examined by using an optical microscope (ZEISS. 
Thornwood, NY, USA). Images were captured at 40X magnification by using a digital 
camera and Image Pro-Plus software. Immunostaining was absent when the primary 
antibody was omitted. 
 
Materials and methods 
70 
 
2.5.2 Double immunohistofluorescence  
Double labeling for GFAP (Sigma) and leptin receptor, Ob-R (Santa Cruz 
Biotechnology Inc., Santa Cruz, CA, USA) was performed on coronal free-floating 
brain sections (40 µm). Six sections per animal were selected throughout the arcuate 
nucleus. All experimental groups were assayed in parallel.  
The same solution for washes, blocking and antibody incubation as described 
in 2.3.1 section were used for immunohistofluorescence. Free-floating sections were 
washed several times with PB to completely remove the cryoprotection solution 
followed by one wash with PBT and then incubated for 1.5 h in the blocking solution. 
Primary antibodies were then added, GFAP (mouse, 1:1000) and leptin receptor Ob-
R (goat, 1:250)., and incubated at 4ºC under mild shaking for 48 hours. 
After primary antibody incubation, the sections were washed (3 times for ten 
minutes each) and incubated in biotinylated anti-goat secondary antibody (1:1000 
for 5 hours at RT) for Ob-R signal amplification. Afterwards, 3 washes were done and 
sections were placed in the secondary antibody Alexa Fluor® 633 goat anti-mouse 
IgG (Molecular Probes. Eugene, OR, USA, 1:2000) and streptavidin, Alexa Fluor® 488 
conjugate (Molecular Probes, 1:2000) and incubated in the dark for 1.5 h. The slices 
were then washed 3 times with 0.1 M PB and carefully mounted while being 
protected from the light and then a coverslip was placed over the tissue using Clear 
Mount. 
Images were captured using a confocal fluorescence microscope (Leica) with 
wavelengths of 495 nm and 632 nm being used for the excitation of Alexa-Fluor-488 
and Alexa-Fluor-633 fluorophores, respectively. Negative controls, where the 
primary antibody was omitted, were included in every assay and in which 
immunofluorescence signal was absent.  
2.5.3 Hematoxylin and eosin staining of visceral adipose tissue (VAT) 
Visceral adipose tissue slices (15 µm thick) were stained with hematoxylin-
eosin. First, sections were fixed in a 10% buffered formalin solution for 15 minutes.  
Following a rinse with distilled water, sections are soaked in hematoxylin (Panreac, 
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Barcelona, Spain) for 10 minutes to stain the nuclei. Next, eosin (Leica Biosystems, 
Barcelona, Spain) staining was carried out during 1 minute and the slides then rinsed 
with water. Sections were dehydrated in increasing concentrations of ethanol (70°, 
96°, 100°) for 1 minute each and then 3 minutes in xylol. Depex was used to place a 
coverslip over the tissue. Sections were imaged with an optical microscope (ZEISS) 
using a 40X objective and the digital images were captured with a digital camera (JAI 
Corporation, CV-S3200, Japan) and analyzed with Image-Pro Plus software (version 
5.0; Media Cybernetics Inc., Silver Spring, MD, USA). The mean perimeter and area of 
the adipocytes were calculated from visceral adipose tissue slices from 4 animals per 
group, analyzing 4 sections per animal and measuring 5-10 cells per section. 
 
2.6 Quantification of GFAP+ cells and morphological analysis 
For the quantitative evaluation of astrocytes, six sections per animal 
throughout the arcuate nucleus were analyzed. In each section, images of a single 
focal plane from twenty rectangular fields of the arcuate nucleus (area of 19.5 mm2 
per field), ten on each side of the third ventricle, were captured using 40X 
magnification with an optical microscope attached to a digital camera. Images were 
processed using Image-Pro Plus software.  
The number of GFAP immunoreactive (GFAP+) cells per field was counted, as 
well as the number of primary projections (those emerging from the soma) of each 
GFAP positive cell determined with ImageJ software.  All morphometric analyses 
were performed without previous knowledge of the experimental group (samples 
were blinded for analysis). 
 Analysis of the mean levels of Ob-R immunoreactivity in GFAP positive cells in 
the arcuate nucleus was performed using ImageJ software. The red and green signals 
over individual somas were separated, measured and recorded in a mean of 10 cells 
per field and 10 fields/animal throughout the arcuate nucleus. From these 
measurements, the mean intensity of Ob-R immunoreactivity in the soma of GFAP 
positive cells was determined. 
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2.7 Double immunocytofluorescence for GFAP and Iba1 in primary 
astrocyte  cultures 
Double immunocytofluorescence was performed in hypothalamic astrocytes 
primary cultures from postnatal day 2 Wistar rats in order to determine if microglia 
can be detected in the enriched astrocyte cultures. An antibody against GFAP was 
used to label astrocytes, whereas the Iba 1 antibody was used to identify microglia.  
Cells were seeded on round coverslips that had been placed in 24-well plates 
and previously treated with poly-L-lysine hydrobromide (10 μg/ml; Sigma-Aldrich). 
All steps were performed in the well plate until coverslips were removed to be 
mounted. 
Forty-eight hours after the cells were seeded the wells were washed three 
times with cool PBS and fixed with 4% paraformaldehyde for 15 minutes at room 
temperature. The wells were washed 3 times and then equilibrated with buffer 
consisting of 0.1 M PB (pH 7.4), 0.1% BSA and 0.3% Triton-X100 for 15 minutes. 
Blocking solution [0.1 M PBS, (pH 7.4), 0.3% BSA and 0.3% Triton-X100] was added to 
the samples for 1.5 hours. The two primary antibodies, mouse anti-GFAP (Sigma, 
1:1000) and rabbit anti-Iba1 (Wako, 1:1000) were added to the corresponding wells 
and incubation was then carried out overnight at 4ºC. 
The following morning, the primary antibody solution was removed and the 
wells rinsed with PB 0.1M, three times, 5 minutes each wash. The two secondary 
antibodies (diluted in blocking solution) were added and incubated during 1 hour in 
the dark and at room temperature. The secondary antibodies (1:1000) used were 
goat anti-mouse and goat anti-rabbit IgG conjugated with Alexa Fluor® 488 and 
Alexa Fluor® 633 (Molecular Probes. Eugene, OR, USA), respectively. The final three 
washes (10 minutes each) were done in the dark and the coverslips were carefully 
mounted on microscope slides cover glasses using a drop of Clear Mount mounting 
medium and stored in the dark at 4ºC until examination.  
Images were captured using a confocal fluorescence microscope. Negative 
controls, where the primary antibody was omitted, were included in every assay and 
in which immunofluorescence signal was absent.  
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Antigen Host 
Working 
dilution 
Commercial 
source 
GFAP Mouse 1:1000 Sigma 
Iba 1 Mouse 1:1000 Wako 
Ob-R Goat 1:500 Santa Cruz 
Table 7. Antibodies used for immunohistochemistry and immunocytochemistry 
 
2.8 Detection of nitrites and nitrates in culture media 
Culture media was collected and kept frozen at -80ºC until used. 
Quantification of nitrites and nitrates (NO3
- and NO2
-
) was performed according to 
Miranda and colleagues (Miranda et al., 2001). The assay is based on the 
simultaneous detection of nitrate and nitrite concentrations by reducing nitrates 
with vanadium (III) and the combined detection by using the acidic Griess reaction 
(Griess, 1879). The resulting color is spectrophotometrically quantified at a 
wavelength of 540nm.  
Briefly, in a 96-well plate, 100 μL of vanadium (III) chloride (VCl3) was added 
to 100 μL of each cell culture media sample and, immediately, 100 μL of Griess 
reagent was added. The Griess reagent was prepared just before use by mixing equal 
volume of ethylenediamine dihydrochloride (NEDD) and sulfonamide. The plate was 
then incubated for 30 minutes at RT and the absorbance read (Tecan Infinite M200). 
The results were compared to a standard curve consisting of sodium nitrate (NaNO2) 
in concentrations from 1 to 200 μM. 
 
2.9 Estimation of the number of cells  
The cristal violet dye elution (CVDE) method was employed to determine cell 
viability in response to each in vitro cell treatment. The cristal violet dye binds to cell 
nuclei, which is then solubilized and quantified spectrophotometrically. The resulting 
absorbance is proportional to DNA content and therefore, cell number.  
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For this assay, cells were grown in 24 well plates. The cells were washed twice 
with PBS and then 1 mL of 1% GT was added in order to fix the cells. After 10 
minutes, the GT was removed and the cells were washed twice with PBS. The cristal 
violet solution (0.1%) was then added (1 mL) and the cells incubated at RT for 20 
minutes. The cristal violet solution was removed and the cells rinsed under running 
tap water for 20 minutes. The plate was then left at RT for 2 hours or at 37°C for 30 
minutes to dry completely. The cristal violet was then dissolved with 10% acetic acid, 
mixed well and 200 µL added to a 96 well plate and the absorbance read at 590 nm. 
The number of cells is calculated according to the following equation: Number of 
cells = (265030* absorbance)-1950. 
 
2.10 Statistical analysis 
The program SPSS version 19.0 (SPSS Inc., Chicago, IL, USA) was used for data 
analysis. To determine the effect and/or interaction of two or more factors two or 
three-way ANOVAs were used. When significant effects were found with the two or 
three-way analyses, a subsequent two-way and/or one-way ANOVA followed by 
Scheffé’s f test was used to determine whether specific differences existed amongst 
the experimental groups. Bonferroni correction was used for multiple comparisions 
in case of primary astrocyte cultures studies. Two-tailed Student’s t tests were used 
to compare differences between two independent groups. All data are presented as 
mean ± SEM. The results were considered statistically significant at p<0.05. The p 
values in the figures represent the results of the one-way ANOVA or Student’s t test 
when indicated. 
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1. Effects of neonatal overnutrition throughout development in male and 
female rats 
1.1 Effects of sex, litter size and age on body weight, body length and food 
intake. 
1.1.1 Body weight 
On the day of birth (PND0), all litters were organized and cross-fostered such 
that the mean starting weight did not differ between groups, as shown in Figure 15A. 
It is of note that body weight at birth was higher in males than females (F(1,284) = 34.1, 
p<0.0001; Figure 15B). 
   
 
 
 
 
Figure 15. A. Mean body weight (BW) of each experimental group on the day of birth. N = 62-66 for each 
experimental group. NS = not significant. B. Mean BW of males and females on the day of birth n =124-
126.  Student’s T test: *** = p<0.0001. 
 
The changes in body weight, body length and food intake were studied from 
birth to PND150. There was an effect of sex (F(1,1923) = 12539.4, p<0.0001), litter size 
(F(1,1923) = 210.05, p<0.0001) and age (F(20,1923) = 4546.4, p<0.0001) on BW, with 
interactions between sex and litter size (F(1,1923) = 20.9, p<0.0001), sex and age 
(F(20,1923) = 381.1, p<0.0001) and litter size and age (F(20,1923) = 2.8, p<0.0001). Figure 16 
shows the evolution of BW from birth to PND150. 
 
 
 
A 
A B 
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Figure 16. Change in body weight (BW) throughout development in male and female rats raised in control 
litters (L12) and small litters (L4). Data are expressed as mean ± SEM. (F(83,2006) = 1253.8); p<0.0001. a= 
Effect of litter size on BW in males; b= Effect of litter size on BW in females; c= Effect of sex on BW in small 
litters (L4); d= Effect of sex on BW in control litters (L12). ANOVA repeated measures: Sex effect (F(1, 42): 
496.15, p<0.0001) and Litter size effect: (F(1, 42): 10.1, p<0.003). 
 
Neonatal overnutrition produced changes in body weight as early as PND10. 
At this early postnatal age, both males and females from L4 weighed more than 
those from L12, (F(1, 48) = 128.0, p<0.0001), with no differences between sexes (Figure 
17). 
 
 
 
 
 
 
 
 
a 
b 
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Figure 17. Mean body weight (BW) at PND10. There was an increase in BW as a consequence of neonatal 
overnutrition in both males and females. L12= litter of 12 pups. L4 = litter of 4 pups. (F(3,47) = 42.8); *** = 
p<0.0001. 
 
The effect of neonatal overnutrition on BW continued at weaning, PND21, 
(F(1,223) =146.9, p<0.0001), with no difference between males and females (Figure 
18A). 
At PND28, both males and females raised in small litters continued to weigh 
more than control litters (F(1,170) = 73.9, p<0.0001). In addition, even at this 
prepubertal stage there was an effect of sex on BW (F(1,170): 10.2, p<0.003), with L4 
males weighing more than L4 females (Figure 18B).  
 
 
 
 
 
 
 
 
 
 
Figure 18. Mean body weight (BW) at PND21 (A) and at PND28 (B) in rats raised in litters of 12 (L12) or 4 
(L4) pups. PND21 (F(3, 226) = 50.1); PND28 (F(3, 173) = 27.9); *** = p<0.0001. 
 
A B 
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As can be observed in Figure 19, at PND56 males weighed more than females 
regardless of their experimental group and this effect remained until the end of the 
study. However, the effect of litter size on body weight ceased to be observed at 
approximately PND56 in both sexes. 
 
 
 
 
 
 
 
 
 
 
Figure 19. Mean body weight (BW) at PND56 in rats reared in litters of 12 (L12) or 4 (L4) pups when the 
effect of litter size was no longer observed in either sex. (F(3,95) = 89.2; *** = p<0.0001. 
 
Although the effect of litter size on BW ceased to be observed at 
approximately PND56, it was again manifest at approximately PND90, but only in 
males (Figure 20A). Male rats from L4 weighed significantly more than those from 
L12 throughout the rest of the study, with no further effect seen in females (Figure 
20 B). 
 
 
 
 
 
 
 
 
Figure 20. Body weight at PND91 (A), when males from litters of 4 pups (L4) again weighed more than 
those from litters of 12 pups (L12). Males continued to weigh more than females regardless of litter size. 
B A 
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(F(3,46) = 165.7; *** = p<0.0001. At PND150 (B) the effect of litter size in males continued to be observed, 
while no effect in females was found. 
 
1.1.2 Body length 
There was an effect of sex (F(1,1144) = 1284.8, p<0.0001), litter size (F(1,1144) = 
27.8, p<0.0001) and age (F(18,1144) = 6242.7, p<0.0001) on body length with 
interactions between sex and age (F(18,1144) = 53.3, p<0.0001) and litter size and age 
(F(18,1144) = 11.1; p<0.0001). The changes in body length throughout development can 
be seen in Figure 21. 
Figure 21. Changes in body length throughout development in male and female rats from control litters of 
12 pups (L12) and overnourished litters of 4 pups (L4). Data are expressed as mean ± SEM. (F(72,1183) = 
1538.4, p<0.0001). a= Effect of litter size on BW in males; b= Effect of litter size on BW in females; c= 
Effect of sex on BW in small litters (L4); d= Effect of sex on BW in control litters (L12). ANOVA 
repeated measures: sex (F(1, 44): 168.91, p<0.0001); litter size (F(1, 44): 24.73 p<0.0001). 
 
On the day of birth, the mean body length did not differ according to litter 
size (Figure 22A; however, there was an effect of sex with males being longer than 
females (F (1,245) = 27.6, p<0.0001; Figure 22B). 
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Figure 22. A. Mean body length of each experimental group on the day of birth N = 64-66, NS = not 
significant. B. Mean body length of male and female rats showing differences between the sexes on the 
day of birth. N=124-126. *** = p <0.0001. 
 
By PND10, both males and females with neonatal overnutrition (L4) were 
longer than those from control litters (L12) (F(1,48) = 50.3, p<0.0001), as can be seen in 
Figure 23. The litter size effect continued at PND21 (F(1,179) = 85.4, p<0.0001) and 
PND28 (F(1,128) = 39.8; p<0.0001). 
 
 
 
 
 
 
 
 
Figure 23. On postnatal day 10, both males and females from litters of 4 pups (L4) were longer than those 
from litters of 12 pups (L12). There was no effect of sex observed at this time. (F(3, 47) = 18.1, *** = 
p<0.0001, n =12. 
 
At PND35, males were found to be longer than females (F(1,94) = 27.2; 
p<0.0001) and remained so at all subsequent ages.  A litter size effect (F(1,94) = 24.6; 
A B 
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p<0.0001) was also found at PND35, but was no longer observed in either sex after 
PND56 (Figure 24).  
 
 
 
 
 
 
 
 
 
 
Figure 24. Males began to be longer than females around PND 35 (A) and at PND 56 (B) the litter size 
effect on body length was no longer observed. PND35: (F(3,93) = 18.1); PND56: (F(3,47) = 38.1) ; *** = p 
<0.0001. 
 
1.1.3 Mean food intake per day  
The mean food intake per day throughout the study, was affected by sex 
being greater in males than in females (F(1,321) = 591.7, p<0.0001), by litter size, with 
L4 rats eating more than L12 rats (F(1,320) = 14.6, p<0.0001) and increased with age 
(F(15,321) = 73.6, p<0.0001), with an interaction between sex and age (F(15,321) = 9.4, 
p<0.0001) and between litter size and age (F(15,321) = 1.9, p<0.03)  . Males ate more 
than females even during the first week after weaning (PND28, sex effect: F(1,58) = 
6.5, p<0.02). At this time both male and female rats from L4 ate more than those 
from L12 (ML12: 11.3 ± 0.2, ML4: 12.7 ± 0.3, FL12: 10.1 ± 0.3, FL4: 11.7 ± 0.3 g/day; 
litter size: F(1,58) = 13.3, p<0.002). Rats from L4 continued to eat more than those 
from L12 until approximately PND50 after which there was no effect of litter size. At 
approximately PND120 (week 14 post-weaning), L4 males ate again significantly 
more than L12 males F(3,11) = 46.1, p<0.0001) . The mean daily food intake from 
weaning until the end of the study was greater in males than in females. However, 
there was no affect of litter size in either sex at the end point of the study, PND150 
B A 
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(ML12: 21.3 ± 0.9, ML4: 23.2 ± 0.5, FL12: 15.3 ± 0.3, FL4: 16.1 ± 1.1 g/rat/day; 
p<0.0001). 
Figure 25. Mean daily food intake measured at each week post-weaning in male and female rats from 
control litters of 12 pups (L12) and overnourished litters of 4 pups (L4). Data are expressed as mean ± 
SEM. (F(63, 384) = 29.4 , p<0.001). a= Effect of litter size on food intake in males (M12 different from M4); b= 
Effect of litter size on food intake in females; c= Effect of sex on food intake in small litters (L4); d= Effect 
of sex on food intake in control litters (L12). 
 
1.2 Effects of litter size and sex on adipose tissue quantity and distribution 
As described above, over-nutrition during early postnatal life resulted in rapid 
weight gain. However, this effect was attenuated in early adulthood, only to appear 
again around PND90 selectively in males. Although no litter size effect was observed 
on body weight in early adulthood, body composition could be affected. Moreover, 
it is well established that adult males and females have different adipose tissue 
distribution both in rodents (Grove et al., 2010) and in humans (Schreiner et al., 1996; 
Jackson et al., 2002; Goodpaster et al., 2005; Shen et al., 2009b), but little is known 
regarding this sex difference during prepubertal life.  
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1.2.1 Subcutaneous adipose tissue  
The amount of SCAT was influenced by sex (F(1,164) = 152.5, p<0.0001), litter 
size (F(1,164) = 78.3, p<0.0001) and age (F(5,164) = 214.8, p<0.0001) with interactions 
between sex and litter size (F(1,164) = 5.2, p<0.05), sex and age (F(5,164) = 57.3, 
p<0.0001), litter size and age (F(5,164) = 3.2, p<0.009), and sex, litter size and age 
(F(4,164) = 6.6, p<0.0001). When the amount of SCAT was normalized to body weight 
(g/100 g BW), these effects remained [sex (F(1,164): 74.0, p<0.0001), litter size (F(1,164) = 
23.8, p<0.0001) and age (F(5,164) = 85.2, p<0.0001)] with interactions between sex and 
age (F(5,164) = 87.8; p<0.0001, litter size and age (F(5,164) = 13.6; p<0.0001) and sex, 
litter size and age (F(5,164) = 3.7; p<0.01). 
At PND10, the amount of SCAT was affected by sex (F(1,47) = 20.5, p<0.0001) 
and litter size (F(1,47) = 150.5, p<0.0001), with animals from small litters having more 
SCAT than those from control litters in both sexes. In addition, L4 females had a 
greater increase in % SCAT than L4 males (F(3,46) = 59.3), p<0.0001.  
Upon weaning at PND21, the influence of litter size in the amount of SCAT 
remained (F(1,46) = 54.3, p<0.0001), as well as the sex effect (F(1,46) = 19.3, p<0.0001). 
The amount of SCAT continued to be higher in L4 rats of both sexes, with females 
having more than males of their corresponding litter size (Figure 27). 
The effect of litter size (F (1, 24) = 10.5, p<0.005) continued to be present at 
PND30, as well as an overall influence of sex (F (1, 24) = 4.5, p<0.05). 
At PND 50, no differences between males and females were observed; 
however, the effect of litter size remained (F (1, 24) = 6.5, p<0.03). 
The effect of litter size (F (1, 24) = 4.6, p<0.05) was still present at PND85, when 
males had an overall higher percentage of SCAT than females (F(1, 24) = 8.61, p<0.01). 
At PND150, there was no significant effect of litter size, but L4 males tended 
to have higher levels compared to control males, with an overall effect of sex 
observed (F(1,23) = 5.2, p<0.05). 
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Figure 26.  Relative amount of subcutaneous adipose tissue (SCAT) throughout development in male (M) 
and female (F) rats from small litters (L4) and control litters (L12). # = p<0.0001. 
 
1.2.2 Visceral adipose tissue  
Visceral adipose tissue was not collected at PND10 due to the fact that there 
was insufficient tissue for analysis. Throughout the study, the absolute weight of VAT 
depots was affected by sex (F(1,118) = 46.1, p<0.0001), and age (F(4,118) = 146.1, 
p<0.0001) and a litter size effect of p= 0.052, with an interaction between sex and 
age (F(4,118) = 18.5; p<0.0001) and sex, litter size and age (F(4,118) = 3.0, p<0.05). After 
normalizing the amount of VAT to body weight, an effect of sex (F(1,117) = 5.2, p<0.05), 
litter size (F(1,117) = 4.4, p<0.05) and age (F(4,117) = 137.1, p<0.0001) was found. 
At PND21, both sex (F(1,39) = 42.5, p<0.0001) and litter size (F(1,39) = 37.7, 
p<0.0001) influenced the relative amount of VAT. Rats raised in small litters had a 
higher percentage of VAT compared to control rats. In addition, this percentage was 
higher in males than in females of the same litter size. 
At PND30, no effect of litter size was observed, but males had a greater 
percentage of VAT than females regardless of litter size (F(1,20) = 46.2, p<0.0001). 
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In postpubertal rats (PND50, PND85 and PND150) the amount of VAT tended 
to be greater in males than females and in those animals raised in small litters 
compared to control litters, but these effects were not statistically significant, most 
likely due to the high variability within the groups. 
Figure 27. Relative amount of visceral adipose tissue (VAT) throughout development in male (M) and 
female (F) rats from small litters (L4) and control litters (L12). # = p<0.0001. 
 
1.3 Effects of litter size and sex on circulating hormones and cytokines. 
To determine how overnutrition during early life influences circulating 
metabolic hormones and cytokines in males and females throughout development 
glucose, insulin, leptin, adiponectin, IL6, IL1β and TNFα, as well as testosterone and 
17β-estradiol levels were measured.  
1.3.1 Glycemia 
Through development, glucose levels were affected by litter size (F(1,248) = 
10.4, p<0.002) and age (F(5,248) = 139.4, p<0.0001) with interactions between these 
two factors (F(5,248) = 6.2, p<0.0001; Table 8). 
At PND10, when rats were still nursing, with both L4 males and females had 
higher levels of glucose than L12 rats (F(1, 44) = 9.6, p<0.001;  
The effect of litter size remained at weaning (F(1, 42) = 25.9, p<0.0001) . 
Results 
87 
 
At PND30, glycemia decreased in rats of all groups. Between PND85 and 
PND150 glycemia rose significantly in all groups except L12 females, where this rise 
was more gradual starting at PND50. 
1.3.2 Circulating insulin levels  
Throughout the study, insulin levels (Table 8) were affected by sex (F(1,117) = 
12.8, p<0.003) and age (F(5,117) = 23.0, p<0.0001), with an interaction between these 
two factors (F(1,117) = 5.8, p<0.0001). Circulating levels of this hormone were 
significantly increased at PND150 in all groups. 
At PND10, sex (F(1,20) = 9.5, p<0.006) and litter size (F(1, 20) = 29.5, p<0.0001) 
affected insulin levels, with males from L4 having higher levels compared to those 
from L12 (F(3,23) = 13.8, p<0.0001). Females from smaller litters also tended to have 
higher levels than control females, although this difference was not significant. In 
addition, L4 males had higher insulin levels than L4 females. 
At PND21, the litter size effect continued (F(1,20) = 10.0, p<0.005), although 
there was no difference between the sexes. 
The effects of sex and litter size were not observed between PND21 and 
PND150. However, at the end of the study the effect of sex on insulin levels was 
again present (F(1,23) = 11.9, p<0.002). 
1.3.3 Homeostatic model assessment-insulin resistance (HOMA-IR) 
As an index of insulin sensitivity, homeostatic model assessment (HOMA; 
Table 8) was calculated (insulin (mIU/ml) x glucose mg/dl/405) (Table 8). There was 
an effect of sex (F(1,132) = 13.0, p<0.0005), litter size F(1,132) =7.4, p<0.008 and age 
(F(5,132) =16.3, p<0.0001), with an interaction between sex and age (F(5,132) = 5.4, 
p<0.0002).  
Males had a higher HOMA than females at PND10 (sex effect:  F(1,20) = 6.5, 
p<0.02) and PND150 (F(1,22) = 4.8, p<0.01). At PND10, L4 rats of both sexes had a 
higher HOMA index than L12 animals (litter effect: F(1,20) = 23.7, p<0.0001, with males 
L4 having a higher index than L4 females (F(3,20) = 10.9, p<0.0002). The effect of litter 
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size was maintained in both sexes at PND21 (F(1,20) = 10.9, p<0.004). There were no 
differences between groups at P30, 50 or 85.  In females, HOMA decreased between 
PND21 and PND30, and then rose again at PND150 regardless of litter size (F(11,65) = 
3.02 p<0.003). In males, HOMA decreased between PND10 and PND30 and also 
increased between PND85 and PND150 (F(11,68) = 7.0, p<0.0001). 
 
    
GLUCOSE (mg/dl) INSULIN (ng/ml) HOMA 
PND 10* 
ML12  114.4±4.1 0.44±0.07 3.2±0.5 
ML4  130.9±5.9a 0.92±0.10a 7.7±1.2 a 
FL12  121.6±5.1 0.34±0.02 2.4±0.2 
FL4  135.8±4.5a 0.60±0.06b 4.8±0.5 a,b 
PND 21* 
ML12  103.6±5.3 0.32±0.05 2.1±0.4 
ML4  131.7±5.5 0.69±0.24 a 5.4±1.9 a 
FL12  109.3±2.9 0.22±0.04 1.5±0.3 
FL4  125.6±3.1 0.80±0.16 a 6.0±1.3 a 
PND 30 
ML12  68.2±2.9c 0.19±0.03 0.8±0.1 c 
ML4  76.9±4.7 c 0.23±0.05 1.1±0.2 c 
FL12  72.7±4.8 c 0.13±0.01 0.6±0.1 c 
FL4  75.8±4.0 c 0.57±0.37 2.6±1.8 c 
PND 50 
ML12  65.7±3.3 0.89±0.44 3.5±1.8 
ML4  63.8±3.8 0.73±0.36 3.1±1.7 
FL12  63.8±2.4 0.71±0.31 2.6±1.1 
FL4  69.7±3.4 0.37±0.07 1.6±0.3 
PND 85 
ML12  68.8±3.7 0.70±0.18 3.1±0.9 
ML4  61.0±2.4 0.94±0.37 3.5±1.3 
FL12  73.3±3.4 0.15±0.03 0.7±0.2 
FL4  66.3±2.9 0.60±0.22 2.2±0.9 
PND 150 
ML12  85.7±4.0c 3.46±0.99c 13.5±4.4 c 
ML4  78.4±4.0c 2.82±0.25c 12.1±1.1 c 
FL12  81.3±8.7 1.03±0.35c 3.8±1.4b,c 
FL4  84.9±6.3c 1.55±0.40c 6.1±1.7b,c 
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Table 8. Circulating glucose and insulin levels at 10, 21, 30, 50, 85 and 150 days of age, from small (L4) 
and control litters (L12). Glycemia: F(23, 271)= 32.2, p<0.0001; Insulin: F(23, 140)= 7.1, p<0.0001; HOMA: F(23, 
150)= 7.1, p<0.0001 
a
different from rats of same age and sex (litter size effect),
b
different from males of 
same age and litter size, 
c
different from preceding age (same sex and litter size). * non-fasting samples. 
 
1.3.4  Oral glucose tolerance test (OGTT) 
To further investigate insulin resistance, we performed an oral glucose 
tolerance test (OGTT) in the animals scarified at PND 150 one week before sacrifice 
as described in 1.1.1 b section. 
Blood glucose levels were measured 30, 60 and 120 minutes after glucose 
administration in all groups. No differences were found after 30 or 60 minutes. 
However, there was an effect of litter size on blood glucose levels at 120 min after 
glucose oral administration (F(1,24) = 6.5, p<0.02), with L4 rats of both sexes having 
higher blood glucose levels (ML12: 98.3 ± 3.8, ML4: 114.5 ± 4, FL12: 98.7 ± 5.2, FL4: 
115.2 ± 10.3). There were no significant differences in the area under the curve 
(AUC).  
1.3.5 Circulating leptin levels  
Circulating leptin levels (Table 9) were dependent on age (F(5,129) = 21.7, 
p<0.0001) and litter size (F(1,129) = 4.9, p<0.03), with an interaction between these 
two factors (F(1,129) = 3.0, p<0.02).  
At PND10, there was an effect of litter size (F(1,28) = 24.0, p<0.0001) with both 
L4 males and females having higher levels of circulating leptin than their controls. 
This effect remained at PND21 (F(1,18) = 9.3, p<0.007). 
Serum leptin levels increased in all groups between PND85 and PND150. In 
addition, at PND150 males had higher leptin concentrations than females regardless 
of litter size and males from small litters had significantly higher leptin levels than 
their controls (F(3,33) = 23.0, p<0.0001). 
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1.3.6 Circulating adiponectin levels  
Throughout development, circulating adiponectin levels (Table 9) were 
influenced by litter size (F(1,113) = 7.1, p<0.009) and age (F(5,113) = 71.8, p<0.0001), with 
an interaction between sex and age (F(5, 113) = 4.21; p<0.002) and sex, litter size and 
age (F(5,113) = 2.4, p<0.05).  Levels of this adipokine increased with age.  
At 10 days of age, both males and females from smaller litters had higher 
levels of circulating adiponectin than control litters (F(1,20) = 108.4, p<0.0001). When 
weaned, the effect of litter size continued (F(1,20) = 16.2, p<0.003), but only in females 
(F(3,23) = 10.9, p<0.0001). At PND21, there was also an effect of sex (F(1,20) = 11.9, 
p<0.001), with L4 females having higher levels than L4males. 
At PND30, there was an effect of sex effect on serum adiponectin levels (F(1,20) 
= 4.8, p<0.05), while at PND 50, no effect of either sex or litter size was observed. 
Females had higher levels than their corresponding male groups at PND85 
[sex effect (F(1,16) = 6.2, p<0.05)]. At PND150, L12 female rats had higher adiponectin 
levels than L12 males. Adiponectin levels were lower in L4 than L12 females, but the 
inverse occurred in males [litter size and sex interaction: (F(1,23) = 6.9, p<0.02)]). 
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LEPTIN 
(ng/ml) 
ADIPONECTIN 
(ng/ml) 
PND 10* 
ML12  1.25±0.21 21.5±2.8 
ML4  2.61±0.32a 40.0±2.3 a 
FL12  1.24±0.16 17.5±2.3 
FL4  2.43±0.322a 41.9±1.5 a 
PND 21* 
ML12  1.12±0.18 27.6±1.8 
ML4  1.80±0.21 31.9±1.6 
FL12  0.99±0.22 30.3±1.7 
FL4  1.91±0.48a 43.9±3.2 a,b 
PND 30 
ML12  0.43±0.12 62.1±6.0c 
ML4  0.97±0.44 58.4±6.3 c 
FL12  0.71±0.32 42.6±3.0 b 
FL4  1.04±0.54 54.2±5.7 
PND 50 
ML12  0.96±0.32 55.2±4.2 
ML4  0.69±0.29 76.2±5.9 a 
FL12  0.77±0.29 62.2±10.1 
FL4  0.64±0.31 60.9±9.7 
PND 85 
ML12  1.65±0.20 71.6±14.0 
ML4  1.42±0.21 78.0±19.1 
FL12  1.22±0.44 108.2±9.1 b 
FL4  1.04±0.18 105.2±2.5 b 
PND 150 
ML12  9.57±1.05c 80.6±11.1 
ML4  14.46±1.23c 109.4±7.4 
FL12  4.33±0.80b,c 108.2±7.5 
FL4  4.56±0.90b,c 86.4±12.3 
 
Table 9. Circulating leptin and adiponectin levels at 10, 21, 30, 50, 85 and 150 days of age, in rats from 
small (L4) and control litters (L12). Leptin: F(23, 146 )= 5.7, p<0.0001 ; Adiponectin: F(23,136 )= 15.7, p<0.0001. 
a
different from rats of same age and sex (litter size effect),
b
different from males of same age and litter 
size, 
c
different from preceding age (same sex and litter size). * non-fasting samples.  
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1.3.7 Serum IL1β levels 
 
The levels of the inflammatory cytokine IL1β (Table 10) were affected by age 
(F(5,124) = 5.1, p<0.0001) with an interaction between sex and litter size (F(1,124) = 5.1, 
p<0.03).  
At PND10, there was an effect of litter size on circulating IL1β levels (F(1,28) = 
7.5, p<0.02) with males and females from L4 tending to have lower levels of this 
cytokine; however, this effect was not significant between specific groups in the  
post hoc analysis. At weaning, males from L4 tend to have higher levels of IL1β than 
L12 males, with females having the opposite tendency. 
This pattern (L4 males having higher levels than L12 males and L4 females 
having lower levels than L12 females) was repeated at most ages, but these 
differences did not reach statistical significance.  
1.3.8 Serum IL6 levels 
There was an overall effect of age on IL6 levels (F(5,125) = 6.2, p<0.0001; Table 
10). At PND 10, there was an overall effect of sex with males having overall higher 
levels of this cytokine than females (F(1,26) = 4.3, p<0.05). Circulating IL6 levels did not 
vary between groups at PND21 or 30.  
At PND50, there was an effect of sex on circulating IL6 levels (F(1,19) = 4.6, 
p<0.05). There was no effect of sex or litter size at PND85 or PND150, with many 
animals having values below the limit of detection.  
1.3.9 Serum TNFα levels 
There was an effect of age (F(5,131) = 5.5, p<0.0001) on circulating TNFα levels 
(Table 10).  
At PND 10, there were overall effects of sex (F(1,28) = 6.9, p<0.02) and litter size 
(F(1,28) = 10.9, p<0.003) on circulating TNFα levels. Females from small litters had 
lower levels than control females and lower levels than males from small litters.  
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There was no effect of either sex or litter size at PND21 or 30. After PND50, 
most of the animals had circulating TNFα levels at the limit of detection of the assay.  
    IL-1β (pg/dl) IL-6 (pg/ml) TNFα (ng/ml) 
PND 10* 
ML12  14.9±3.1 126.1±38.5 5.1±0.3 
ML4  5.1±1.2a 89.2±44.6 3.4±0.7a 
FL12  15.0±4.1 16.4±12.2 4.0±0.6 
FL4  7.9±2.0a 40.9±29.7 1.3±0.4 a,b 
PND 21* 
ML12  19.6±6.8 56.5±44.6 4.6±1.0 
ML4  46.9±11.3 85.6±39.7 2.5±1.2  
FL12  28.0±9.4 60.4±34.3 2.5±0.8 
FL4  22.8±3.7 112.1±69.8 1.9±0.6 
PND 30 
ML12  32.1±8.0 76.2±47.4 1.6 ±0.4 
ML4  61.3±41.4 18.4±14.4 2.0±0.9 
FL12  67.5±29.0 86.5±35.0 4.1±1.3 
FL4  29.2±13.6 78.3±23.8 2.1±0.7 
PND 50 
ML12  10.6±2.3 0.62 BLD 
ML4  20.9±3.9 0.62 BLD 
FL12  19.3±8.9 17.7±12.7 BLD 
FL4  7.3±2.4 22.1±11.4 BLD 
PND 85 
ML12  15.6±5.5 5.63±5.01 BLD 
ML4  15.7±6.6 4.50±3.88 BLD 
FL12  6.1±2.1 2.58±1.96 BLD 
FL4  6.7±2.1 0.62 BLD 
PND 150 
ML12  23.4±9.6 14.5±6.2 BLD 
ML4  35.3±20.0 15.5±3.6 BLD 
FL12  29.3±26.4 16.4±3.7 BLD 
FL4  22.6±8.0 19.1±0.7 BLD 
 
Table 10. Circulating levels of IL-1β, IL-6 and TNFα at 10, 21, 30, 50, 85 and 150 days of age, from small 
(L4) and control (L12) litters. IL-1β: F(23, 147)= 1.6 , p<0.05; IL-6: F(23, 148)= 2.1 , p<0.005; TNFα: F(3, 31)= 6.1 , 
p<0.003.   adifferent from rats of same age and sex (litter size effect), bdifferent from males of same age 
and litter size, 
c
different from preceding age (same sex and litter size), BLD: below limit of detection * 
non-fasting samples.  
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1.3.10 Testosterone levels 
Circulating testosterone levels in males varied according to age (F(5,50) = 15.1, 
p<0.0001), showing an increase in levels at PND85 and a further increase at PND150. 
(Table 11). 
 
    Testosterone (ng/dl) 
PND 10* 
ML12  0.19±0.05 
ML4  0.76±0.27 a 
PND 21* 
ML12  0.60±0.20 
ML4  0.63±0.21 
PND 30 
ML12  0.48±0.24 
ML4  0.35±0.13 
PND 50 
ML12  0.72±0.41 
ML4  0.63±0.15 
PND 85 
ML12  2.60±0.91 
ML4  2.61±0.87 
PND 150 
ML12  11.55±3.42 
ML4  18.68±4.46 
 
Table 11.  Circulating testosterone levels at 10, 21, 30, 50, 85 and 150 days of age in males from small and 
control litters. a: Litter size effect. 
 
1.3.11 17β-Estradiol levels  
Circulating 17β-estradiol levels were affected by age (F(5,41) = 6.4, p<0.0001), 
with an interaction between age and litter size (F(5,41) = 2.7; p<0.04). At PND21, 
females from small litters tended to have higher levels than control females (F(1,5) = 
7.5, p=0.052), as well as at PND30 (F(1,7) = 6.1; p= 0.06). No differences were 
observed at PND50 or PND85. However, 17β-estradiol levels increased at PND150 in 
L4 females such that they were higher than in L12 females (F(1, 16) = 7.78; p<0.02; 
Table 12). 
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    17β-estradiol (pg/ml) 
PND 10* 
FL12  10.96±1.51 
FL4  8.51±3.53 
PND 21* 
FL12  7.06±3.07 
FL4  17.60±2.23 
PND 30 
FL12  16.69±1.72 
FL4  26.18±3.90 
PND 50 
FL12  22.86±1.61 
FL4  24.10±1.39 
PND 85 
FL12  26.61±4.68 
FL4  24.31±1.99 
PND 150 
FL12  32.45±4.42 
FL4  89.38±18.78a 
 
Table 12. Circulating 17β-estradiol levels at 10, 21, 30, 50, 85 and 150 days of age, in females from small 
and control litters. a Litter size effect. 
 
1.3.12 Circulating triglycerides at PND150. 
Circulating triglyceride levels at PND150 were affected by litter size (F(1,21) = 
5.7, p<0.03), being increased in rats from small litters, but only in males (F(3, 24) = 4.1, 
p<0.05; Figure 28). 
 
 
 
 
 
 
 
 
 
 
Figure 28. Circulating triglyceride levels at PND150 in male and female rats from L12 and L4 litters. * = 
p<0.05. 
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1.3.13 Non-sterified fatty acids (NEFA) at PND150. 
Niether litter size nor sex affected circulating NEFA levels at PND150 (ML12: 
0.77 ± 0.06, ML4: 1.00 ± 0.08, FL12: 1.03 ± 0.09, FL4: 0.96 ± 0.09 mmol/L). 
 
1.4 Effects of litter size, sex and age on adipokine expression in adipose 
tissue 
Because the amount of adipose tissue changed as a consequence of neonatal 
overnutrition in a sexually dimorphic manner, as did circulating adipokine levels, we 
analyzed adipokine expression in adipose tissue at PNDs 10, 21, 85 and 150 to better 
understand these changes. 
1.4.1 Adipokine expression in subcutaneous adipose tissue 
As early as 10 days of life, overnutrition (F(1,20) = 12.8, p<0.002) produced an 
increase in leptin mRNA levels (Figure 29A) in SCAT of both sexes, although this 
increase was only statistically significant in males. Adiponectin mRNA levels (Figure 
29 B) were not significantly modified. 
 
Figure 29. Relative leptin (A) and adiponectin (B) mRNA levels in subcutaneous adipose tissue at PND10 in 
male and female rats from litters of 4 (L4) and 12 (L12) pups. Leptin mRNA: (F (3, 19) = 4.9)  * = p<0.02.  
 
IL-1β mRNA levels (Table 13) were reduced in L4 compared to L12 rats (F(1,16) = 
11.6; p<0.004) with this being significant only in females. IL-6 and TNFα mRNA levels 
(Table 13) were not affected by either sex or litter size. 
 
B A 
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At PND21, litter size (F(1,19) = 14.7, p<0.001) continued to affect leptin mRNA 
levels in SCAT, but with this being significant only in males (Figure 30 A). Adiponectin 
mRNA levels were modulated by litter size (F(1,19) = 20.7, p<0.0001) with an 
interaction between litter size and sex (F(1,19) = 5.7, p<0.03) as this affect was only 
significant in males (Figure 30 B).  
 
 
 
 
 
 
 
 
 
Figure 30. Leptin (A) and adiponectin (B) mRNA levels in subcutaneous adipose tissue at PND21 in male 
and female rats from litters of 4 (L4) and 12 (L12) pups. Leptin mRNA: (F(3, 22) = 7.1); Adiponectin mRNA: 
(F(3, 22) = 8.7). * = p<0.02; **= p<0.001. 
 
In general, the expression of cytokines in SCAT tended to be decreased in 
over-nourished animals at PND21, although a significant effect of litter size was only 
observed on IL6  levels (F(1,18) = 6.5, p<0.02), with L12 rats having higher levels than 
L4 in both sexes. No effect of litter size or sex was found on IL1β or TNFα mRNA 
levels at PND21.  
 
At PND85 there was an overall effect of sex on leptin mRNA levels (F(1,18) = 5.3, 
p<0.04, Figure 31A). Likewise, IL1β mRNA levels were affected by sex (ML12: 100 ± 
27.7, ML4: 78.2 ± 27.2, FL12: 7.6 ± 2.2, FL4: 8.2 ± 4.1; F(1,18) = 6.9, p<0.02). 
Adiponectin mRNA levels (Figure 31B) were not statistically different between 
groups. As to IL6 and TNFα levels most of the results were very late in amplifying and 
thus not reliable. 
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Figure 31. Leptin (A) and adiponectin (B) mRNA levels in in SCAT at PND85 in male and female rats from 
litters of 4 (L4) and 12 (L12) pups.  
 
At PND150, leptin mRNA levels (Figure 32A) were different between the sexes 
(F(1,18) = 62.8, p<0.0001) and there was a litter size effect on adiponectin mRNA levels 
(Figure 32B) (F(1,19)= 7.1, p<0.02). At PND150, expression of IL1β, IL6 and TNFα in 
SCAT was below the detection limits of the assay.   
 
Figure 32. Leptin (A) and adiponectin (B) mRNA levels in subcutaneous adipose tissue at PND 150 in male 
and female rats from litters of 4 (L4) and 12 (L12) pups.  
 
1.4.2 Adipokine expression in visceral adipose tissue 
At PND10 there was insufficient VAT for analysis. 
At PND21, L4 rats had higher leptin mRNA levels than L12 rats in both sexes 
(litter size effect: F(1,21) = 21.7, p<0.0001; Figure 33 A). Adiponectin mRNA levels were 
not affected by sex or litter size, although males from small litters clearly tended to 
A B 
NS 
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have increased expression levels of this adipokine compared to control males and 
females (Figure 33B). 
 
 
 
 
 
 
 
 
Figure 33. Leptin (A) and adiponectin (B) mRNA levels in visceral adipose tissue at PND21 in male and 
female rats from litters of 4 (L4) and 12 (L12) pups. Leptin mRNA levels: F(3,20) = 7.3 **= p<0.003. 
 
IL6 mRNA levels in VAT were increased in L4 rats of both sexes (F(3,23) = 6.6; 
p<0.01). Males had higher levels of the inflammatory cytokine IL1β than females (sex 
effect: F(1,19) = 12.7, p<0.002), with this being significant between control males and 
females (F(3,22) = 5.2; p<0.009; Table 14). Males also had higher TNFα mRNA levels in 
VAT compared to females (sex effect: F(1,20) = 4.9; p<0.04). 
 At PND85, leptin mRNA levels in VAT were lower in females compared to 
males (sex effect: F(1,24) = 18.1, p<0.0001, Figure 34A). There was a similar effect of 
sex on adiponectin (F(1,24) = 11.1, p<0.003 Figure 34B), IL1β (F(1,19) = 8.9, p<0.008), IL6 
(F(1,22) = 23.9, p<0.0001) and TNFα (F(1,23) = 22.6, p<0.0001) (Table 15), with females 
having lower levels than males. 
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Figure 34. Leptin (A) and adiponectin (B) mRNA levels in visceral adipose tissue at PND85 in male and 
female rats from litters of 4 (L4) and 12 (L12) pups. Leptin mRNA: (F(3,23) = 6.7); Adiponectin mRNA: (F (3,23) 
= 4.5) **= p<0.01; *= p<0.03. 
At PND150, leptin expression remained higher in males than females (F(1, 22) = 
71.2; p<0.0001) regardless of litter size (Figure 35A). Adiponectin mRNA levels were 
also higher in males than females from both litter sizes (F(1,23) = 63.8; p<0.0001; 
Figure 35B). 
Figure 35 . Leptin (A) and adiponectin (B) mRNA levels in visceral adipose tissue at PND150 in male and 
female rats from litters of 4 (L4) and 12 (L12) pups. Leptin mRNA: F(3, 21) = 24.4; Adiponectin mRNA: F(3, 22) = 
24.5; ***=p<0.0001. 
However, IL1β mRNA were higher in females compared to males (F(1,23) = 29.4, 
p<0.0001) with both L12 and L4 females having higher IL1β mRNA levels than L12 
and L4 males (F(3,22) = 9.99; p<0.0001; Table 16). TNFα mRNA levels were affected by 
litter size (F(1,23) = 9.9, p<0.01), being higher in L4 compared to L12 males (F (3, 22) = 
4.22, p<0.03. 
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IL6 mRNA levels were below the detection limit in many of the samples and 
therefore not reported. 
  
SCAT mRNA VAT mRNA 
IL1β IL6 TNFα IL1β IL6 TNFα 
PND 10* 
ML12  100±21.3 100±10.5 100±10.5 TNA TNA TNA 
ML4  100.5±29.6 99.6±56.6 88.9±13.2 TNA TNA TNA 
FL12  156.4±44.6 94.9±22.4 89.8±12.3 TNA TNA TNA 
FL4  32.4±13.3a 38.7±12.1 54.3±11.1 TNA TNA TNA 
PND 21* 
ML12  100±55.4 100±38.7 100±28.9 100±23.7 100±18.5 100±21.5 
ML4  42.5±9.3 19.3±1.7a   95.0±25.7 70.3±21.5 339.8±73.8a 161.4±53.6 
FL12  97.8±42.5 112.3±46.6 142.1±32.9 18.4±4.7b 72.8±20.1 50.2±13.8 
FL4  51.3±23.6 20.7±8.2a 41.7±6.3 36.2±8.1 331.0±79.9a 75.4±13.2 
PND 85 
ML12  BLD BLD BLD 100±42.1 100±28.9 100.0±28.8 
ML4  BLD BLD BLD 70.0±19.3 124.3±30.3 124.3±30.3 
FL12  BLD BLD BLD 47.7±29.1 174.8±135.4 31.8±24.7b 
FL4  BLD BLD BLD 51.0±23.5 22.9±12.4b 15.8±90.1b 
PND 150 
ML12  BLD BLD BLD 100±29.5 BLD 100±39.5 
ML4  BLD BLD BLD 80.5±37.0 BLD 450.5±186.6a 
FL12  BLD BLD BLD 703.9±142.6b BLD   211.0±49.4 
FL4  BLD BLD BLD 617.3±145.8b BLD 256.4±65.2 
 
Table 16. Relative mRNA levels of cytokines in subcutaneous and visceral adipose tissue at post-natal days 
(PND) 10, 21, 85 and 150 in male (M) and female (F) rats raised in litters (L) 4 or 12 pups. 
a 
different from 
rats of same age and sex (litter effect),
b 
different from males of same age and litter size (sex effect). 
@
Litter size effect by 2-ways ANOVA. * Non-fasting samples. TNA: tissue not available. BLD: below limit of 
detection 
 
1.5 Central effects of early overnutrition throughout development in 
males and females. 
To correlate the metabolic changes observed as a consequence of neonatal 
overnutrition with possible signs of hypothalamic inflammation, hypothalamic levels 
of leptin, IL-6, IL-1β, IL-10 and TNF-α were determined at PND10, 50 and 150.  
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1.5.1 Hypothalamic cytokine levels at PND 10 
At PND10 there was an overall litter size effect on hypothalamic leptin levels 
(F(1,24) = 6.7, p<0.02), with L4 rats tending to have higher levels than L12 rats (Figure 
36A).  
There was an interaction between sex and litter size (F(1,20) = 5.3, p<0.05) on 
hypothalamic IL6 levels, with this cytokine tending to increase in L4 males and 
decrease in L4 females.  
 
 
 
 
 
Figure 36.  Leptin (A) and IL6 (B) levels in the hypothalamus at PND 10 in male and female rats from litters 
of 4 (L4) and 12 (L12) pups. IL6: T-test, *p<0.05. 
 
No significant differences were found in hypothalamic IL-1β, IL-10, or TNF-α 
levels, although there was a trend for all of these cytokines to increase in L4 males 
(Table 17).  
  Hypothalamic cytokine levels  
  
IL10 
(pg/mL) 
IL1β  
(pg/mL) 
TNFα 
(pg/mL) 
PND 10* 
ML12  22.7±5.7 27.1±4.9 1.8±0.1 
ML4  42±11.1 39.6±8.7 4.5±1.6 
FL12  31.7±7.7 34.1±6.3 2.5±1.2 
FL4  27.4±3.9 29.2±3.4 0.8±0.1 
 
Table 17. Hypothalamic levels of IL10, IL1 β and TNFα at PND10 in males and females from L12 and L4.  
*: Non- fasting samples. 
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1.5.2 Hypothalamic cytokine levels at PND50 
At PND50, when the litter size-induced changes in body weight or circulating 
metabolic factors were no longer observed, leptin levels in the hypothalamus did not 
differ between groups. However, L4 males had higher hypothalamic IL6 levels 
compared to females from the same litter size (sex effect: F(1,24) = 4.8, p<0.05; Figure 
37). 
 
 
 
 
 
Figure 37.  Leptin (A) and IL6 (B) levels in the hypothalamus at PND 50 in male and female rats from litters 
of 4 (L4) and 12 (L12) pups. IL6: ANOVA: F (3, 23) = 3.5 *= p<0.05. 
There were no significant differences between groups in hypothalamic levels 
of IL10 or IL1β. There was an overall sex effect on TNFα levels (F (1, 22) = 4.5, p<0.05) 
with levels being generally higher in males. 
  
Hypothalamic cytokine levels  
IL10 
(pg/mL) 
IL1β (pg/mL) TNFα (pg/mL) 
PND 50 
ML12  101±17.9 70.9±10 1.6±0.2 
ML4  108±17.5 76.7±9 5.0±1.8 
FL12  85.6±11.4 57.9±4.9 1.2±0.2 
FL4  197±74.8 79.3±14.7 1.2±0.1 
Table 18. IL10, IL1 β and TNFα hypothalamic levels at PND50 in males and females from L12 and L4. 
1.5.3 Hypothalamic cytokine levels at PND 150 
At PND150, leptin levels in the hypothalamus were found to be higher in 
males than in females (sex effect: F(1,24) = 6.1, p<0.03, Figure 38). 
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Figure 38.  Leptin levels in the hypothalamus at PND 150 in male and female rats from litters of 4 (L4) and 
12 (L12) pups. 
 
No significant differences in hypothalamic IL1β, IL6 or IL10 levels were found, 
although L4 males tended to have higher levels of all these cytokines (Table 19). 
 
  
Hypothalamic cytokine levels  
IL10 (pg/mL) IL1β (pg/mL) IL-6 (pg/mL) 
PND 150 
ML12  50.0±12.0 45.3±7.7 706.5±205.4 
ML4  69.7±14.3 51.9±7.3 1144.1±417.2 
FL12  55.4±8.9 42.3±4.2 614.9±88.6 
FL4  53.1±5.3 40.6±3.8 347.6±55.1 
 
Table 19. Hypothalamic IL10, IL1 β and IL6 levels at PND150 in males and females from L12 and L4. 
 
In contrast, TNFα levels in the hypothalamus were affected by sex (F(1,11) = 
42.6, p<0.0001) and litter size (F(1,11) = 22.17, p<0.02), with an interaction between 
these two factors (F(1,11) = 14.3, p<0.01). Males from small litters had higher 
hypothalamic TNFα levels than those from control litters and higher levels than 
females from small litters (Figure 39). 
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Figure 39. Hypothalamic TNFα levels at PND150 in male and female rats from litters of 4 (L4) and 12 (L12) 
pups. F(3,10) = 24.2, ***= p<0.0001. 
 
1.5.4 Effects of early overnutrition and sex on hypothalamic glial proteins  
Hypothalamic GFAP protein levels were not affected by sex or litter size at 
PND10, PND21, PND30, PND50 or PND85 (Table 20). At PND 150, hypothalamic GFAP 
levels were affected by litter size (F(1, 20) = 5.5, p<0.03; Figure  40A), with L4 males 
having higher levels than L12 males. 
At PND150, the microglia marker, Iba 1, was influenced by litter size (F(1, 20) = 
5.9, p<0.03; Figure 40B), with its levels being lower in the rats that had been exposed 
to neonatal overnutrition, regardless of sex.  
 
 
 
 
 
 
 
 
 
 
Figure 40.Relative hypothalamic GFAP (A) and Iba1 (B) protein levels in male and female rats from L12 and 
L4 at PND 150. N=6. #: p<0.05 Litter size effect by 2-ways ANOVA. 
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    GFAP 
PND 10* 
ML12  100 ± 7.8 
ML4  97.7 ± 12.9 
FL12  93.7 ± 12.9 
FL4  103.1 ± 12.9 
PND 21* 
ML12  100 ± 6.7 
ML4  101 ± 8.4 
FL12  101 ± 6.5 
FL4  107.6 ± 12 
PND 30 
ML12  100 ± 4.2 
ML4  73.9 ± 14.2 
FL12  105.8 ± 5.7 
FL4  95.7 ± 12.2 
PND 50 
ML12  100 ± 12.6 
ML4  106.1 ± 17.4 
FL12  98.8 ± 10 
FL4  81.6 ± 17.2 
PND 85 
ML12  100 ± 10 
ML4  88.4 ± 5 
FL12  117.1 ± 202 
FL4  87.8 ± 5.8 
 
Table 20. Hypothalamic GFAP protein levels at PND10, PND21, PND30, PND50 and PND85, which 
levels were not significantly different between the experimental groups. 
 
Hypothalamic vimentin protein levels were affected by litter size at PND30 (F 
(1, 24) = 6.5, p<0.02; Figure 41), when the animals exposed to early over nutrition had 
lower levels of this protein. There was no effect at any other ages (results not 
shown). 
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Figure 41. Relative hypothalamic vimentin protein levels in male and female rats from L12 and L4 at PND 
30. N=6 
 
To investigate whether neuronal maturation was affected by neonatal 
overnutrition during the prepubertal stages, nestin levels were analyzed at PND 10, 
21 and 30. There was no effect of sex or litter size at PND10 or 21. In contrast, at 
PND30, nestin protein levels tended to be increased in the animals raised in small 
litters in both sexes (ML12: 100 ± 28.1, ML4: 191.1 ± 79.0, FL12: 37.3 ± 11.8, 
FL4:175.5 ± 60.1 %ML12; litter size effect p=0.058).  
 
Given that changes in hypothlamic GFAP levels were found in response to 
early overnutrition in males, but not females, at PND150 we asked whether this was 
associated with increased markers of inflammation and/or changes in the activation 
of intracellular pathways associated with leptin and insulin signaling.  
The p-Stat3(Tyr705) protein levels were increased by litter size (F(1,20) = 6.1, 
p<0.03) in both sexes. However, p-Stat3(Ser 634) protein levels were unaffected (data 
not shown). 
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Figure 42. Relative hypothalamic pSTAT3
(Tyr705) protein levels in male and female rats from L12 and L4 at 
PND 30. N=6 #: p<0.03 litter size effect by 2-ways ANOVA. 
 
There was an interaction between litter size and sex on SOCS3 protein levels (F(1,18) = 
5.1, p<0.05), with this inhibitor of cytokine signaling tending to decrease in L4 males 
and increase in L4 females. 
 
 
 
 
 
 
 
 
 
Figure 43. Relative hypothalamic SOCS3 protein levels in male and female rats from L12 and L4 at PND 30. 
N=6  
 
Hypothalamic protein levels of p-IRS, p-AKT, p-Iκβ and p-PTEN were not 
different between groups at PND150 (data not shown).  
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1.5.5 Early overnutrition and sex influence on astrocyte cell number and 
morphology  
Although neonatal overnutrition did not increased GFAP levels in PND150 
females, it is possible that the number or morphology of astrocytes could be 
affected. Hence, we analyzed the number and morphology of astrocytes in the 
hypothalamus of male and female rats at PND150.  
There was an effect of litter size (F (1,19) = 9.8, p<0.005; Figure 44A), with an 
increase in the mean number of GFAP cells/area in the arcuate nucleus of the 
hypothalamus of males that had been exposed to early overnutrition. There was an 
overall effect of sex (F (1,19) = 5.4, p<0.04; Figure 44B) on the number of projections 
per GFAP cell, with females tending to have more primary projections. Primary 
projections were also measured to determine their length, an effect of litter size was 
found (F (1,19) = 19.4, p<0.003; Figure 44C), with ML4 having shorter primary 
projections than ML12 and no effect on females. 
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Figure 44. Number of GFAP positive cells/area (A), number of projections per GFAP positive cell (B) and 
primary projections length (C) in the arcuate nucleus of male and female rats from L12 and L4 at PND 150. 
Number of cells/area: F(3, 22) = 3.8, *=p<0.0 3; Length of projections: F(3,22)= 8.1**=p<0.01 
 
As leptin receptor expression in astrocytes has been reported to increase in 
hypothalamic astrocytes as a result of HFD-induced obesity (Hsuchou et al., 2009), we 
analyzed whether the increase in weight in male rats due to neonatal nutrition is 
associated with changes in LepR levels in astrocyte of the arcuate nucleus. The level of 
LepR immunoreactivity over GFAP positive somas was increased in rats raised in a small 
litter (litter effect: F(1,8)=24.6, p<0.001; Figure 45), regardless of sex.  
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Figure 45. Relative signal intensity of ObR over GFAP cells in male and female rats from L12 and L4 at PND 
90.  
1.5.6 Early overnutrition and sex effects on microglia cell number 
There were no significant differences in the mean number of Iba1+ cells/area 
in the arcuate nucleus of the hypothalamus of 150 day old rats (Figure 46), although 
the number of Iba1+ cells tended to decrease in rats with neonatal overnutrition, 
similar to that observed for Iba1 protein levels in the hypothalamus. 
 
 
 
 
 
 
 
Figure 46. Mean number of Iba1 positive cells/ and immunohistochemitry images in the arcuate nucleus 
of male and female rats from L12 and L4 at PND 150.   
 
 
 
 
 
ML4 ML12 
FL12 FL4 
Results 
112 
 
2. Neonatal androgenization 
2.1 Metabolic effects of neonatal androgenization 
2.1.1 Metabolic effects of neonatal androgenization at PND10 
At PND10, testosterone levels remained elevated in females that received 
testosterone on PND1 (M: 6.6 ± 3.4, F: 1.2 ± 0.4. AF: 7.0 ± 2.9 ng/ml). To determine if 
neonatal testosterone levels could play a role in the development of the sexually 
dimorphic effects observed at PND10 in the neonatal overnutrition study, 
testosterone levels were also measured in females at this age. At PND10 there was 
an effect of litter size (F(1,18) = 4.4, p<0.05) with an interaction between sex and litter 
size (F(1,18) = 5.7, p<0.03), as L12 males had lower levels than L4 males, but with no 
effect in females (ML12: 0.19 ± 0.05, ML4: 0.76 ± 0.27, FL12PND10: 0.35 ± 0.04, 
FL4PND10: 0.31 ± 0.02 ng/ml). 
Circulating 17β-estradiol levels showed no differences between groups (M: 
37.2 ± 4.0, F: 39.7 ± 6.1, AF: 28.4 ± 2.3 pg/ml) 
Neonatal androgenization did not alter body weight (M: 17.7 ± 0.4, F: 17.8 ± 
0.4, AF: 18.3 ± 0.4 g) or body length (M: 7.4 ± 0.1, F: 7.5 ± 0.1, AF: 7.7 ± 0.1 cm) at 
PND10.  
The amount of SCAT was higher in females than in males and even greater in 
androgenized females (Figure 47). 
 
 
 
 
 
Figure 47. Percentage (A) and absolute (B) amount of subcutaneous fat (SCAT) at PND10 in males, females 
and androgenized females SCAT/100g BW: (F(2,28)= 53.9); SCAT (g): (F (2,28)= 47.8) ***= p<0.0001. 
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At PND10, glycemia (M: 112.3 ± 3.1, F: 104.1 ± 4.0, AF: 102.1 ± 3.7 mg/dl) and 
insulin levels (M: 0.69 ± 0.24, F: 0.72 ± 0.19, AF: 0.49 ± 0.07 ng/ml) were not 
different between groups. 
Serum leptin levels were higher in females compared to males, but 
androgenized females were not different from either males or females (F(1,18) = 10.3; 
p<0.01; Figure 48). There was a similar effect on serum adiponectin levels, with 
higher levels of this adipokine in females compared to males (F(1,25) = 11.3; p<0.01) 
with androgenization reducing adiponectin levels so that they were no longer 
different from males. 
 
 
 
 
 
Figure 48. Serum leptin (A) and adiponectin (B) levels at PND10 in males, females and androgenized 
females. Leptin: (F(2,17) = 6.3, p<0.02; Adiponectin: (F(2,22) = 5.6; p<0.01)   *= p<0.05. 
 
Circulating levels of the inflammatory cytokines IL1β (M: 41.8 ± 24.7, F: 39.2 ± 
9.2, AF: 27.1 ± 14.9 pg/ml) and TNFα (M: 1.7 ± 0.3, F: 1.1 ± 0.4, AF: 1.0 ± 0.4 pg/ml) 
were not affected by neonatal androgenization. In contrast, circulating IL6 levels 
were lower in females than in males, with androgenization of females ablating this 
difference (F(2,16) = 4.0, p<0.05; (Figure 49). 
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Figure 49. Serum IL6 levels at PND10 in males, females and androgenized females. (F(2,16) = 4.0, *= p<0.05 
 
2.1.2 Metabolic effects of neonatal androgenization at PND90 
At PND90 circulating testosterone levels were not affected by neonatal 
testosterone injection, with males having significantly higher levels than both control 
and androgenized females (F(1,29) = 20.0, p<0.0001; Figure 50). No significant 
differences were found in circulating 17β-estradiol levels (M: 49.1 ± 2.1, F: 47.6 ± 
2.8, AF: 42.1 ± 2.2 pg/ml).  
 
 
 
 
 
 
 
Figure 50. Circulating testosterone levels at PND90 in males, females and androgenized females. 
Testosterone: F(2, 28) = 13.5, ***= p<0.0001.  
 
At PND90, males were heavier than both females and androgenized females 
(F(1,31) = 231.3, p<0.0001) and the latter weighed more than control females (Figure 
51). No differences in length were observed at this age. 
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Figure 51.  Representation of BW (A) and length (B) at PND90 in males, females and androgenized 
females.  BW: F (2,30) = 128.6 ***=p<0.001; T-student: F vs AF *= p<0.05 . 
 
The percentage of both SCAT (F(1,22) = 84.7, p<0.0001) and VAT (F(1,21) = 15, 
p<0.001) was higher in males compared to both female groups, with no effect of 
neonatal testosterone treatment, Figure 52. 
 
 
 
 
 
Figure 52. Percentage of subcutaneous adipose tissue (SCAT; A) and visceral adipose tissue (VAT; B) at 
PND90 in males, females and androgenized females. SCAT/100 g BW: F(2,21) = 7.9; VAT/100g BW: F(2,20) = 
7.9 *= p<0.01. 
 
At PND90, glycemia was higher in males compared to females (sex effect: 
F(1,26) = 5.1; p<0.05, Figure 53A) and neonatal androgenization of females increased 
glucose levels such that they were no longer different from males. Insulin levels 
were lower in both females groups (sex effect: F(1,13) = 6.8, p<0.01; Figure 53B).  
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Figure 53.  Serum glucose (A) and insulin (B) levels at PND 90 in males, females and androgenized 
females. Glycemia: F(2,28) = 3.7 *= p<0.05 ; Insulin: F(2,15) = 5.1 **= p<0.01 
 
Serum leptin levels were lower in females compared to males and neonatal 
testosterone treatment resulted in leptin levels being higher than in control females 
(F(1,18) = 10.3, p<0.01; Figure 54A) and not different from males. At PND90, circulating 
adiponectin levels (Figure 54B) did not vary between the experimental groups.  
 
 
 
 
 
 
 
 
 
Figure 54. Serum leptin (A) and adiponectin (B) levels at PND90 in males, females and androgenized 
females. Leptin: F(2,17) = 22.3; ***= p<0.0001.  
Circulating levels of IL1β were lower in females compared to males (F(1,17) = 
15.1, p<0.003) and neonatal androgenization increased the levels of this cytokine in 
adult female rats (F(1,17) = 8.8, p<0.03; Fig. 55). Serum TNFα levels were below the 
limit of detection of the assay employed.  
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Figure 55. Serum IL1β levels at PND90 in males, females and androgenized females. ANOVA: F (2,16) = 5.9 
*= p<0.03. 
 
2.2 Cytokine profile in adipose tissue 
2.2.1 Expression of cytokines in subcutaneous adipose tissue at PND10 
The injection of testosterone to neonatal females had no significant effect on 
the mRNA levels of leptin, adiponectin, IL1β, IL6 or TNFα in SCAT (Table 21) at 
PND10. 
 
  
Leptin 
mRNA 
Adiponectin 
mRNA 
IL1β mRNA IL6 mRNA TNFα mRNA 
MALES 100 ± 26.3 100 ± 21.0 100 ± 22.8 100± 20.8 100±34.1 
FEMALES 138.8± 21.7 130.4 ± 9.5 57.8± 14.8 74.1±16.3 115.1±13.3 
ANDROGENIZED 
FEMALES 
142.9± 27.2 103.7 ± 15.3 80.3± 14.4 94.1±17.6 132.5 ± 13 
 
Table 21. Expression of leptin, adiponectin, IL1β, IL6 and TNFα mRNA levels in subcutaneous adipose 
tissue at PND10 in males, females and androgenized females. All data are normalized to the expression 
level of males. 
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2.2.2 Expression of adipokines and cytokines in subcutaneous adipose 
tissue at PND90 
The expression of leptin, adiponectin and TNFα did not differ between groups 
in SCAT, while IL1β and IL6 were not reliably detectable in most samples (Table 22) 
at PND90. 
  
Leptin 
mRNA 
Adiponectin 
mRNA 
IL1β mRNA IL6 mRNA TNFα mRNA 
MALES 100 ± 67.8 100 ± 50.2 BLD BLD 100 ± 64.8 
FEMALES 
151.2 ± 
77.6 
188.1 ± 27.1 BLD BLD 156.6 ± 43.9 
ANDROGENIZED 
FEMALES 
170.2 ± 
74.3 
293.8 ± 90.3 BLD BLD 129.5 ± 19.8 
Table 22. Expression of leptin, adiponectin, IL1β, IL6 and TNFα mRNA levels in subcutaneous adipose 
tissue at PND90 in males, females and androgenized females. BLD= below limits of detection. Data are 
normalized to the levels in males. 
2.2.3 Expression of adipokines and cytokines in visceral adipose tissue at 
PND90 
At PND90, leptin mRNA levels in VAT were higher in males compared to 
females of both groups, but androgenization of females increased leptin expression 
so that it was higher than in normal females (F(2,14) = 18.5, p<0.0002; Fig. 56). 
Adiponectin (F(2,14) = 6.5, p<0.01; Fig. 57A), IL6 (F(2,15) = 9.7, p<0.003; Fig 57B) and 
TNFα (F(2,15) = 15.1, p<0.0001; Fig. 57C) were lower in both groups of females 
compared to males. IL1β mRNA levels were not significantly different between 
groups (M: 100 ± 41.4, F: 30.6 ± 23.7, AF: 282.9 ± 154.9 % M). 
 
 
 
 
 
 
 
Results 
119 
 
 
 
 
 
 
 
 
Figure 56. Relative leptin mRNA levels  in visceral adipose tissue at PND90 in males, females and 
androgenized females. ***= p<0.0001.  
 
 
 
 
 
 
 
Figure 57.  Relative adiponectin (A), IL6 (A) and TNFα (B) mRNA levels in visceral adipose tissue at PND 90 
in males, females and androgenized females. **= p<0.001, ***=p<0.0001. 
 
2.3 Histological analysis of visceral adipose tissue at PND90 
The histological study of VAT at PND90, indicated that VAT adipocytes were 
larger in males than females and andogenized females (F(1,7) = 21.9, p<0.003; Figure 
58), with no differences between females and androgenized females. 
 
 
 
 
 
 
Figure 58.  Relative adipocyte area in visceral adipose tissue at PND 90 in males, females and 
androgenized females. F(2,9) = 13.9, **= p<0.005. 
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2.4 Central effects of neonatal androgenization of female rats 
2.4.1 Effects of neonatal androgenization on glial proteins in the 
hypothalamus at postnatal days 10 and 90 
At PND10 neonatal androgenization had no effect on GFAP (M: 100 ± 24.4; F: 
91.5 ± 22.3; AF: 100.2 ± 18.6 % M) or vimentin (M: 100 ± 42.7; F: 71.1 ± 17.9; AF: 82.9 
± 7.8 %M) protein levels in the hypothalamus. However, at PND90 females tended to 
have lower hypothalamic GFAP levels than males, while neonatal androgenization 
increased GFAP levels such that they were significantly higher than in the control 
females (F(1,14) = 8.4, p<0.03; Figure 59A). Vimentin protein levels in the 
hypothalamus tended to be higher in females than in males, but this was not 
statistically significant due to high variability within the groups (Figure 59B). 
 
 
 
 
 
 
 
 
 
 
Figure 59. Relative GFAP (A) and vimentin (B) protein levels in the hypothalamus at PND90 in males, 
females and androgenized females. GFAP: (F(2,16) = 4.2) *= p<0.05. NS = not significant. 
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3. Primary astrocyte cultures 
Neonatal overnutrition resulted in changes in GFAP expression in the 
hypothalamus of male, but not female, rats. Indeed, the number of GFAP positive 
cells was higher in males from small litters compared to control males at PND150. 
Moreover, the effects seen on hypothalamic inflammatory markers were different 
between males and females. Therefore, we analyzed whether male and female 
hypothalamic astrocytes in vitro respond differently to hormonal signals and fatty 
acids (FAs).  
3.1 Dose response curve of male and female hypothalamic astrocytes to 
palmitic acid 
We performed a dose response curve to palmitic acid in primary astrocyte 
cultures of both sexes. Astrocytes were exposed to increasing concentrations of 
palmitic acid: 0.05, 0.1, 0.25 and 0.5mM during 24 hours as concentrations between 
0.05 and 0.6 mM have been shown to induce cytokine release and are within a 
physiological range in serum, as NEFA levels in rat range from 100–200 μM in 
control, non-fasting conditions to 500–600 μM in fasted animals (Rustan et al. 1992), 
(Xu et al. 2010).  Samples were processed to determine if the expression of diverse 
proteins was affected as a consequence of FAs exposure.  
 
3.1.1 Change in cell number in response to palmitic acid treatment 
We first determined if PA affects the number of astrocytes in vitro. No 
significant change in the number of cells was found in response to this FA (Figure 
60). 
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Figure 60. Number of cells in primary astrocyte cultures from 2 day old male and female Wistar rats after 
treatment with increasing levels of palmitic acid (PA) for 24 hours. N=4 cultures with each experimental 
group being performed in triplicate in each culture.   
3.1.2 Changes in the mRNA levels of GFAP, IL6, IL1β, TNFα, CHOP and IGF-
1 in response to increasing concentrations of palmitic acid 
GFAP mRNA levels were progressively decreased in response to increasing 
concentrations of PA (F(4,30) = 21.34; p<0.0001; Figure 61). 
Figure 61. Relative GFAP mRNA levels in primary hypothalamic astrocyte cultures from 2 day old male and 
female Wistar rats. (F(9,39) = 9.9; p<0.0001). Ct: control; PA: Palmitic acid. N=4 cultures with at least 3 
repetitions of each group in experiment.  
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Carnitine palmytoil transferase 1a increased in astrocytes from both sexes in 
response to PA (F(4,31) = 6; p<0.002; Figure 62), although specific differences between 
the groups were not found in the posthoc analysis. 
Figure 62. Relative CPT-1a mRNA levels in primary hypothalamic astrocyte cultures from 2 day old male 
and female Wistar rats. (F(9,40) = 2.9; p<0.02). Ct: control; PA: Palmitic acid. N=4 cultures with at least 3 
repetitions of each group in experiment.  
The expression of IL6 increased with increasing levels of palmitic acid in both 
sexes (F(4, 29) = 5.4, p<0.003; Figure 63). 
Figure 63. Relative IL6 mRNA levels in primary hypothalamic astrocyte cultures from 2 day old male and 
female Wistar rats. Ct: control; PA: Palmitic acid. ANOVA: (F(9,38) = 3, p<0.03). N=4 cultures with at least 3 
repetitions of each group in each experiment.  
Results 
124 
 
No significant effects were found on IL1β mRNA levels (Males: Ct0: 100, 
Ct24h: 49.9 ± 15.7, PA 0.05 mM: 61.2 ± 18.6, PA 0.1 mM: 91.2 ± 34.2, PA 0.25 mM: 
96.0 ± 50.9, PA 0.5mM: 159 ± 115.7; Females: Ct0h: 104.3 ± 35.8, Ct24h: 54.9 ± 21, 
PA 0.05 mM: 116.9 ± 31.6, PA 0.1 mM: 83.4 ± 28.9, PA 0.25 mM: 34.4 ± 8.8, PA 0.5 
mM: 144.1 ± 66.6 %Ct0 Males). 
 There was an effect of sex on TNFα expression, with females expressing 
lower levels than males (F(1,29) = 4.7, p<0.05; Figure 64). No effect of PA was found. 
Figure 64. Relative TNFα mRNA levels in primary hypothalamic astrocyte cultures from 2 day old male and 
female Wistar rats. Ct: control; PA: Palmitic acid. N=4 cultures with at least 3 repetitions of each group in 
each experiment.  
Levels of CHOP mRNA were increased after PA exposure (F(4,31) = 8.6, 
p<0.0001; Figure 65). This difference reached significance at the highest dose in 
males. 
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Figure 65. Relative CHOP mRNA levels in primary hypothalamic astrocyte cultures from 2 day old male and 
female Wistar rats. Ct: control; PA: Palmitic acid. ANOVA: (F(9,40) = 4, p<0.003). N=4 cultures with at least 3 
repetitions of each group in each experiment. 
On the contrary, the mRNA levels of the trophic factor IGF1 were reduced 
when exposed to PA (F(4,31) = 6.3, p<0.003; Figure 66), with this effect being more 
pronounced in females. 
Figure 66. IGF-1 mRNA levels in primary hypothalamic astrocyte cultures from 2 day old male and female 
Wistar rats. Ct: control; PA: Palmitic acid. ANOVA: (F(9,40) = 3.8, p<0.003) **p<0.003. N=4 cultures with at 
least, 3 repetitions of each group in each experiment.  
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3.1.3 Nitrites and nitrates released in response to PA  
Palmitic acid stimulated the release of NO2 and NO3 to the culture media in a 
dose dependant manner in astrocytes from both sexes (F(4,28) = 4.4, p<0.01; Figure 
67). 
Figure 67. Concentration of NO2 and NO3 in the culture medium of hypothalamic astrocytes after 24 hours 
of palmitic acid (PA) exposure. Ct: control; ANOVA: (F(9,37) = 2.2), p=0.057. N=4 cultures with at least 3 
repetitions of each experimental group in each culture.  
 
3.2 Response of male and female astrocytes to saturated and unsaturated 
fatty acids. 
The hypothalamic inflammatory response to FAs has been shown to depend 
on the type of FFAs, therefore we analyzed if male and female astrocytes were 
differentially affected by different classes of FFAs. Astrocytes were exposed to oleic 
(monounsaturated) and palmitic (saturated) acids for 24 hours, as these are 
common FFAs found in our diet. In addition, as these FFAs are not normally 
consumed individually, the effect of the combination of OA and PA on astrocytes was 
also analyzed.  
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3.2.1 Changes in the mRNA levels of GFAP, CPT-1a IL-6, IL-1β, TNFα, CHOP 
and IGF-1   
Astrocyte cultures were treated with 0.5 mM of each FA, as this is reported to 
be at the high end of physiological concentrations (Thaler and Schwartz, 2010; Gupta et al., 
2012; Yuan et al., 2013). 
Palmitic acid alone drastically reduced the mRNA levels of the astroglial 
marker GFAP (F(1,24) = 47.7, p<0.0001). There was no effect of OA on GFAP mRNA 
levels; However, there was an interaction between PA and OA (F(1,24) = 9, p<0.01), 
with OA partially blocking the effect of PA. In addition, GFAP mRNA levels were 
affected by sex (F(1,24) = 4.3, p<0.05; Figure68). 
Figure 68. Relative GFAP mRNA levels in primary hypothalamic astrocyte cultures from 2 day old male and 
female Wistar rats. Ct: control; F(7, 31) = 10; ***: p<0.0001, @: p<0.05 by T-test. N=4 cultures with at least 3 
repetitions of each experimental group in each one.  
CPT-1a mRNA levels were modulated by OA (F(1, 17) = 24.3 p<0.0001), with this 
FA increasing CPT-1a mRNA levels regardless of the presence or not of PA (Figure69). 
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Figure 69. Relative CPT-1a mRNA levels in primary hypothalamic astrocyte cultures from 2 day old male 
and female Wistar rats. Ct: control; F(7, 31) = 11.2; ***: p<0.0001. N=4 cultures with at least 3 repetitions of 
each experimental group in each one.  
Palmitic acid induced the expression of IL6 mRNA levels in both sexes (F (1, 17) = 
24.3 p<0.0001;Figure 70). Oleic acid had no effect alone, but reduced the effect of 
PA (F(1, 17) = 24.3 p<0.0001). 
Figure 70. Relative IL6 mRNA levels in primary astrocyte cultures from 2 day old male and female Wistar 
rats. Ct: control; (F(7,24) = 5.1); **:p<0.005. N=4 cultures with at least, 3 repetitions of each experimental 
groups in each one.  
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IL1β mRNA levels were unaffected (MCt-0h: 100; MCt-24h: 140.1 ± 37.1; M-
OA: 138.2 ± 35.2; M-PA: 168.5 ± 148.8; M-OA+PA: 73.7 ± 25.7; F-Ct24h: 417.2 ± 
134.1; F-OA: 212.1 ± 89.4; F-PA: 181.7 ± 97.5; F-OA+PA: 89.6 ± 16 % MCt0h). 
TNFα mRNA levels were affected by PA (F(1,20) = 36.4 p<0.0001) and OA (F(1, 20) 
= 14.4 p<0.003), with an interaction between PA and sex (F(1, 20) = 4.2 p=0.054) and 
PA and OA (F(1, 20) = 5.4 p<0.05; Figure 71). Both OA and PA reduced TNFα mRNA 
levels, with an additive effect of these FAs. 
Figure 71. TNFα mRNA levels in astrocyte primary cultures from 2 days old male and female Wistar rats. 
Ct: control; h: hours. ANOVA: (F (7,27) = 8.9, p< 0.0001). N=3 cultures with at least 3 repetitions of each 
experimental group in each one. 
We analyzed CHOP mRNA levels, which is activated by ER stress and 
promotes apoptosis. We found expression of this gene to be affected by OA (F(1,16) = 
5.3, p<0.05) and PA (F(1,16) = 17.3, p<0.002; Figure 72), with PA inducing CHOP and OA 
inhibiting the effect of PA. 
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Figure 72. CHOP mRNA levels in astrocyte primary cultures from 2 days old male and female Wistar rats. 
Ct: control; h: hours. ANOVA: (F (7, 23) = 4, p< 0.02). **: p<0.02. N=4 cultures with at least 3 repetitions of 
each experimental group in each one. 
 
As IGF-1 production by astrocytes is involved neuronal protection, we 
analyzed the expression of this trophic factor. IGF-1 mRNA levels (Figure 73) were 
decreased by PA (F(1,24) = 16.5, p<0.0001). On the contrary, OA stimulated IGF-1 
expression (F(1, 24) = 11.8, p<0.03), with this effect being significant in male astrocyte 
cultures. The addition of both FAs simultaneously resulted in no change in IGF-1 
mRNA levels, suggesting that PA affects the ability of these cells to produce this 
neuronal protector factor in response to OA. 
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Figure 73. Relative IGF-1 mRNA levels in primary astrocyte cultures from 2 day old male and female Wistar 
rats. Ct: control; (F (7,31) = 4.7, p< 0.003). **: p<0.02. N=4 cultures with at least 3 repetitions of each 
experimental group in each one.  
 
3.2.2 Nitrites and nitrates released to the culture media after FAs 
treatment  
As astrocytes are activated and can respond to FAs by releasing inflammatory 
signals, we asked if they also released neurotoxic free radicals such as nitric oxide 
(NO) in response to FAs. 
The amount of NO2 and NO3 released to the culture media by astrocytes was 
affected by PA exposure (F(1,17) = 32.6, p<0.0001), with an interaction between OA 
and PA (F(1,17) = 8.1 p<0.02; Figure 74). Although OA alone had no significant effect, in 
combination with PA the release of NO2 and NO3 was significantly increased. 
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Figure 74. Concentration of NO2 and NO3 in the culture media of hypothalamic astrocytes after 24 hours of 
exposure to palmitic acid (PA), oleic acid (OA) or a combination of these two fatty acids. Ct: control; (F(7,24) 
= 6.1, p< 0.002). N=4 cultures with at least 3 repetitions of each experimental group in each one. 
 
3.3 Palmitic acid and 17β -estradiol 
To determine if estrogens can modify the astrocytic response to PA, 17β–
estradiol (E2) was added to the astrocyte cultures 3 hours before PA (0.1 mM) 
exposure. There was no effect of sex on the mRNA levels of either ERα or ERβ. ERα 
mRNA levels (Figure 75) were decreased by PA (F(1,17) = 15.4, p<0.002) and E2 
increased the levels of this receptor (F(1,17) = 16.7, p<0.002). Besides, E2 
pretreatment followed by PA impede the decrease in ERα in females but not in 
males. 
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Figure 75. Relative ERα mRNA levels in primary astrocyte cultures from 2 day old male and female Wistar 
rats. Ct: control; PA: Palmitic acid; E2: 17β-estradiol. ANOVA (F(7,24) = 3.5, p<0.03). 
 N=4 cultures with at least, 3 repetitions of each experimental groups in each one. 
 
As found in the previous experiments, GFAP expression was reduced by PA, but 
this decrease did not reach significance in this experiment (Figure 76). 
Figure 76. Relative GFAP mRNA levels in primary astrocyte cultures from 2 day old male and female 
Wistar rats. Ct: control; PA: Palmitic acid; E2: 17β-estradiol. N=4 cultures with at least 3 repetitions of 
each experimental group in each one.  
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 IL6 mRNA levels (Figure 77) were affected by PA (F (1, 20) = 48, p<0.0001), E2 (F 
(1, 20) = 15.4, p<0.002) and the interaction between these two factors (F (1, 34) = 13.4, 
p<0.03). Palmitic acid increased IL6 mRNA levels, and the previous addition of E2 
reduced this effect. 
Figure 77. Relative IL6 mRNA levels in primary hypothalamic astrocyte cultures from 2 day old male and 
female Wistar rats. Ct: control; PA: Palmitic acid; E2: 17β-estradiol. ANOVA (F (7, 27)= 10.6, p<0.0001). N=4 
cultures with at least 3 repetitions of each experimental group in each one. 
 
The expression of IL1β  (Figure 78) was also affected by PA (F (1, 19) = 7.9, p<0.02) 
and E2 (F(1, 19) = 4.7, p<0.05). Although PA increased IL-1β levels and this was reduced 
by E2, no significance differences were found by one-way ANOVA probably due to 
the increased variability. 
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Figure 78. Relative IL1β mRNA levels in primary astrocyte cultures from 2 day old male and female Wistar 
rats. Ct: control; PA: Palmitic acid; E2: 17β-estradiol. N=4 cultures with at least 3 repetitions of each 
experimental group in each one. 
 
Similar results were found with TNFα mRNA levels, where PA tended to 
increase the levels of this cytokine and E2 impeded this increase, although these 
changes were not significant (MCt-24h: 147 ± 4.4; M-PA: 215.9 ± 86.9; M-E2: 124.4 ± 
32.1; M-PA+E2: 132.3 ± 28.3; F-Ct24h: 169.9 ± 66.2; F-PA: 204.3 ± 82.3; F-E2: 164.2 ± 
31.9; F-PA+E2: 196.6 ± 109.8), again most likely due to the high variability.  
 
IL10 mRNA levels decreased in astrocytes in response to PA (F(1,19) = 13.4, 
p<0.003; Figure 79), but with individual differences not being found in the posthoc 
analysis. 
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Figure 79. Relative IL10 mRNA levels in primary astrocyte cultures from 2 day old male and female Wistar 
rats. Ct: control; PA: Palmitic acid; E2: 17β-estradiol. ANOVA (F(7, 26) = 2.9, p<0.03). N=4 cultures with at 
least 3 repetitions of each experimental group in each one. 
 
The mRNA levels of IGF-1 tended to decrease with PA, but these effects did 
not reach significance in this experiment (MCt0h: 100; MCt-24h: 92.7 ± 18.2; M-PA: 
65.2 ± 6.8; M-E2: 89 ± 25; M-PA+E2: 62.4 ± 7.4; F-Ct24h: 68.7 ± 12.9; F-PA: 50 ± 18.3; 
F-E2: 72.8 ± 12.2; F-PA+E2: 68.3 ± 11.8). 
 
 The mRNA levels of CHOP (Figure 80) were affected after PA exposure (F(1,17) = 
29, p<0.0001), E2 (F(1,17) = 5.6, p<0.05) and the interaction between these two factors 
(F(1,19) = 5.4, p<0.05 ). There was an increase in response to PA that was reduced by 
pre-incubation with E2. 
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Figure 80. Relative CHOP mRNA levels in primary astrocyte cultures from 2 day old male and female 
Wistar rats. Ct: control; PA: Palmitic acid; E2: 17β-estradiol. ANOVA (F (7, 24) = 5.8, p<0.002). N=4 cultures 
with at least 3 repetitions of each experimental group in each one. 
 
3.4 Palmitic acid and the Toll receptor 4 antagonist RS-LPS 
It has been proposed that FAs can activate glial cells through activation of 
TLR4 (Milanski et al., 2009). Hence, we analyzed whether the observed astroglial 
responses to palmitic acid could be inhibited with a TLR4 antagonist. Palmitic acid at 
0.1mM was combined with LPS-RS to determine if the expression of inflammatory 
cytokines induced by PA was via Toll receptor 4 in astrocytes. The mRNA levels of (IL) 
1β, 6, TNFα, CHOP, nuclear factor of kappa light polypeptide gene enhancer in B-cells 
inhibitor alpha (NFKBIA) and inhibitor of kappa light polypeptide gene enhancer in B-
cells kinase beta (IKBKB) were determined. 
 
IL1β mRNA levels (MCt-24h: 60 ± 9.3; M-RS-LPS: 685.5 ± 2031; M-PA: 105.5 ± 
8.9; M-PA+RS-LPS: 1330.5 ± 684.8; F-Ct24h: 39.9 ± 2.9; F-RS-LPS: 420 ± 246.4; F-PA: 
46.4 ± 9.6; F-PA+RS-LPS: 843.8 ± 574) were increased by RS-LPS (F(1,16) = 10.2, p<0.01) 
and females tended to have lower levels than males, although no specific differences 
were found in the posthoc analysis. 
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IL6 mRNA levels (Figure 81) were increased by both PA (F(1,16) = 8.9, p<0.01) 
and RS-LPS (F(1,16) = 10.9, p<0.01), with this increase being greatest with the 
combination of these two substances. 
Figure 81. Relative IL6 mRNA levels in primary astrocyte cultures from 2 day old male and female Wistar 
rats. Ct: control; PA: Palmitic acid; LPS-RS: Lipopolysaccharide from the photosynthetic bacterium 
Rhodobacter sphaeroides. ANOVA (F(7,23) = 4.5, p<0.01). N=4 cultures with at least 3 repetitions of all 
experimental groups in each one. 
 
TNFα mRNA levels (Figure 82) were increased by RS-LPS (F(1,16) = 17.8, p<0.01). 
Figure 82. TNFα mRNA levels in astrocyte primary cultures from 2 days old male and female Wistar rats. 
Ct: control; h: hours; PA: Palmitic acid; LPS-RS: Lipopolysaccharide from the photosynthetic bacterium 
Rhodobacter sphaeroides. mM: mili Molar. ANOVA (F (7, 23) = 2.9, p<0.05). N=4 cultures with at least, 3 
experimental groups in each one 
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CHOP mRNA levels (Figure 83) were affected by PA (F(1,16) = 9.6, p<0.01) and 
RS-LPS (F(1, 16) = 5.5, p<0.05). 
Figure 83. CHOP mRNA levels in astrocyte primary cultures from 2 days old male and female Wistar rats. 
Ct: control; h: hours; PA: Palmitic acid; LPS-RS: Lipopolysaccharide from the photosynthetic bacterium 
Rhodobacter sphaeroides. mM: mili Molar. N=4 cultures with at least, 3 experimental groups in each one. 
 
NFκB inhibitor α (NFKBIA) (F (1, 16) = 6.5, p<0.03; Figure 84) and IKKβ (IKBKB) (F 
(1, 16) = 11, p<0.01; Figure 85) mRNA levels tended to increase by RS-LPS and the 
combination with PA although these differences did not reach significance due to 
variability. 
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Figure 84. NFKBIA mRNA levels in astrocyte primary cultures from 2 days old male and female Wistar rats. 
Ct: control; h: hours; PA: Palmitic acid; LPS-RS: Lipopolysaccharide from the photosynthetic bacterium 
Rhodobacter sphaeroides. mM: mili Molar. N=4 cultures with at least, 3 experimental groups in each one. 
Figure 85. IKBKB mRNA levels in astrocyte primary cultures from 2 days old male and female Wistar rats. 
Ct: control; h: hours; PA: Palmitic acid; LPS-RS: Lipopolysaccharide from the photosynthetic bacterium 
Rhodobacter sphaeroides. mM: mili Molar. ANOVA (F (9, 29) = 2.5, p<0.05). N=4 cultures with at least, 3 
experimental groups in each one. 
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3.5 Intracellular signaling in astrocytes in response to PA 
Astrocyte lysates were processed after PA 0.1mM exposure to detect possible 
changes in the following phosphoproteins: cAMP response element-binding protein 
(CREB), c-Jun N-terminal kinase (JNK), nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-κB), P38 mitrogen activated protein kinase (p38), extracellular  
signaling-regulated kinases 1 (ERK1) and 2 (ERK2), protein kinase B (Akt), the 70kDa 
ribosomal S6 kinase (p70S6K), STAT3 and signal transducer and activator of 
transcription 5 (STAT5). 
Table 22 encompasses the mean fluorescent intensity of the cited 
phosphoproteins corrected by their corresponding total proteins. 
  Males Females 
  Ct 15 min  PA 15 min Ct 15 min  PA 15 min 
p-CREB 100 ± 0 66.6 ± 23.9 79.7 ± 24.6 43.1 ± 17 
p-JNK 100 ± 0 109.2 ± 50.6 82.5 ± 29.1 113.5 ± 68.6 
p-NF-κB 100 ± 0 138.8 ± 41.2 166 ± 105.9 351.3 ± 236.9 
p-P38 100 ± 0 88.7 ± 24.9 99.6 ± 49 158.7 ± 115.7 
p-AKT 100 ± 0 91.3 ± 21.4 99.4 ± 24.7 123.2 ± 50.6  
p-ERK 100 ± 0 99.1 ± 3.1 96.2 ± 0.9 97.7 ± 2.1 
p-P70s6k 100 ± 0 111.6 ± 43 83.4 ± 26 146.6 ± 44.1 
p-STAT3 100 ± 0 105.3 ± 42.5 88.4 ± 38.3 132.1 ± 64.3 
p-STAT5 100 ± 0 145.5 ± 15.4
a 125.9 ± 31.6 159.4 ± 71.2 
 
Table 22. Mean fluorescent intensity of CREB, JNK, (NF-κB), p38, ERK2, Akt, p70
S6K
, STAT3 STAT5 in 
primary astrocyte cultures after 15 minutes with PA incubation. 
a 
different from control group of the same 
sex by T-test, p<0.05. Ct: control group; PA: Palmitic acid group. N= 3. 
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Obesity and its associated comorbidities continue to be one of the major 
public health concerns in developing countries, without signs of a decrease in this 
epidemic. We now know that becoming overweight or obese is not only the result of 
poor nutrition and/or the lack of physical activity, but also that early nutritional 
perturbations can have long-term consequences on metabolism. The experimental 
model employed here, neonatal overnutrition, is known to cause abnormal 
metabolic responses and obesity in adulthood (Godfrey and Barker, 2000; Stettler et al., 
2002; Viner and Cole, 2006; Barker, 2007; Gluckman et al., 2007; Freedman et al., 2009; 
Reynolds et al., 2015a). In addition, although not thoroughly studied, males and 
females have been previously reported to respond differently to this and other early 
nutritional alterations (Fuente-Martin et al., 2012c; Reynolds et al., 2015a). The studies 
reported here indicate that early postnatal weight gain as a consequence of being 
raised in a small litter not only causes alterations in diverse metabolic parameters, 
but that many of these alterations are both age and sex dependent. 
In rodents, the long-term disruption of energy homeostasis induced by 
overfeeding during critical periods of development has been shown to be at least 
partially due to effects on metabolic neurocircuit formation (Plagemann et al., 1999b; 
Fuente-Martin et al., 2012c; Vogt et al., 2014; Collden et al., 2015). Here we show that 
being raised in a small litter, which results in increased food intake during this early 
age due to increased maternal milk availability (Fiorotto et al., 1991; Fink et al., 2001), 
resulted in increased body weight, body length and fat mass, as well as elevated 
serum glucose, insulin, leptin and adiponectin levels during the period of nursing in 
rats of both sexes. Some of the changes could be involved in the modifications in 
neurocircuit formation. Importantly, increased weight gain during this critical period 
was not only associated with systemic metabolic alterations, but also with 
hypothalamic changes, with both metabolic and central changes being different 
between males and females. 
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1. Effects of neonatal overnutrition on food intake, body weight and body 
length throughout development 
In rodents, the neonatal period is the most sensitive developmental stage 
with regards to hormonal programming of the brain, with hormonal fluctuations 
during this period having an impact in the adult brain (Sun et al., 2012; Vogt et al., 2014). 
The increased availability and intake of milk (Fiorotto et al., 1991; Cunha et al., 2009) is 
most likely a direct cause of the increased body weight gain of pups raised in small 
litters, but it is the resulting hormonal and metabolic changes that induce the long-
term effects.  
We found that pups raised in small litters showed increased body weight, 
length, SCAT and glycemia, as well as hyperinsulinemia and hyperleptinemia, as early 
as PND10. These early modifications in L4 pups are most likely due to the increased 
energy intake during nursing as described above, but could also be influenced by 
changes in maternal nurturing (Connor et al., 2012; Reynolds et al., 2014; Segovia et al., 
2014). Even after weaning, when all rats had ad libitum access to a chow diet, L4 rats 
of both sexes continued to eat more than L12 rats, but only until approximately 
PND50, suggesting that at this point in the study their higher energy intake is not 
due to more food availability, but probably to having an increased appetite. An 
increase in food intake in adult rats previously exposed to early overnutrition has 
been reported by some authors (Rodrigues et al., 2011; Fuente-Martin et al., 2012b; 
Collden et al., 2015), while other studies report no effect (Stefanidis and Spencer, 2012; 
Bei et al., 2015). These discrepancies could be due to differences in the age at which 
the animals were studied, as here we found that this effect changed throughout 
postnatal development. In addition, even before pubertal onset, males ate more 
than females, with L4 males already being heavier than L4 females, indicating that 
even before the influence of post-pubertal gonadal steroids there are differences 
between the sexes. These early difference could be at least partially due to the 
neonatal peak of testosterone in males that could affect the neuronal circuits 
involved in food intake regulation. 
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The effect of litter size on food intake was present until approximately PND50 
and then waned until later adulthood, when L4 males again began to eat more than 
control males. In association with this, during adolescence and early adulthood, the 
effects of litter size on body weight and metabolic hormone levels also disappeared. 
This observation is in accordance with several studies showing that some of the 
changes produced in the early ages, are normalized when the animal reaches young 
adulthood (Vickers et al., 2005; Glavas et al., 2010; Stefanidis and Spencer, 2012). As many 
hormonal and metabolic changes occur during puberty, it is possible that the early 
neonatal effects are masked or modified during this period.  
Despite the attenuation of some of these outcomes in young adult rats, the 
effect of early overnutrition on body weight reappeared in later adulthood, but in a 
sexually dimorphic manner, as it was only present in males. Litter size effects on 
body weight and leptin levels have been previously shown to vary with age in male 
rats, being present early in development and disappearing at 11 weeks of age 
(Velkoska et al., 2005), while Wiedmer and colleagues (Wiedmer et al., 2002) reported 
that male rats from small litters weighed more than those from large litters from 2 
to 5 weeks of age and then again from 10 to 12 weeks of age.  Metabolism is known 
to change with age (Aasum et al., 2003), with an animal or individual becoming more 
susceptible to body weight gain and fat accumulation as they become older (Han et 
al., 2013). This can occur although energy intake is not increased, as there is an age 
dependent decrease in energy expenditure (Han et al., 2011). Thus, it is possible that 
neonatal overnutrition advances the physiological aging of metabolism, with males 
being more susceptible to this process. Moreover, some of the intracellular 
mechanisms involved in aging are identical to those activated in obesity associated 
complications (Tang et al., 2015). For instance, low-grade hypothalamic inflammation 
can be triggered by both obesity (De Souza et al., 2005; Zhang et al., 2008; Purkayastha et 
al., 2011; Cai, 2013) and aging (Tang and Cai, 2013; Zhang et al., 2013). Several studies have 
reported that inflammation in the hypothalamus induces the development of 
systemic aging (Purkayastha and Cai, 2013; Tang and Cai, 2013; Zhang et al., 2013). 
Likewise, ER stress is also linked to both overnutrition (Zhang et al., 2008; Ozcan et al., 
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2009) and aging (Greenamyre and Hastings, 2004; Katayama et al., 2004; Wootz et al., 2004). 
This inflammation in the hypothalamus also involves glial cells, including astrocytes 
that can produce cytokines, as well as diverse factors such as transforming growth 
factor beta (TGF-β) in response to obesity or aging conditions. This process can lead 
to loss of function of IκBα and consequently, activation of NF-κB (Yan et al., 2014). 
Here not only did L4 males begin to gain more weight as adults, but they also 
demonstrated signs of hypothalamic inflammation as TNFα levels were increased. 
Neither of these processes were observed in females at PND150, but this does not 
negate the fact that they might occur at an older age. 
At PND90, when an increase in body weight was again found in L4 males, 
there was no difference in food intake. This suggests that the metabolic efficiency of 
the neonatally over-nourished rats may begin to be affected at this time, at least in 
males. This is in agreement with a report by Stefanidis and Spencer indicating that 
there is metabolic compensation by these rats in attempt to restore a normal body 
weight, but this compensation is different between the sexes (Stefanidis and Spencer, 
2012). Around PND119, food intake again began to be higher in males from small 
litters compared to their controls. During the following weeks there are variations in 
food intake in the neonatally over-nourished rats compared to their controls and this 
could indicate that these animals are continuously trying to readjust their body 
weight/food intake. In addition to increased food intake, a decrease in energy 
expenditure, especially as they get older, could also contribute to body weight gain, 
but this was not analyzed here. 
2. Effects of neonatal overnutrition on circulating parameters throughout 
development: hormones and cytokines 
The long-term effects of being raised in a small litter could be due to 
modification of the postnatal leptin surge as a result of neonatal overfeeding. Leptin 
is a key signal in determining the development of hypothalamic neuronal circuits 
involved in feeding behavior (Bouret et al., 2004a; Bouret and Simerly, 2007; Bouret, 2013). 
Although in the rodent most neurons are born prenatally, the outgrowth of their 
Discussion 
147 
 
projections occurs after birth (Ishii and Bouret, 2012). Hence, changes in leptin levels in 
perinatal life can impact on the development of hypothalamic “wiring” and result in 
lifelong metabolic deregulation (Bouret et al., 2008). Some long-term effects of 
changes in neonatal leptin levels have been shown to become manifest only later in 
adulthood (Granado et al., 2011; Granado et al., 2014); here we found long-term effects 
until approximately PND50, which disappear to reappear again in later adulthood. In 
the studies by Granado et al., leptin levels were directly modified; here other factors 
such as insulin levels in addition to leptin were indirectly modified. This, as well as 
the temporal differences in these hormonal changes, could underlie the differential 
outcomes of our studies. Variations in neonatal leptin concentrations can also 
modify leptin receptors expression in the hypothalamus, possibly modifying 
feedback mechanisms of this hormone. Rodrigues et al reported higher leptin levels 
at PND21 as a consequence of neonatal overnutrition; but they show no change in 
leptin receptor protein levels at PND21 or PND180 (Rodrigues et al., 2009). However, 
Toste et al showed a decrease in leptin receptor levels in the adult hypothalamus 
after leptin treatment during lactation (Toste et al., 2006), We observed that 
neonatally overfed male and female adults presented higher intensity of leptin 
receptor immunoreactivity specifically over GFAP-positive cells, this is in accordance 
with (Hsuchou et al., 2009), who showed that diet-induced obesity increases astrocytic 
leptin receptor expression.  
A change in neonatal leptin levels could also have direct effects on adipose 
tissue development and adipocyte functions, which could modify their ability to 
produce metabolic cytokines (Harris et al., 1998). Leptin expression in adipose tissue 
was increased at PND10 and PND21 in L4 rats of both sexes, a similar effect  has 
been previously observed in lambs whose mothers where overfed in late gestation 
(Muhlhausler et al., 2007). Thus, the higher circulating leptin levels at this age are most 
likely due to the rise in fat mass, as well as increased relative leptin production per 
gram of adipose tissue. These results suggest that leptin could indeed play a role in 
the observed long-term effects on metabolism by inducing permanent changes in 
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the hypothalamic feeding circuits during this sensitive period of development and 
possibly in adipose tissue development, although this remains to be demonstrated.  
Perinatal insulin levels are also implicated in hypothalamic maturation, as this 
hormone affects the development of projections of the main metabolic neuronal 
populations (Plagemann et al., 1999a; Konner et al., 2009; Vogt et al., 2014), with aberrant 
development due to changes in insulin levels disrupting glucose homeostasis and 
possibly leading to obesity and metabolic disorders such as T2D (Vogt et al., 2014). 
Here, glycemia and circulating insulin levels were higher in prepubertal L4 rats 
compared to L12 rats of both sexes. These results are in accordance with several 
studies that have reported elevated insulin levels in neonatally over-nourished 
rodents (Boullu-Ciocca et al., 2005; Pereira et al., 2006). Therefore, this perinatal 
hyperinsulinemia could also participate in the development of metabolic alterations 
seen in the adult. Moreover, at PND 10 insulin levels in L4 males were higher than in 
L4 females, which could possibly contribute to the sex differences observed in the 
long-term outcomes of this experimental manipulation.  
At PND 10, adiponectin levels were elevated in L4 male and female rats, with 
this elevation remaining at weaning in females. The effect of adiponectin on 
hypothalamic metabolic circuit development remains unknown; however, this 
adipokine is positively correlated with leptin levels and adiposity in cord blood and is 
suggested to play a role in early growth (Kotani et al., 2004; Tsai et al., 2004; Ballesteros 
et al., 2011). Moreover, adiponectin receptors are expressed in the embryonic mouse 
brain (Zhou et al., 2005). Although adiponectin is implicated in glucose metabolism, 
with high adiponectin levels acting to increase insulin sensitivity and, on the 
contrary, decreased adiponectin levels associated with a higher risk of developing 
insulin resistance (Yamauchi et al., 2001), there is little evidence linking adiponectin 
with insulin sensitivity in neonates (Kotani et al., 2004; Meral et al., 2011). Thus, it is 
possible that during early life, adiponectin has a different physiological role; indeed, 
PND10 and PND21 pups from L4 litters had higher adiponectin levels despite having 
higher insulin and HOMA index than their control litter mates. Supporting these 
observations, neonates are reported to have higher adiponectin levels at birth and in 
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contrast to adults, adiponectin levels in neonates are positively correlated with birth 
weight (Kotani et al., 2004; El-Mazary et al., 2015). Hence, in neonatal overnutrition, 
insulin and adiponectin, two metabolic hormones involved in the control of glucose 
homeostasis in adulthood, are elevated in early ages and this could participate in 
development of the observed metabolic effects. Moreover, these hormones are 
increased in a sexually dimorphic manner and this could possibly contribute to the 
sex differences in the long-term metabolic outcomes.  
Obesity is reported to course with systemic inflammation (Gregor and 
Hotamisligil, 2011), but the increased weight gain due to neonatal overnutrition did 
not result in a rise in circulating cytokines at any age. Indeed, in adult animals levels 
of these cytokines were either very low or undetectable. This of course could be due 
to the fact that the increase in weight gain was not severe, at least in adults. 
However, during the neonatal and peripubertal periods, although there was 
approximately a 40% increase in body weight at PND10 and a 50% increase at PND21 
in both sexes, the cytokines measured either decreased or did not change. At 
PND10, TNF-α and IL-1β levels were actually lower in rats raised in small litters, with 
no significant change in IL-6 levels. One possibility is that the developing animal 
responds differently to this increase in weight gain, as discussed below.  
The decrease in circulating TNF-α and IL-1β were associated with a significant 
decline in the mRNA levels of IL-1β in SCAT of females at PND10, but not in males. It 
is possible that at this age circulating levels of these cytokines do not reflect their 
production by SCAT. On the contrary, there was no effect of neonatal overnutrition 
on circulating cytokine levels at PND21, but the mRNA levels of IL6 were increased in 
VAT and decreased in SCAT of both sexes. These opposite changes in the expression 
of IL-6 could result in a net result of no change in circulating levels. This interleukin 
has a dual role, as it can be either anti-inflammatory or pro-inflammatory depending 
on the basal situation, the type and/or duration of the stimuli and the tissue where it 
is exerting its actions, with the correlation between IL-6 and obesity and insulin 
resistance being controversial (Wallenius et al., 2002; Di Gregorio et al., 2004; Vida et al., 
2015). In this line, while IL-6 is reported to induce insulin resistance in adipocytes 
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(Rotter et al., 2003), IL-6 treatment improves insulin-stimulated glucose metabolism in 
humans and enhances glucose uptake and fatty acid oxidation in myotubes, in 
addition to exerting anti-inflammatory actions (Starkie et al., 2003; Carey et al., 2006). 
Although there was no effect of litter size on IL-6 levels at these early ages, there 
was an effect of sex, with males having higher IL-6 levels than females, which could 
also contribute to the metabolic differences observed between the sexes. 
At PND10, testosterone levels were higher in L4 males compared to L12 
males, with 17β-estradiol levels being unaffected by neonatal overnutrition. 
Therefore, the neonatal testosterone surge that occurs in males (Raisman and Field, 
1973) appears to be modified by early overnutrition and this could be involved in the 
sexually dimorphic long-term responses. Indeed, the early sex steroid environment is 
important for the correct development of the hypothalamus (Lenz and McCarthy, 
2010), and modifications in androgen levels during early development have been 
shown to modify later metabolism (Nohara et al., 2013a; Nohara et al., 2013b; Ongaro et 
al., 2015). Hence, during neonatal overnutrition there are early changes in the 
hormonal environment, including leptin, insulin, adiponectin and testosterone that 
could influence the normal development of hypothalamic feeding circuits, as well as 
adipose tissue development and, thereby condition the metabolic status later in life.  
During the adolescent and young adult stages (PND30, 50 and 85), few effects 
of neonatal overnutrition were found. However, as mentioned above, in older adults 
(PND150) males were again found to be affected, although females were not. Not 
only was weight increased, but these rats were also hyperleptinemic, as reported in 
other studies (Fuente-Martin et al., 2012b; Stefanidis and Spencer, 2012; Ye et al., 2012). 
Circulating adiponectin levels were unaffected, which is in accordance with other 
studies analyzing neonatally overnourished male rats of 120 (Velkoska et al., 2005) and 
180 days of age (Rodrigues et al., 2011). In contrast, Boullu-Ciocca et al. reported 
hypoadiponectinemia in over-nourished male rats at PND150 (Boullu-Ciocca et al., 
2008). However, there was an interaction between sex and litter size on adiponectin 
levels, which tended to be higher in L4 males compared to their controls, with the 
inverse occurring in females. Adult females had higher adiponectin levels than males 
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and this could be associated with the lower insulin levels in females, as adiponectin 
acts as an anti-diabetic hormone. 
Triglyceride levels were also elevated in PND150 male rats, in association with 
the increased body weight. This is consistent with a study by Cai  and coworkers in 
which higher levels of triglycerides were found in males from small litters, in addition 
to being more elevated than in females (Cai et al., 2014). In contrast, no significant 
change or sex differences were found in circulating NEFA levels. Together these 
results suggest that male rats are more susceptible than females to the long-term 
metabolic effects of neonatal overnutrition. 
3. Effects of neonatal overnutrition on adipose tissue throughout 
development: amount, distribution and cytokine gene expression  
Many studies have established that WAT distribution in adult humans and 
animals is different between the sexes (Power and Schulkin, 2008; Fuente-Martin et al., 
2013a). Men are prone to accumulate central visceral fat, whereas women store 
peripheral or SCAT (Kotani et al., 1994; Demerath et al., 2007). However, less is known 
regarding fat distribution and its possible implications in the prepubertal period. In 
our experimental model, there was a very rapid increase in SCAT as a consequence 
of increased food intake during the neonatal period. Moreover, this increase in SCAT 
was sexually dimorphic even before puberty, with overnourished females having a 
greater increase in SCAT than males from the same litter size. The same pattern was 
observed at weaning, but at this age, both female groups had a greater percentage 
of SCAT than both male groups. These differences in SCAT continued at PND30 with 
litter size continuing to increase the amount of SCAT at PNDs 50 and 85. However, at 
PNDs 85 and 150, the sex differences are inverted, with males having more SCAT 
than females, which suggest a possible influence of post-pubertal gonadal steroids. 
Visceral adipose tissue was also increased by neonatal overnutrition at 
PND21, but in this case L4 males accumulated more VAT than L4 females. Although 
the effect of litter size did not persist at PND30, males continued to accumulate 
more VAT than females. SCAT and VAT differences between over-nourished and 
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control rats dissipated in the young adult rat, being coincident with the loss of effect 
of neonatal overnutrition on food intake, body weight and body length. At the end of 
the study, males tended to have higher amounts of both SCAT and VAT than females 
without reaching significant differences, most likely due to high variability among the 
experimental groups and the method used. A more refined method, such as MRI, 
would be more suitable to detect these changes (Johnson et al., 2008). 
Therefore, even before the pubertal rise in gonadal steroids, clear sex 
differences exist regarding adipose tissue distribution and accumulation in response 
to overnutrition. Excess VAT accumulation is a source of proinflammatory cytokines, 
which contribute to the development of insulin resistance, type 2 diabetes and 
cardiovascular diseases (Carey et al., 1997; Weiss, 2007b; Macotela et al., 2009; Shulman, 
2014). In contrast, SCAT has been associated with beneficial metabolic effects, such 
as lower cardiovascular and diabetes mortality and protecting against impaired 
glucose metabolism (Van Pelt et al., 2002; Tran et al., 2008; Manolopoulos et al., 2010), 
with the greater accumulation of SCAT possibly protecting females from some of the 
negative consequences of obesity. Hence, as the amount and distribution of adipose 
tissue differs significantly between males and females during the early postnatal 
period, this could contribute to the earlier development of metabolic complications 
in males. This is consistent with the fact that at PND10 and PND21 males had a 
greater increase in circulating insulin levels, which could be associated to the 
increased amount of VAT and cytokine production by VAT (discussed below), which 
is related to insulin resistance (Hotamisligil et al., 1993; Uysal et al., 1997; Bastard et al., 
2002; Jager et al., 2007; Nov et al., 2010). Therefore, even before sex steroids rise, there 
is a sexual dimorphic response to overnutrition in adipose tissue distribution.  
The early increase in fat mass in L4 pups was also directly related with 
elevated leptin mRNA levels in adipose tissue and circulating leptin concentrations. 
At PND21, L4 males had higher leptin expression in SCAT than L12 males, an effect 
that was not significant in females. At this age, VAT expression of leptin was higher 
in L4 than L12 pups of both sexes. In adulthood (PND85 and 150) males, expressed 
more leptin mRNA levels than females in SCAT and VAT, regardless of litter size as 
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previously shown by others in humans and rodents (Montague et al., 1997; Shen et al., 
2009b). These increases in leptin expression in adipose tissue correlated with 
circulating leptin levels.  
In normal adults, adiponectin expression in adipose tissue is inversely 
correlated with the amount of fat mass (Kern et al., 2003). In contrast, during the 
neonatal period when fat mass was greater in L4 rats, we found circulating 
adiponectin levels to also be higher. This was coincident with significantly increased 
expression of adiponectin in adipose tissue in L4 males, with the same trend 
occurring in females. In adult rats, although there was no effect of neonatal 
overnutrition on circulating adiponectin levels, there was an overall increase in the 
expression levels in SCAT at PND150 and in VAT at PND85 and PND150 in males, 
whereas circulating adiponectin levels were higher in females. How this change in 
cytokine production affects overall metabolism cannot be determined from the 
studies presented here, but it is of interest that apparent rise in production is found 
when effects on bodyweight have begun to reappear in males and males had higher 
adiponectin mRNA levels than females in both adipose depots. These differences 
could be attributed to the greater affectation of metabolic control in males, with the 
increased expression of adiponectin in males being a protective response.   
Obesity and the accumulation of white adipose tissue particularly, VAT, are 
often accompanied by a chronic low-grade inflammatory state (Gregor and 
Hotamisligil, 2011). At PND10, although there was a significant increase in SCAT in the 
over-nourished rats, cytokine mRNA levels were not increased. One possibility is that 
the organism must be exposed to the inflammatory-inducing factors associated with 
increased weight gain for a more extended period of time. In addition, adipose tissue 
is still developing in these animals and the characteristics of developing adipose 
tissue differ from mature adipose tissue (Rosen and Spiegelman, 2014). At this young 
age, the increase in fat mass could be due to hyperplasia (formation of new 
adipocytes) more than to hypertrophy (increase in adipocyte size) of the existing 
adipocytes. The two mechanisms of adipose tissue growth, hyperplasia and 
hypertrophy, have different outcomes; whereas hyperplasia is characterized by an 
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increase in adipocyte number by infiltration and proliferation of new and small 
preadipocytes, which have a higher fat storage capacity and are more sensitive to 
insulin; hypertrophy of adipose tissue implies that the volume of the adipocyte 
increases, which is associated with higher metabolic risk (Weisberg et al., 2003; 
Lundgren et al., 2007). Therefore, the observed decrease in expression of IL-1β and IL-6 
in SCAT at PND21, as well as in IL-1β at PND10 in females SCAT, could possibly be 
associated with adipose tissue expansion due to proliferation more than 
hypertrophy of the existing adipocytes, although this observation requires further 
investigation. Indeed, as adipocytes differentiate, their expression of cytokines 
changes, with for example, only mature adipocytes producing leptin (Rosen and 
Spiegelman, 2014). Hence, the early changes in adipokine expression could be 
representative of modifications in adipocyte proliferation and maturation in 
response to early over-nutrition. 
In contrast, at PND21, over-nourished rats had higher expression of IL-6 in 
VAT. This observation does not necessarily indicate inflammation, as it is possible 
that the initial response to nutrient and energy excess in VAT is to produce this 
cytokine as an acute anti-inflammatory response in an attempt to fight against the 
excessive nutritional insult. IL-6 has been shown to have inhibitory actions on TNF-α 
and IL-1β through activation of interleukin-1 receptor antagonist (IL-1ra) (Tilg et al., 
1994). Although this anti-inflammatory effect has been more thoroughly studied in 
response to the IL6 increase after exercise (Starkie et al., 2003), it is possible that this 
mechanism could participate in other situations such as early overnutrition. 
However, if weight gain becomes chronic, this cytokine could contribute to the 
pathophysiological inflammatory process in obesity (Rotter et al., 2003).  
In adults, cytokine expression in SCAT was undetectable, indicating the lack of 
inflammatory processes in this tissue.  The only indication of inflammation in VAT 
was the increased expression of TNF-α in L4 males, which is coincident with the 
increase in bodyweight in these animals. Males raised in small litters are reported to 
have increased content of IL-6 mRNA in mesenteric adipose tissue at 150 days of age 
(Boullu-Ciocca et al., 2008), although the expression of this cytokine was undetectable 
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in the two adipose depots studied here. As different functions and implications on 
health are associated with the different types of adipose tissue, this cytokine may 
also have different roles in each type of adipose tissue. In this line, it has been 
reported that omental adipose tissue release 2-3 times more IL6 than subcutaneous 
abdominal adipose tissue (Fried et al., 1998). Visceral adipose tissue is directly related 
with secondary complications of obesity and this may be the first site that responds 
to the excess of calories, secreting IL-6 at first as an anti-inflammatory signal, as 
explained above. It is also possible that this rise in IL6 represents a signal that is 
already associated with the induction of insulin resistance, as previously reported 
(Rotter et al., 2003). These changes did not occur in SCAT, which is not as tightly 
associated with obesity secondary complications. 
 Increased TNF-α is reported to be directly related to metabolic syndrome and 
impairment of insulin signaling (Hotamisligil et al., 1993). However, although L4 males 
had increased expression of TNF-α in VAT at PND150, no change in their HOMA 
index suggests that systemic insulin resistance is not present. Circulating levels of 
this cytokine were below the level of detection of the assay employed, thus other 
tissues might not be affected. Moreover, it is suggested that TNF-α does not induce 
insulin resistance when IL6 is down regulated in adipose tissue (Sultan et al., 2009), 
and here IL-6 expression was undetectable in VAT. High circulating leptin levels also 
contribute to maintain the chronic inflammatory state (Paz-Filho et al., 2012) and at 
the same time, pro-inflammatory cytokines induce the increase in circulating leptin 
levels and its expression in adipose tissue (Grunfeld et al., 1996; Faggioni et al., 1998). 
Thus, together these results could indicate that these male rats are beginning to 
exhibit signs of further metabolic impairment. Moreover, leptin has differential 
effects on male and female adipocytes (Guo et al., 2009) and this could also contribute 
to the sex differences observed. 
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4. The neonatal sex steroid environment influences the long-term 
responses to neonatal overnutrition 
Adult males and females are known to respond differently to some metabolic 
challenges, including being raised in a small or large litter (Fuente-Martin et al., 2012c; 
Sanchez-Garrido et al., 2014; Sanchez-Garrido et al., 2015),and this is at least partially due 
to post-pubertal differences in sex steroids (Castellano et al., 2011; Sanchez-Garrido et 
al., 2013). As males and females responded differently to neonatal overnutrition even 
prepubertally, we hypothesized that these differences could be due, at least in part, 
to sex differences in the neonatal hormonal milieu. It is possible that the neonatal 
testosterone surge that occurs in males (Miyachi et al., 1973) could be involved, not 
only in the differential response to overnutrition during the neonatal period, but also 
in the sex differences in long-term metabolic outcomes. Administration of 
testosterone to neonatal females has been classically used as an experimental model 
to study the mechanisms underlying sex differences in the brain (Raisman and Field, 
1973). This model has also been employed to analyze the long-term effects of 
increased neonatal androgen levels on the female reproductive axis and the 
development of polycystic ovary syndrome (Dunlap et al., 1972; Gellert et al., 1977; 
Goomer et al., 1977; Ongaro et al., 2015), and more recently on metabolic abnormalities 
(Nohara et al., 2013c; Mauvais-Jarvis, 2014; Ongaro et al., 2015).  
Testosterone levels remained elevated at PND10 in females that had received 
an injection of this sex steroid on PND1, and this was associated with the loss of 
some early sex differences. For example, the higher levels of adiponectin seen at 
PND10 in females compared to males in the neonatal overnutrition experiment were 
reduced by androgenization of females, such that they were no longer different from 
males. This could be due to the direct inhibitory effect of testosterone on 
adiponectin synthesis (Xu et al., 2005; Capllonch-Amer et al., 2014). Likewise, the lower 
levels of IL-6 in PND10 females were increased in androgenized females and were no 
longer different from males. This could be due to androgen effects on adipocyte 
differentiation, which can affect their expression of cytokines (Chazenbalk et al., 2013; 
O'Reilly et al., 2014). However, neonatal androgenization exacerbated the sex 
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difference in subcutaneous fat mass observed at PND10. This observation is of 
interest as studies have indicated that the number of X chromosomes determines 
adiposity (Chen et al., 2012) and the results obtained here suggest that this might also 
affect the response to early sex steroid levels. Indeed, hyperandrogenism in 
polycystic ovarian syndrome (PCOS) is associated with increased abdominal fat in 
women (Dunaif, 1997). Thus, some of the sex differences seen at PND10 could be at 
least partially due to sex differences in testosterone levels at this early age. 
Furthermore, testosterone levels were increased in over-nourished PND10 males 
compared to their controls. This rise in sex steroid levels could play a role in the 
development of long-term metabolic effects in over-nourished males and contribute 
to the sexually dimorphic outcomes of this experimental manipulation. 
Adult levels of testosterone and estradiol were unaffected in females that had 
received testosterone neonatal treatment. However, there were long-term changes 
in metabolic parameters in response to neonatal androgenization, as previously 
reported in other studies (Perello et al., 2003; Ongaro et al., 2013). Although body 
weight and glycemia were slightly increased at PND90 in androgenized females, the 
most drastic effects were observed on circulating leptin and IL1β levels, which rose 
above normal female values. The rise in serum leptin correlated with increased 
expression of this adipokine in VAT, while the sexual dimorphism in visceral adipose 
expression of IL6 and TNFα was not affected by neonatal testosterone. Thus, the 
neonatal rise in testosterone in males could play a role in the development of sexual 
dimorphisms in adipose tissue function. However, the fact that the production of 
some adipokines was actually increased above the levels found in both males and 
females suggests that female rats exposed to increased levels of testosterone, at 
least at this period of development, are prone to develop metabolic pathologies. 
Indeed, neonatal androgenization of females is associated with metabolic 
dysfunctions and PCOS development in the adult (Roland et al., 2010; Nohara et al., 
2013c; Mauvais-Jarvis, 2014). 
The factors involved in the sex differences observed in the long-term 
responses to neonatal overnutrition could thus include differential changes in 
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testosterone and some metabolic factors such as insulin. These changes could affect 
the development of central metabolic circuits, as previously shown (Mauvais-Jarvis, 
2014; Vogt et al., 2014), as well as that of other metabolic tissues such as adipose 
tissue. These developmental modifications would then also interact with the 
differential hormonal environment found in post-pubertal animals. For example, 
higher estrogen levels in post-pubertal females would have protective effects 
through inhibition of food intake and increasing energy expenditure (Palmer and Gray, 
1986; Musatov et al., 2007; Xu et al., 2011) and it is possible that this could reduce or 
delay the long-term effects of rapid neonatal weight gain. Estrogens also modulate 
adipose tissue deposition and function, favoring lipid accumulation in the 
subcutaneous depot in women and visceral fat deposition in men. Indeed, direct 
administration of estrogens to the CNS was shown to drastically reduce visceral 
adiposity (Adler et al., 2012) and increase thermogenesis (Martínez de Morentin et al., 
2014). Thus, another factor involved in the sexual dimorphic responses could be the 
differences found with regards to the amount, distribution and function of adipose 
tissue between the sexes from very early ages, as previously discussed, and the later 
interaction of this adipose tissue with the adult sex steroid environment. 
5. Central response to neonatal overnutrition in males and females 
Neonatal overnutrition has been previously reported to modify the levels of 
hypothalamic neuropeptides in the adult (Davidowa et al., 2003; Velkoska et al., 2005; 
Bouret et al., 2007; Chen et al., 2009). Here we analyzed the association between the 
rapid early weight gain due to neonatal overnutrition and the hypothalamic changes 
regarding inflammatory markers specifically, in glial cells. 
 
Astrocytes in neuroendocrine control 
Astrocytes participate in the regulation of the neuroendocrine functions 
including reproduction, osmotic control and energy homeostasis (Tweedle and Hatton, 
1977; Garcia-Segura et al., 1996b; Garcia-Caceres et al., 2012). Although astrocytes have 
also been shown to participate in the neuroendocrine control of metabolism 
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(Cheunsuang and Morris, 2005; Horvath et al., 2010; Garcia-Caceres et al., 2011; Yi et al., 2011; 
Fuente-Martin et al., 2012a), much is yet to be learned , including whether astrocytes 
participate in the long-term metabolic effects of neonatal nutritional or hormonal 
changes.  
Hypothalamic development in rodents takes place mainly during the 
postnatal period (Markakis, 2002; Bouret, 2013; Alvarez-Bolado et al., 2015), with 
astrogenesis occurring primarily during the second and third postnatal weeks 
(Bandeira et al., 2009; Freeman, 2010). Therefore, changes in the hormonal 
environment, such as in leptin, glucocorticoids, insulin, sex steroids or in other 
factors known to influence the development of this brain area (Bouret, 2010b; 2013), 
occurring during this period could affect not only neuronal, but also astrocyte 
development. Moreover, astrocytes are essential for neuronal proliferation, 
maturation, synaptic connectivity and homeostasis maintenance in the extracellular 
space (Chowen et al., 1996; Fields and Stevens-Graham, 2002), which indicates that any 
modification in these glial cells could impact on neuronal development and function, 
including the regulation of energy homeostasis and overall metabolism. 
5.1 Effects of neonaltal overnutrition on astrocytes  
In the hypothalamus of adult male rats that had been exposed to neonatal 
overnutrition, GFAP levels are increased and this is associated with an increase in the 
number of GFAP-positive astrocytes and structural changes in these glial cells (Garcia-
Caceres et al., 2011; Fuente-Martin et al., 2012a). One possibility is that this increase in 
the number of hypothalamic astrocytes is due to developmental influences. The 
neonatal leptin surge that normally occurs between postnatal days 5 and 13 
promotes not only promotes neuronal outgrowth and maturation, but also 
astrogenesis (Ahima et al., 1998; Bandeira et al., 2009; Rottkamp et al., 2015) and astrocyte 
development (Udagawa et al., 2006; Fisette and Alquier, 2015). Moreover, Wang et al 
recently showed that leptin receptor ablation in GFAP-positive astrocytes of 
embryonic mice reduces leptin-induced STAT3 activation in the hypothalamus and 
make these mice more vulnerable to diet-induced obesity (Wang et al., 2015), 
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indicating a key role of leptin signaling in astrocytes in the organization of 
hypothalamic neurocircuits. Thus, it is coherent to hypothesize that the rise in 
circulating leptin levels induced at PND10 by neonatal overnutrition could modulate 
astrocyte development. However, at this early age, GFAP protein levels in the 
hypothalamus were not modified in L4 pups despite having increased leptin levels. 
This does not necessarily indicate that there is no change in astrocyte development 
or even the number of astrocytes at this age. We have to take into consideration 
that GFAP protein levels were analyzed in the whole hypothalamus and not in 
specific hypothalamic areas directly involved in food intake regulation. Of note, 
immature astrocytes and radial glia mainly express vimentin early in development; 
whereas GFAP is more highely expressed in differentiated astroglial cells(Bignami and 
Dahl, 1995; Gomes et al., 1999). Moreover, during CNS development, GFAP can label 
radial glial, which give rise to neurons, astrocytes and oligodendrocytes. Thus, it is 
possible that at this early age, GFAP levels also reflect other cell types. Under normal 
circumstances GFAP levels increase with age (Nichols et al., 1993) and it is possible that 
at this early age, when the astrocyte population is being formed, a high percentage 
of astrocytes are GFAP negative (Sofroniew, 2009). Althgouh vimentin is expressed in 
immature astrocytes (Pixley and de Vellis, 1984; Bignami and Dahl, 1995), at PND10 
hypothalamic vimentin did not vary in L4 pups from control levels in males or 
females. However, at PND30 vimentin levels were lower in L4 pups of both sexes, 
suggesting overnutrition might accelerate astrocyte maturation. 
Further studies are necessary to determine if astrocyte 
proliferation/development is affected by this manipulation. However, it is of interest 
to note that the level of expression of the leptin receptor in hypothalamic astrocytes 
appears to be increased, as indicated by the double immunohistochemistry analysis 
reported here. These changes were found in the hypothalamus of both adult male 
and female rats that had experienced neonatal overnutrition. In contrast, although 
the number of GFAP positive cells in the hypothalamus of adult males that had 
experienced neonatal overnutrition was increased as previously reported (Fuente-
Martin et al., 2012a), this effect was not observed in females. Based on these results, 
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one might hypothesize that both the number and phenotype of the hypothalamic 
astrocytes are modulated by the early nutritional environment.  
Neonatal overnutrition did not affect hypothalamic levels of GFAP at any 
timpoint throughout development until PND150, when neonatally overnourished 
males had higher levels than control males. The changes in GFAP levels did not 
correlate with changes in bodyweight, as L4 males began to weigh more than their 
controls around PND90. Moreover, as stated above over-nourished animals of both 
sexes weighed more than their controls before weaning and GFAP levels were 
unaffected. Although it has been reported that activation of glial cells is not directly 
related to changes in body weight and that signals such as leptin are most likely 
involved (Gao et al., 2014), here changes in GFAP levels did not correlate with 
modifications in either body weight or serum leptin levels, at least in neonatal 
animals. Previously we have found hypothalamic GFAP levels to be modified in 
neonatally overnourished males at PND85-90, (Fuente-Martin et al., 2012a); however, 
in contrast to what we observed here the animals in the previous study were already 
hyperleptinemic at this earlier age. It is unclear why there was a delay in the 
development of hyperleptinema in the rats in the studies reported here, even 
though the rats had begun to weigh significantly more than their controls. However, 
it does appear that there is an influence of hyperleptinemia on the increase in 
hypothalamic GFAP levels, although other factors are most likely involved. 
Hypothalamic GFAP levels have been shown to increase in other models of 
obesity, such as in HFD-induced obese rats (Hsuchou et al., 2009). These obese animals 
are hyperleptinemic and leptin increases GFAP levels both in vivo and in vitro (Garcia-
Caceres et al., 2011), whereas low or null leptin levels are associated with decreased 
GFAP in spite of the animals presenting obesity (Ahima et al., 1999). Hyperleptinemia 
is reported to be associated with increased hypothalamic leptin levels (Hsuchou et al., 
2009). In our study, at PND150 neonatally overnourished male rats were 
hyperleptinemic, but the levels of leptin in the hypothalamus were not significantly 
increased, although there was a tendancy to do so. This could indicate a possible 
impairment of the leptin transport system in L4 males, which is suggested to occur 
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into become saturated in obese animals (Banks et al., 1999; Burguera et al., 2000). It is of 
interest to note that males had higher hypothalamic leptin levels than females, 
reflecting what occurs in serum. 
Circulating leptin increases in obese individuals and in response to fat rich 
diets (Argente et al., 1997; Hoffler et al., 2009), and obese subjects often develop leptin 
resistance which is thought to participate in further weight gain and secondary 
complications (El-Haschimi et al., 2000; Scarpace and Zhang, 2009). The increased 
resistance is reported to be partially due to decreased leptin transport into the brain 
(Caro et al., 1996; Schwartz et al., 1996) and/or decreased signaling in response to leptin 
(Van Heek et al., 1997).  At PND150, hypothalamic p-Stat3(Tyr705) levels were increased 
by neonatal overnutrition in both sexes with no changes in SOCS3 levels, an inhibitor 
of cytokine signaling including of the leptin signaling pathway; thus, we found no 
signs of central leptin resistance. This observation is in contrast to a study by 
Rodrigues et al where they found decreased pSTAT3 and an increase in SOCS3 
expression in the hypothalamus of neonatally overnourished rats (Rodrigues et al., 
2011). In the study by Rodrigues the rats also desplayed persistent hyperphagia, 
which also indicates central leptin resistance; however, the detected no 
hyperleptinemia in these 180 day old animals. The explanation for this is unclear. .  
At PND150, in our study the animals were also eating more, so it is possible that a 
failure in leptin signaling is beginning to appear although not detected here. Indeed, 
the age of the rats could be an important factor, since the animals in which central 
leptin resistance was found were 180 days old and it is possible that our animals 
would continue to develop further metabolic complications, including central leptin 
resistance. 
As mentioned above, we found an increase in the intensity of leptin receptor 
immunoreactivity over GFAP positive cells in hypothalamic astrocytes of male and 
female adult rats that were neonatally overfed. This increase in astrocytic leptin 
receptor expression was correlated with increased weight in both sexes, as the 
neonatally overnourished rats of both sexes weighed more at the timpoint used in 
this study.  This increased leptin receptor expression in adulthood could be the result 
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of developmental influences, or of signals related to the weight gain. The increase in 
leptin concentrations due to early overnutrition have been previously reported to 
modify the expression of the leptin receptor in the hypothalamus (Toste et al., 2006; 
Manuel-Apolinar et al., 2010). Thus, the observed hyperleptinemia at PND10 and 21 in 
both sexes could be responsible for the increase in leptin receptors in astrocytes in 
adulthood.  
The expression of leptin receptors in astrocytes increases in response to diet 
induced-obesity, at least in males (Hsuchou et al., 2009). The physiological role of 
leptin signaling in astrocytes was established by Kim et al (Kim et al., 2014a). In this 
study that the lack of the leptin receptor in adult GFAP-positive cells, was shown to 
blunt the anorectic effect of leptin and increase the response to ghrelin as well as 
the response to fasting when the animals were refeeding. In addition, leptin receptor 
ablation in GFAP cells modified astrocyte morphology, reduced glial coverage and 
altered synaptic inputs to AgRP and POMC neurons of the ARC.  
Together these data indicate that astrocytes are respond to early nutritional 
disturbances, possibly in a sexually dimorphic pattern, and that they could be 
involved in the long-term metabolic consequences. However, further investigation is 
required todetermine the different responses to metabolic challenges in male and 
female astrocytes. 
5.2 Hypothalamic inflammatory signals in response to neonatal 
overnutrition 
The hypothalamus is now known to be an important site of cytokine 
bioactivity within the CNS, as they appear to modulate appetite and energy 
homeostasis (Schobitz et al., 1993; Wong and Pinkney, 2004). Hypothalamic inflammation 
was first reported in obese rodents by De Souza and coworkers approximately 10 
years ago, when mice maintained on HFD were found to have an increase in the 
production of inflammatory cytokines and insulin resistance in the hypothalamus (De 
Souza et al., 2005). Inflammation within the hypothalamus in association with obesity 
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appears to occur as a consequence of a combination of factors, including the type of 
diet and the resulting changes in circulating nutrients and hormones. These factors 
can to lead to an inflammatory response disrupting metabolic, glucose and 
cardiovascular homeostasis (Cai and Liu, 2012). The inflammatory response of the 
hypothalamus to HFD-induced obesity can thus lead to decreased sensitivity to 
leptin and/or insulin and therefore have negative consequences on the regulation of 
food intake, triggering the development of secondary complications, such as type 2 
diabetes (Carvalheira et al., 2003). However, there is little information regarding the 
changes in cytokine levels in obesity that is not due to HFD, such as  increased 
weight gain as a result of early overnutrition, or in young animals. 
At PND10, hypothalamic IL-6 levels were increased by overnutrition in males, 
but not in females. This could indicate an increase in central production of this 
cytokine, or increased transport of IL-6 across the BBB (Banks et al., 1995), although no 
increase in serum levels was found.  The fact that this rise was only observed in 
males in response to overnutrition is of interest, as both sexes had increased weight 
gain and increased leptin levels. Androgenization of females resultsed in a rise in 
circulating IL6, and it is possible that the central differences in this cytokine are due 
to the sex steroid environment at this time. The increase of IL-6 at this early age 
could be related to the regulation of food intake (Wallenius et al., 2002; Flores et al., 
2006; Senaris et al., 2011), and not necessarily inflammatory processes.  
Hypothalamic inflammation during development in response to early 
overfeeding was studied in pups by Ziko et al., where they found a reduction in IL-1β 
expression in overfed pups at PND14 and suppression of TNFα in overfed pups at 
PND7 (Ziko et al., 2014), with no change in IL-6 expression at any of these early ages. 
This is similar to our observations, where we found no change in protein levels of IL-
1β or TNFα, and supports the hypothesis that hypothalamic inflammation does not 
occur in these young overweight animals. 
Peripheral and central IL-6 levels have been previously reported to be 
increased in adult male rats (8 weeks old) in response to neonatal overfeeding 
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(Stofkova et al., 2009; Tapia-González et al., 2011; Ziko et al., 2014) and we found an 
increase in the hypothalamus of males at PND50, although it did not reach signficance. 
The higher levels of central IL-6 were not associated with a change in body weight at 
this age and IL-6 could act as an anorectic signal to prevent overfeeding (Ropelle et al., 
2010). Indeed, in older animals that had increased food intake and were overweight, 
IL-6 levels in the hypothalamus were not increased.  
No differences in hypothalamic IL-1β or TNF-α levels were found at PND50, 
which was in accordance with Ziko et al. where no changes in these proinflammatory 
cytokines were found in the hypothalamus of neonatally overfed male adults at 
PND70 (Ziko et al., 2014). Here similar results are also shown in females. Levels of the 
proinflammatory cytokine IL-1β in the hippocampus are reported to be higher in 
males than in females (Bilbo and Tsang, 2010), but we found no differences between 
the sexes in the levels of hypothalamic IL-1β, IL6, or IL10. In contrast, TNFα levels 
were higher in males than in females, regardless of littersize. 
 Hypothalamic inflammation has been tightly associated with increased TNF-α 
levels and signaling (Thaler et al., 2012; Wang et al., 2012; Valdearcos et al., 2015). At 
PND150, hypothalamic TNF-α levels were only found to be increased in neonatally 
overnourished males, which was associated to increased body weight. This 
observation could indicate that these animals could develop hypothalamic insulin 
and/or leptin resistance, as observed in other studies (De Souza et al., 2005; Milanski et 
al., 2009; Posey et al., 2009; Thaler et al., 2013), although hypothalamic levels of p-
Stat3(Tyr705) were increased with no change in SOCS3. However, the techniques 
employed would not detect changes if only select cell populations become leptin or 
insulin resistant. The elevated hypothalamic TNFα levels could be related to the 
increase in GFAP protein levels and GFAP+ cell number in L4 males. Increased 
hypothalamic TNF-α levels in response to saturated fatty acids has been associated 
with activated microglia (Valdearcos et al., 2014); however, here we did not detect 
changes in Iba1 protein levels or immunostaining as a consequence of neonatal 
overnutrition. Microglial activation does not always correlate with weight gain 
(Fuente-Martin et al., 2013b; Gao et al., 2014; Garcia-Caceres et al., 2014), indicating that 
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other factors are involved, such as the diet associated with the weight gain. At 
PND150, hypothalamic TNF-α levels were higher in males than females, regardless of 
litter size. This could also indicate that overfed males are starting to show 
vulnerability to the early overnutrition as they get older, which does not occur in 
females, at least at this age. Thus TNFα could be one factor participating in the 
sexual dimorphism in response to aging.  
6. Sex differences in the responses to neonatal overnutrition 
According to the results presented, it is clear that modification of the 
nutritional status during the sensitive period of lactation, produces a hormonal 
imbalance during the initial postnatal weeks in L4 pups and triggers short and long-
term effects not only on peripheral, but also central systems that regulate energy 
balance in a sexually dimorphic manner. The most striking differences that we found 
between the sexes were the long-term effects of neonatal overnutrition reflected in 
an increased body weight in males, but not females, as well as a change in GFAP 
immunopositive cells in males but not females. This is consistent with previous 
studies in which neonatal overnutrition alters body weight in adulthood (Glavas et al., 
2010; Hou et al., 2011; Fuente-Martin et al., 2012b; Bei et al., 2015; Collden et al., 2015) and is 
associated with an increase in the number of GFAP-positive cells in the 
hypothalamus (Garcia-Caceres et al., 2011; Fuente-Martin et al., 2012a), although all of 
these studies employed only male animals. In addition, androgenized females had 
increased hypothalamic GFAP compared to control females and this was associated 
with higher body weight and circulating leptin levels, which is consistent with 
previous studies that show that perinatal androgens cause sexual differences in 
GFAP expression and morphology in different brain areas (Garcia-Segura et al., 1988; 
Chowen et al., 1995; Mong et al., 1999; Amateau and McCarthy, 2002; Conejo et al., 2005). 
Whether glial changes due to early weight gain as a consequence of neonatal 
overnutrition affect synaptic inputs to metabolic neurons and if this is sexually 
dimorphic requires further investigation. 
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Thus, taking together body weight, GFAP protein levels and the number of 
GFAP positive cells, these results suggest that males and females have a differential 
long-term response to neonatal overnutrition. There are scarce data showing the 
long-term effects in females. However, as seen here some studies indicate that long-
term effects are influenced by sex, with males suggested to be more susceptible 
than females to early nutritional disturbances (Bassett and Craig, 1988; Boubred et al., 
2009; Fuente-Martin et al., 2012c; Stefanidis and Spencer, 2012). As previously discussed, 
neonatal testosterone among other factors could be involved in the sexually 
dimorphic long-term effects of early nutritional alterations. 
6.1 Response of male and female hypothalamic astrocytes in vitro 
Astrocytes can participate in hypothalamic inflammation and HFD-induced 
obesity results in hypothalamic astrogliosis (Horvath et al., 2010; Thaler et al., 2012; 
Buckman et al., 2013). Along with microglia, astrocytes participate in the central 
inflammatory response (Rivest, 2009; Thaler et al., 2012; Buckman et al., 2014; Morselli et 
al., 2014; Valdearcos et al., 2014), producing pro- and anti-inflammatory cytokines, 
chemokines or other factors in response to a stimulus; therefore, these glial cells 
could be the source of the increases in central cytokine levels. Indeed, astrocytes are 
directly exposed to nutrients, including FAs, and have essential roles in relaying 
information concerning hormonal and nutritional signals to neurons; therefore, FAs 
could produce modifications in astrocytes that could indirectly affect neuronal 
regulation of energy balance. Specifically, the saturated FA, palmitic acid, is reported 
to induce pro-inflammatory cytokine production and central leptin sensitivity, but 
this leptin resistance is not observed in response to the unsaturated oleic acid 
(Karaskov et al., 2006; Milanski et al., 2009; Gupta et al., 2012; Morselli et al., 2014). The 
initial responses of glial cells are thought to be mainly protective; however, a 
prolonged inflammatory response and glial activation can be damaging and 
contribute to further metabolic complications. 
Studies indicate that the inflammatory response of astrocytes differs between 
the sexes, with a more exaggerated inflammatory response from male compared to 
Discussion 
168 
 
female astrocytes.  (Liu et al., 2007; Santos-Galindo et al., 2011; Morselli et al., 2015), 
Likewise, we found sex differences in the long-term glial and inflammatory response 
to neonatal overnutrition, including changes in GFAP and hypothalamic cytokines, 
with males being more affected than females. Estrogens could be involved in the 
protective effects in females (Wang et al., 2014a; Zhang et al., 2014), but sex differences 
in astrocytes could also be due to differences in the sex chromosomes or from sex 
steroid exposure during development (Arnold, 2009). Here we analyzed whether the 
response of these glial cells to fatty acids was sex dependent and if estrogens 
affected this response. 
7. The effect of fatty acids on hypothalamic primary astrocytes from male 
and female rats  
7.1 Palmitic acid 
Studies show that excesive ingestion of dietary fats is associated with 
increased GFAP expression and astrocyte reactivity in the brain (Hsuchou et al., 2009; 
Horvath et al., 2010). Palmitic acid is the most abundant saturated FA in the diet and in 
plasma. In addition, plasma PA levels increase in obesity (Opie and Walfish, 1963; 
Reaven et al., 1988) and this FA has been suggested to directly induce hypothalamic 
inflammation (Milanski et al., 2009; Cheng et al., 2015). Importantly, obese patients with 
metabolic syndrome have a higher FA uptake into the brain than healthy patients, 
with HFD intake increasing this uptake (Wang et al., 1994; Karmi et al., 2010). However, 
in addition to FAs, other metabolic signals are modified in obesity and reach the 
brain and therefore, could be also responsible for the observed changes in glia and 
inflammation. Indeed, HFD ingestion alters circulating levels of insulin, 
glucocorticoids, estrogens and cytokines (Tannenbaum et al., 1997; Kubota et al., 1999; 
Cohen, 2000; Hoffler et al., 2009), which can modify astrocytes (Toran-Allerand et al., 1991; 
Garcia-Segura et al., 1996b; Garcia-Caceres et al., 2011) and these factors could be 
involved in astrocyte activation independently of FAs. Indeed, ob/ob mice in which 
leptin levels are nule, GFAP levels are decreased (Ahima et al., 1999). Astrocytes from 
mixed male and female cerebral cortices have been shown to respond to FAs in vitro 
Discussion 
169 
 
(Gupta et al., 2012); hence, we aimed to further understand the response of these glial 
cells, but specifically in the hypothalamus, to increased levels of FAs in both sexes.  
Hypothalamic astrocytes cultured in vitro responded to palmitic by decreasing 
GFAP mRNA levels and this response was similar in both sexes. The decrease in GFAP 
expression was not associated with a decrease in cell number. These results are in 
contrast to the study by Morselli and colleagues (Morselli et al., 2015) where GFAP 
expression was increased after exposure to palmitic acid. In the study by Morselli et 
al., the time of exposure to this fatty acid was only 8 hours compared to 24 hours 
used here. As the protein levels of GFAP in the hypothalamus and in hypothalamic 
astrocyte cultures change in a biophasic manner in response to leptin (Garcia-Caceres 
et al., 2011), it is possible that a similar phenomenon occurs in response to FAs. 
Another possibility is that palmitic acid is inhibiting growth, as shown by Beeharry et 
al (Beeharry et al., 2003), and this occurs after longer exposition. Moreover, the 
astrocyte cultures of Morselli et al were derived from mice and thus the response 
could be different in rat astrocytes. In support of this, we have found that the GFAP 
response to ghrelin differs between astrocyte cultures from male mice and male rats 
(Fuente-Martin et al., in press). Reactive astrocyes are structurally more complex and 
present higher GFAP level (Gomes et al., 1999), therefore a decrease in GFAP levels 
could indicate decreased astrocyte differentiation and/or proliferation. Moreover, 
astrocyte morphology could also be affected and the decrease in GFAP due to fewer 
or shorter projections as a result of palmitc acid. Further studies are necessary to 
determine if the change in mRNA levels is associated with similar changes in protein 
levels and in astrocyte morphology, as well as to determine if the changes in GFAP 
mRNA levels in response to palmitic acid depend on the time of exposure to this FA. 
Free fatty acids, especially saturated FAs, can activate an inflammatory 
response in different cell types (Boden and Shulman, 2002; Iyer et al., 2010), as well as ER 
stress (Gregor and Hotamisligil, 2007). In addition to inducing central inflammation 
(Milanski et al., 2009; Gupta et al., 2012; Morselli et al., 2014), palmitate causes ER stress, 
ERK activation, and apoptosis in adipocytes (Guo et al., 2007) and hepatocytes (Malhi et 
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al., 2006), as well as in hypothalamic neurons (Mayer and Belsham, 2010). In agreement 
with this, we found that in astrocytes palmitic acid increased IL6 and CHOP 
production in a dose dependent manner. Astrocytes are the predominant source of 
IL-6 in the CNS (Van Wagoner and Benveniste, 1999) and the PA-induced increase in IL-6 
expression could be part of an inflammatory response, as IL-6 is one of the effectors 
of the neuroinflammatory cascade (Rothwell and Hopkins, 1995; Allan and Rothwell, 
2003). However, IL-6 could also be functioning as a neuroprotective beneficial signal, 
avoiding brain damage and enhancing neuronal survival (Van Wagoner et al., 1999). 
Indeed, an increase in IL6 in astrocytes and microglia has also been shown to have a 
protective role from diet induced obesity, preventing further weight gain and 
limiting the adverse hypothalamic consequences (Hidalgo et al., 2010).  Moreover, IL-6 
functions as a neuroendocrine signal and could be acting as an anorectic signal to inhibit food 
intake in response to FA excess (Ropelle et al., 2010). 
The increase in CHOP production by palmitic acid suggests ER stress, which 
has been linked to obesity, with increased levels of FFAs known to contribute to the 
development of ER stress in other cell types (Oyadomari and Mori, 2004; Ozcan et al., 
2004; Nakatani et al., 2005; Ozcan et al., 2006; Szegezdi et al., 2006; Ron and Walter, 2007; 
Zhang et al., 2008). Increased ER stress can induce cytokine production, and thus induce 
inflammatory processes that can lead to insulin resistance (Ozcan et al., 2004; Ozcan et 
al., 2006; Shi et al., 2006) and can also lead to apoptotic cell death (Oyadomari and Mori, 
2004; Karaskov et al., 2006; Szegezdi et al., 2006).  
Palmitic acid also stimulated the release of nitrites and nitrates to the culture 
media in a dose dependent manner, which can have a cytotoxic role on the 
surrounding cells under pathological circumstances (Moncada et al., 1991; Zhang et al., 
1994a). Nitric oxide production increases in pancreatic β-cells in response to palmitic 
acid (Shimabukuro et al., 1997). Nitric oxide is proposed to link ER stress and 
inflammation (Gotoh and Mori, 2006) and is associated with insulin resistance (Kaneki et 
al., 2007). There is evidence of induction of CHOP by nitric oxide (Kawahara et al., 2001; 
Gotoh et al., 2004), which is consistent with our results. Studies have indicated that in 
vitro, hypothalamic neurons do not have an inflammatory response to saturated 
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fatty acids, although an ER stress response does occur (Choi et al., 2010). Prolonged 
HFD is reported to induce neuronal apoptosis (Moraes et al., 2009) and to decrease the 
neuronal number in the hypothalamus (Thaler et al., 2012). A similar response was also 
observed in neural stem cells (NSCs), which differentiate into neurons and 
astrocytes, after exposure to palmitic acid (Yuan et al., 2013). Therefore, FAs induce 
stress in hypothalamic astrocytes with these glial cells releasing factors that could 
regulate or damage surrounding neurons and thus indirectly affect neuronal 
regulation of energy balance. 
Astrocytic production of IGF-1 is involved in neuroprotection (Madathil et al., 
2013; Genis et al., 2014) and IGF-1 protects astrocytes from oxidative stress (Davila et 
al., 2016). PA reduced IGF-1 mRNA levels in astrocytes, with this reduction being more 
apparent in females at higher doses. Whether this decrease in IGF-1 production is 
related to the increased ER stress in response to PA, as well as whether there is a 
decreased protective effect of astrocytes on the surrounding neurons, remains to be 
demonstrated.  
The increase in CHOP mRNA levels in response to PA was significant in males, 
but not in females. In addition, the release of nitrites and nitrates and the increase in 
IL-6 expression was higher in males than females, although this did not reach 
statistical significance. This is probably due to the large variability in some groups, 
and the large number of groups being analyzed. Indeed, if the sexes are analyzed 
separately, some changes do become significant. Moreover, increasing the number 
of experiments could possibly reduce the variability in these results. 
7.2 Palmitic and oleic acids interaction 
There are distinct inflammatory responses to the different fatty acids present 
in our diet. Likewise, saturated and unsaturated fatty acids are reported to produce 
different effects on energy homeostasis (Lee et al., 2001; Karaskov et al., 2006; Gupta et 
al., 2012; Itariu et al., 2012; Kien et al., 2014). Here, the response of hypothalamic 
astrocytes to oleic acid was significantly different from that seen in response to 
palmitic acid.  
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Oleic acid did not produce the dramatic decrease in GFAP seen in response to 
PA exposure, nor were IL-6 or CHOP expression levels or the release of nitrites and 
nitrates increased by OA. Moreover, when OA was added, it was capable of blocking 
the effects of PA on GFAP, IL-6 and CHOP mRNA levels. However, although the 
increased release of nitrites and nitrates that was found after PA exposure was 
unapparent with OA, the combination of both fatty acids still stimulated the release 
of nitrites and nitrates, which was significant in males but not in females. 
This suggests that OA does not trigger the inflammatory, ER stress or certain 
cytotoxic effects on astrocytes that are seen with PA and supports the fact that 
saturated and unsaturated FAs can have different impacts on energy homeostasis 
(Lee et al., 2001; Beeharry et al., 2003; Karaskov et al., 2006; Benoit et al., 2009; Milanski et 
al., 2009; Cintra et al., 2012; Gupta et al., 2012; Itariu et al., 2012; Kien et al., 2014). Here we 
show that some of these differential effects of fatty acids could possibly be mediated by 
astrocytes. 
The observation that CPT1A mRNA levels were differentially regulated by 
palmitic and oleic acids in astrocytes is of interest. This enzyme is essential for fatty 
acid oxidation, as it is the first and rate-limiting step in the formation of 
palmitoylcarnitine (Lee et al., 2011). Palmitoylcarnitine, or acyl-carnitine, is then 
moved to the inner mitochondrial membrane through a specific shuttle system to be 
oxidized. The fact that palmitic acid is less capable than oleic acid of inducing CPT1A 
in astrocytes, and thus of initiating  fatty acid oxidation in these cells, could 
contribute to its toxicity. In combination with OA, palmitic acid could be more freely 
shuttled into the mitochondria and oxidized due to the increased levels of CPT1A 
and this could decrease its toxicity. 
Interestingly, OA increased the expression of IGF-1, with this elevation being 
significant in males, but not in females. Although PA alone had no effect on the 
expression of this neuroprotective factor, it inhibited the effect of OA in males.  In 
contrast in females, PA reduced IGF-1 mRNA levels and OA blocked this reduction. 
Further studies are necessary to determine the mechanisms by which fatty acids 
modulate IGF-1 production in astrocytes, including whether this is a primary 
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response to the fatty acids, or an indirect response through previous modulation of 
other factors. Indeed, these studies were done at 24 hours of exposure to fatty 
acids. However, it is of interest that this neuroprotective factor (Genis et al., 2014) is 
differently modulated by these fatty acids in males and females.  
In contrast to the studies with PA alone, here we found a decrease in TNFα 
mRNA levels in response to both PA and OA, with the combination of these fatty 
acids being additive. The fact that the variability in the results of the first 
experiments was greater could explain this differential result as there was also a 
tendency to decrease in the previous study. This decrease in TNFα mRNA levels was 
unexpected, as this cytokine has been directly associated with the inflammatory 
response to fatty acids, however TNFα is also reported to be inhibited by IL-6; 
therefore, it could be that the increased production of IL-6 in response to PA is 
exerting an inhibitory effect on TNFα levels (Oh et al., 1998; Calder et al., 2013). 
7.3 Protective effects of estrogens against palmitic acid 
The central anti-inflammatory effects of estradiol have been widely studied 
(Arevalo et al., 2010; Cerciat et al., 2010; Guo et al., 2012). However, less is known 
regarding the effect of estradiol specifically in hypothalamic astrocytes in 
overnutrition or obese conditions. Here we found that PA decreased the expression 
of ERα in primary astrocytes of both sexes, but estradiol had the opposite effect and 
was able to block the effect of PA, especially in female astrocytes. It has been 
reported that female hypothalamic astrocytes express higher levels of ERα in in 
response to estradiol stimulation (Kuo et al., 2010). This was in accordance to the 
observations of Morselli et al (Morselli et al., 2014), despite that they employed 
hypothalamic astrocytes from mice, the estradiol concentration used was higher, the 
PA concentration lower and the treatment exposuretime was only 8 hours. 
Pretreatment of astrocytes with estradiol reversed some of the changes 
produced by palmitic acid, such as IL6 and CHOP production, showing protective 
effects in both sexes. Neuroprotection and anti-inflammatory effects through ERα 
has been shown in astrocytes and neurons (Barreto et al., 2009; Spence et al., 2013; 
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Arevalo et al., 2015). Moreover, estrogens are known to be inhibitors of inflammatory 
cytokines such as IL6 and IL1β in peripheral tissues and brain (Koka et al., 1998; Bruce-
Keller et al., 2000). 
Although IGF-1 production tended to decrease after PA, no effect of estradiol 
was found. As IGF-1 is produced by astrocytes as a neuroprotective factor and as 
protection against oxidative stress (Genis et al., 2014), it would be coherent to think 
that estradiol may protect astrocytes and thus surrounding neurons by modulating 
the release of IGF-1. However, although female astrocytes showed a slight increase, 
there was no significant increase in IGF-1 levels after estradiol pre-treatment , 
although with an increased “n” the effect could possibly be found to be significant. 
Likewise, the anti-inflammatory cytokine IL-10 showed a light increase in response to 
estradiol alone and estradiol plus PA compared to PA alone in females, but not in 
males. These results suggest that estradiol may mediate its protective effects in 
females by stimulating the release of IGF-1 and IL-10 in response to PA, althoug 
further experiments are needed to confirm this hypothesis. 
These data indicate that estradiol could play an important role as an anti-
inflammatory or anti-ER stress factor in astrocytes when exposed to saturated fatty 
acids. In males, estradiol was less capable of protecting against the decline in ERα 
expression induced by PA, which could possibly decrease the ability of estradiol to 
impede neuronal damage, as previously shown (Carbonaro et al., 2009). The increase in 
IL-6 and CHOP expression induced by PA were similarly reversed by estradiol in 
males and females. However, as in vivo females have higher circulating levels of 
estradiol than males, this mechanism could be involved in the higher level of 
protection against high fat diets observed in females.  
7.4 Palmitic acid and the Toll receptor 4 antagonist RS-LPS 
 Activation of TLR signaling cascades produce a wide array of proinflammatory 
cytokines, including IL-1β, IL-6 and TNF-α, in addition to reactive oxygen and 
nitrogen species mediators such as NO (Takeda and Akira, 2015). In response to PA, the 
most striking results that we observed were the increase in CHOP, IL-6 and the 
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amount of nitrites and nitrates released to the media, which are signs of 
inflammation and oxidative stress. Importantly, oxidative stress activates 
mechanisms that result in glia-mediated inflammation, which can produce secondary 
neuronal damage. As saturated fatty acids have been proposed to activate TLR4 in 
the hypothalamus (Milanski et al., 2009), we asked whether PA activated TLR4 in 
astrocytes. It is well known that TLR4 is activated by lipopolysaccharide (LPS) 
(Poltorak et al., 1998). Whereas LPS stimulates TLR4 in microglia, the main cells 
responsible for the immune response in the CNS to activate an inflammatory 
response (Qin et al., 2005; Rivest, 2009), lower constitutive expression of TLR4 is found 
in astrocytes. However, TLR4 activation in astrocytes is also reported to activate 
proinflammatory processes mediated by the NFκB, MAPK and Jak1/Stat1 signaling 
pathways (Carpentier et al., 2005; Gorina et al., 2011). We used a form of LPS, RS-LPS, 
that is purported to antagonize TLR4 (Kutuzova et al., 2001) to determine if 
hypothamic astrocytes respond to PA through this receptor. However, not only did 
RS-LPS not block the effects of PA, but it also stimulated IL-6, CHOP, IL-1β, Nfκbia 
(IκBα) mRNA levels and this was additive with the effects of PA. This could indicate 
that in astrocytes the expression of these factors in response to PA is not dependant 
on TLR4 activation. Inflammation could be activated in astrocytes through another 
TLR, such as TLR3, which is reported to be more highly expressed in these glial cells 
than is TLR4 (Farina et al., 2005). This receptor mediates the release of a wide variety of 
predominantly anti-inflammatory and neuroprotective, as well as pro-inflammatory 
factors, IL-6 among them (Bsibsi et al., 2006), whereas TLR4 mainly triggers the release 
of pro-inflammatory mediators such as TNF-α (van Noort and Bsibsi, 2009). What is 
clear is that RS-LPS is not acting as a TLR4 antagonist in these cells, but as at least a 
partial agonist. Moreover, the effects of PA and RS-LPS appear to be additive.  
Astrocytes from cerebral cortex are reported to release proinflammatory 
cytokines in response to TLR4 activation (Gorina et al., 2011)  and the TLR4 antagonist 
used here has been shown to attenuate inflammation in microglial cells by reducing 
TLR4 and NF-κB and MAPKs signaling pathways (Gaikwad and Agrawal-Rajput, 2015). 
However, the activation of TLRs in astrocytes and microglia is not the same, as 
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astrocytes respond later than microglia to activation of TLRs (Rivest, 2003; Owens, 
2005). Thus, the mechanism of activation could be different and could possibly 
explain the lack of an antagonist response to this factor in astrocytes. 
7.5 Intracellular signaling in astrocytes in response to PA 
We found that male astrocytes rapidly increased the amount of STAT5 in 
response to PA. The STAT family has a central role in inflammatory reactions and is 
stimulated by multiple cytokines to regulate the expression of inflammatory 
mediators. Particularly, STAT5 has been shown to be activated by glycogen synthase 
kinase-3 (GSK-3) in primary cultures of cerebral cortical astrocytes to trigger 
inflammatory responses (Beurel and Jope, 2008; Wang et al., 2011) and PA induces GSK-3 
activation in cultures of primary hepatocytes (Ibrahim et al., 2011). Thus, STAT5 
activation appears to be one of the inflammatory signaling pathway activated by PA. 
In addition, STAT5 participates in the regulation of glycogen storage in astrocytes 
(Bosier et al., 2013) and the increase found in STAT5 could indicate an increase in 
glycogen storage in response to fatty acids, however if GSK-3 is activated to induce 
STAT5 increase and trigger inflammation, glycogen synthase would be inactivated by 
GSK-3 and thus glycogen storage inhibited. Further studies are necessary to 
determine the implication of this signaling pathway in astrocytes response to 
nutrient–derived signals. 
Stress and inflammation can also activate NFκB, ERK and JNK pathways in 
astrocytes leading to the synthesis and release of inflammatory mediators (Gao and Ji, 
2010; Gorina et al., 2011). NFκB and MAPKs play an important role in triggering 
microglia activation and subsequent secretion of inflammatory mediators 
(Vallabhapurapu and Karin, 2009). However, we found no changes in the activation of 
these pathways. This could be due to the degree of variability found in these result . 
Moreover, as only one time-point after exposure to PA is reported here, it is possible 
that some of these pathways are activated either more rapidly, or at a later time-
point. 
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1. Males and females respond differently to increased food intake even 
during the neonatal period; thus, the sex differences in metabolic control 
cannot be solely attributed to post-pubertal differences in circulating 
gonadal steroid levels.  
 
2. Neonatal overnutrition induces significant changes in circulating insulin, 
leptin, and adiponectin levels during a critical period of hypothalamic 
development. Hence, modifications in the levels of these hormones, some 
of which are known to influence hypothalamic development, could be 
involved in the long-term metabolic effects of early overnutrition. 
 
3. The hormonal changes induced by overnutrition differed between males 
and females during the neonatal period. The greater increase in serum 
insulin, as well as in testosterone levels in males, during this critical 
developmental period, could be involved in the differential long-term 
metabolic outcomes observed between the sexes.   
 
4. The long-term effects of neonatal overnutrition change throughout 
development, with males being more susceptible to metabolic alterations 
during adulthood.  
 
5. Increased weight gain during the perinatal period was not associated with 
any indication of systemic inflammation, which could be due to the ability 
of adipose tissue to expand due to hyperplasia during early development. 
This observation supports the fact that obesity during childhood is 
different from that seen in adults. 
 
6. The increased bodyweight in adult male rats was associated with 
significant elevations in the hypothalamic levels of the inflammatory 
cytokine TNFα and the astroglial marker GFAP, as well as the number of 
GFAP+ astrocytes. However, there was no increase in other markers of 
astrocyte activation, such as vimentin, or in microglial markers or 
inflammatory signaling. This suggests that the inflammatory and gliosis 
responses in the hypothalamus may occur gradually in conditions of 
increased weight gain that are not due to ingestion of diets, such as those 
high in fats, that have direct effects on inflammatory processes and on 
glial cells. 
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7. Hypothalamic astrocytes respond differentially to palmitic acid and oleic 
acid, with oleic acid protecting against the inflammatory processes 
induced by palmitic acid. Thus, the harmful effects of a high fat diet will 
depend on the relative composition of the different fatty acids and not 
only the quantity.  
 
8. Higher circulating levels of estrogens in adult females can have protective 
effects on astrocytes against palmitic acid. 
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1. Machos y hembras responden de forma diferente al incremento de la 
ingesta de alimentos, incluso durante el periodo neonatal. Por 
consiguiente, las diferencias sexuales en el control metabólico no pueden 
atribuirse únicamente a las diferencias postpuberales en los niveles 
circulantes de esteroides gonadales.  
 
2. La sobrenutrición neonatal induce cambios significativos en los niveles 
circulantes de insulina, leptina y adiponectina durante un periodo crítico 
del desarrollo hipotalámico. Por tanto, las modificaciones en los niveles de 
estas hormonas, algunas de las cuales son conocidas por influenciar el 
desarrollo hipotalámico, podrían afectar los efectos metabólicos a largo 
plazo de la sobrenutrición temprana. 
 
3. Los cambios hormonales inducidos por la sobrenutrición difieren entre 
machos y hembras durante el periodo neonatal. El mayor incremento en 
insulina sérica, así como de los niveles de testosterona, en machos 
durante este periodo crítico de desarrollo, podría intervenir en la 
diferenciación de los efectos metabólicos a largo plazo observados entre 
ambos sexos.   
 
4. Los efectos a largo plazo de la sobrenutrición neonatal se modifican 
durante el desarrollo, siendo los machos más susceptibles a las 
alteraciones metabólicas durante la época adulta.  
 
5. El incremento de la ganancia ponderal durante el periodo perinatal no se 
asoció con ningún signo de inflamación sistémica. Este hecho podría 
deberse a la capacidad del tejido adiposo a expandirse debido a la 
hiperplasia durante el desarrollo temprano. Esta observación apoya el 
hecho de que la obesidad durante la infancia es diferente a la que se 
aprecia en adultos. 
 
6. El incremento del peso corporal en las ratas adultas se asoció con 
elevaciones significativas en los niveles hipotalámicos de citoquina TNFα y 
del marcador astroglial GFAP, así como del número de astrocitos GFAP+. 
No obstante, no se evidenció incremento de otros marcadores de la 
activación astrocítica, tales como vimentina, o marcadores de microglía o 
de señalización inflamatoria. Esto sugiere que las respuestas inflamatorias 
y de gliosis en el hipotálamo pueden acontecer gradualmente en 
situaciones de ganancia ponderal que no son debidas a la ingesta de 
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dietas, como es el caso de aquellas ricas en grasas, que tienen efectos 
directos sobre los procesos inflamatorios y sobre las células de la glía. 
 
7. Los astrocitos hipotalámicos responden de forma diferente a los ácidos 
palmítico y oleico. En efecto, el ácido oleico es capaz de proteger contra 
los procesos inflamatorios inducidos por el ácido palmítico. Por 
consiguiente, los efectos nocivos de una dieta con alto contenido graso, 
dependerán de la composición relativa de los diferentes ácidos grasos y 
no únicamente de su cantidad.  
 
8. Los niveles circulantes más elevados de estrógenos en las ratas hembra 
adultas pueden tener efectos protectores en los astrocitos contra el ácido 
palmítico. 
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